id	sid	tid	token	lemma	pos
ajlm-5	1	1	article	article	PROPN
ajlm-5	1	2	information	information	NOUN
ajlm-5	1	3	authors	author	NOUN
ajlm-5	1	4	:	:	PUNCT
ajlm-5	1	5	madisa	madisa	NOUN
ajlm-5	1	6	mine1,2	mine1,2	PROPN
ajlm-5	1	7	sikhulile	sikhulile	NOUN
ajlm-5	1	8	moyo2	moyo2	NOUN
ajlm-5	1	9	penny	penny	NOUN
ajlm-5	1	10	stevens3	stevens3	NOUN
ajlm-5	1	11	kurt	kurt	PROPN
ajlm-5	1	12	michael3	michael3	PROPN
ajlm-5	1	13	vladimir	vladimir	PROPN
ajlm-5	1	14	novitsky2,6	novitsky2,6	PROPN
ajlm-5	1	15	kgomotso	kgomotso	PROPN
ajlm-5	1	16	makhaola1,2	makhaola1,2	PROPN
ajlm-5	1	17	aida	aida	PROPN
ajlm-5	1	18	asmelash2	asmelash2	PROPN
ajlm-5	1	19	s’khatele	s’khatele	PROPN
ajlm-5	2	1	molefhabangwe2	molefhabangwe2	PROPN
ajlm-5	2	2	elias	elias	PROPN
ajlm-5	2	3	woldegabriel2	woldegabriel2	PROPN
ajlm-5	2	4	gaseboloke	gaseboloke	PROPN
ajlm-5	2	5	mothowaeng2	mothowaeng2	PROPN
ajlm-5	3	1	talkmore	talkmore	PROPN
ajlm-5	3	2	maruta2	maruta2	PROPN
ajlm-5	3	3	charity	charity	NOUN
ajlm-5	3	4	kamhukamwe1	kamhukamwe1	PROPN
ajlm-5	4	1	phibeon	phibeon	NOUN
ajlm-5	4	2	m.	m.	NOUN
ajlm-5	4	3	mangwendeza2	mangwendeza2	PROPN
ajlm-5	4	4	molly	molly	PROPN
ajlm-5	4	5	holmes	holmes	PROPN
ajlm-5	4	6	-	-	PUNCT
ajlm-5	4	7	pretorius6	pretorius6	NOUN
ajlm-5	4	8	isaac	isaac	PROPN
ajlm-5	4	9	mtoni1	mtoni1	PROPN
ajlm-5	4	10	modisa	modisa	PROPN
ajlm-5	4	11	motswaledi4	motswaledi4	PROPN
ajlm-5	5	1	rosemary	rosemary	ADJ
ajlm-5	5	2	musonda2	musonda2	PROPN
ajlm-5	6	1	ndwapi	ndwapi	PROPN
ajlm-5	6	2	ndwapi4	ndwapi4	PROPN
ajlm-5	6	3	joseph	joseph	PROPN
ajlm-5	6	4	makhema2	makhema2	PROPN
ajlm-5	6	5	richard	richard	PROPN
ajlm-5	6	6	marlink2,6	marlink2,6	PROPN
ajlm-5	6	7	khumo	khumo	PROPN
ajlm-5	6	8	seipone5	seipone5	NOUN
ajlm-5	6	9	tendani	tendani	PROPN
ajlm-5	6	10	gaolathe2	gaolathe2	PROPN
ajlm-5	6	11	max	max	PROPN
ajlm-5	6	12	essex2,6	essex2,6	PROPN
ajlm-5	6	13	affiliations	affiliation	NOUN
ajlm-5	6	14	:	:	PUNCT
ajlm-5	6	15	1national	1national	NUM
ajlm-5	6	16	health	health	NOUN
ajlm-5	6	17	laboratory	laboratory	NOUN
ajlm-5	6	18	,	,	PUNCT
ajlm-5	6	19	gaborone	gaborone	PROPN
ajlm-5	6	20	,	,	PUNCT
ajlm-5	6	21	botswana2botswana	botswana2botswana	PROPN
ajlm-5	6	22	-	-	PUNCT
ajlm-5	6	23	harvard	harvard	PROPN
ajlm-5	6	24	aids	aids	PROPN
ajlm-5	6	25	institute	institute	PROPN
ajlm-5	6	26	partnership	partnership	PROPN
ajlm-5	6	27	(	(	PUNCT
ajlm-5	6	28	bhp	bhp	PROPN
ajlm-5	6	29	)	)	PUNCT
ajlm-5	6	30	,	,	PUNCT
ajlm-5	6	31	princess	princess	PROPN
ajlm-5	6	32	marina	marina	PROPN
ajlm-5	6	33	hospital	hospital	PROPN
ajlm-5	6	34	,	,	PUNCT
ajlm-5	6	35	gaborone	gaborone	PROPN
ajlm-5	6	36	,	,	PUNCT
ajlm-5	6	37	botswana	botswana	PROPN
ajlm-5	6	38	3safety	3safety	NUM
ajlm-5	6	39	monitoring	monitoring	NOUN
ajlm-5	6	40	in	in	ADP
ajlm-5	6	41	international	international	ADJ
ajlm-5	6	42	laboratories	laboratory	NOUN
ajlm-5	6	43	(	(	PUNCT
ajlm-5	6	44	smile	smile	NOUN
ajlm-5	6	45	)	)	PUNCT
ajlm-5	6	46	,	,	PUNCT
ajlm-5	6	47	johns	johns	PROPN
ajlm-5	6	48	hopkins	hopkins	PROPN
ajlm-5	6	49	university	university	PROPN
ajlm-5	6	50	,	,	PUNCT
ajlm-5	6	51	baltimore	baltimore	PROPN
ajlm-5	6	52	,	,	PUNCT
ajlm-5	6	53	maryland	maryland	PROPN
ajlm-5	6	54	,	,	PUNCT
ajlm-5	6	55	united	united	PROPN
ajlm-5	6	56	states	states	PROPN
ajlm-5	6	57	4department	4department	NUM
ajlm-5	6	58	of	of	ADP
ajlm-5	6	59	clinical	clinical	ADJ
ajlm-5	6	60	services	service	NOUN
ajlm-5	6	61	,	,	PUNCT
ajlm-5	6	62	ministry	ministry	PROPN
ajlm-5	6	63	of	of	ADP
ajlm-5	6	64	health	health	PROPN
ajlm-5	6	65	,	,	PUNCT
ajlm-5	6	66	gaborone	gaborone	PROPN
ajlm-5	6	67	,	,	PUNCT
ajlm-5	6	68	botswana	botswana	PROPN
ajlm-5	6	69	5department	5department	NUM
ajlm-5	6	70	of	of	ADP
ajlm-5	6	71	hiv	hiv	PROPN
ajlm-5	6	72	/	/	SYM
ajlm-5	6	73	aids	aids	PROPN
ajlm-5	6	74	prevention	prevention	NOUN
ajlm-5	6	75	and	and	CCONJ
ajlm-5	6	76	care	care	NOUN
ajlm-5	6	77	,	,	PUNCT
ajlm-5	6	78	ministry	ministry	PROPN
ajlm-5	6	79	of	of	ADP
ajlm-5	6	80	health	health	PROPN
ajlm-5	6	81	,	,	PUNCT
ajlm-5	6	82	gaborone	gaborone	PROPN
ajlm-5	6	83	,	,	PUNCT
ajlm-5	6	84	botswana	botswana	PROPN
ajlm-5	6	85	6harvard	6harvard	NUM
ajlm-5	6	86	school	school	NOUN
ajlm-5	6	87	of	of	ADP
ajlm-5	6	88	public	public	ADJ
ajlm-5	6	89	health	health	NOUN
ajlm-5	6	90	,	,	PUNCT
ajlm-5	6	91	boston	boston	PROPN
ajlm-5	6	92	,	,	PUNCT
ajlm-5	6	93	massachusetts	massachusetts	PROPN
ajlm-5	6	94	,	,	PUNCT
ajlm-5	6	95	united	united	PROPN
ajlm-5	6	96	states	states	PROPN
ajlm-5	6	97	correspondence	correspondence	NOUN
ajlm-5	6	98	to	to	PART
ajlm-5	6	99	:	:	PUNCT
ajlm-5	6	100	madisa	madisa	VERB
ajlm-5	6	101	mine	mine	PRON
ajlm-5	6	102	postal	postal	ADJ
ajlm-5	6	103	address	address	NOUN
ajlm-5	6	104	:	:	PUNCT
ajlm-5	6	105	5353	5353	NUM
ajlm-5	6	106	church	church	NOUN
ajlm-5	6	107	road	road	NOUN
ajlm-5	6	108	,	,	PUNCT
ajlm-5	6	109	extension	extension	NOUN
ajlm-5	6	110	10	10	NUM
ajlm-5	6	111	,	,	PUNCT
ajlm-5	6	112	gaborone	gaborone	PROPN
ajlm-5	6	113	,	,	PUNCT
ajlm-5	6	114	botswana	botswana	PROPN
ajlm-5	6	115	dates	date	NOUN
ajlm-5	6	116	:	:	PUNCT
ajlm-5	6	117	received	receive	VERB
ajlm-5	6	118	:	:	PUNCT
ajlm-5	6	119	15	15	NUM
ajlm-5	6	120	june	june	PROPN
ajlm-5	6	121	2011	2011	NUM
ajlm-5	6	122	accepted	accept	VERB
ajlm-5	6	123	:	:	PUNCT
ajlm-5	6	124	11	11	NUM
ajlm-5	6	125	nov	nov	NOUN
ajlm-5	6	126	.	.	PROPN
ajlm-5	6	127	2011	2011	NUM
ajlm-5	6	128	published	publish	VERB
ajlm-5	6	129	:	:	PUNCT
ajlm-5	6	130	15	15	NUM
ajlm-5	6	131	dec	dec	PROPN
ajlm-5	6	132	.	.	PROPN
ajlm-5	6	133	2011	2011	NUM
ajlm-5	6	134	how	how	SCONJ
ajlm-5	6	135	to	to	PART
ajlm-5	6	136	cite	cite	VERB
ajlm-5	6	137	this	this	DET
ajlm-5	6	138	article	article	NOUN
ajlm-5	6	139	:	:	PUNCT
ajlm-5	6	140	how	how	SCONJ
ajlm-5	6	141	to	to	PART
ajlm-5	6	142	cite	cite	VERB
ajlm-5	6	143	this	this	DET
ajlm-5	6	144	article	article	NOUN
ajlm-5	6	145	:	:	PUNCT
ajlm-5	6	146	mine	mine	PROPN
ajlm-5	6	147	m	m	PROPN
ajlm-5	6	148	,	,	PUNCT
ajlm-5	6	149	moyo	moyo	PROPN
ajlm-5	6	150	s	s	PART
ajlm-5	6	151	,	,	PUNCT
ajlm-5	6	152	stevens	stevens	PROPN
ajlm-5	6	153	p	p	X
ajlm-5	6	154	,	,	PUNCT
ajlm-5	6	155	et	et	PROPN
ajlm-5	6	156	al	al	PROPN
ajlm-5	6	157	.	.	PUNCT
ajlm-5	7	1	immunohaematological	immunohaematological	ADJ
ajlm-5	7	2	reference	reference	NOUN
ajlm-5	7	3	values	value	NOUN
ajlm-5	7	4	for	for	ADP
ajlm-5	7	5	hiv	hiv	NOUN
ajlm-5	7	6	-	-	PUNCT
ajlm-5	7	7	negative	negative	ADJ
ajlm-5	7	8	healthy	healthy	ADJ
ajlm-5	7	9	adults	adult	NOUN
ajlm-5	7	10	in	in	ADP
ajlm-5	7	11	botswana	botswana	PROPN
ajlm-5	7	12	.	.	PUNCT
ajlm-5	8	1	afr	afr	PROPN
ajlm-5	8	2	j	j	PROPN
ajlm-5	8	3	lab	lab	PROPN
ajlm-5	8	4	med	med	PROPN
ajlm-5	8	5	.	.	PUNCT
ajlm-5	9	1	2011;1(1	2011;1(1	NUM
ajlm-5	9	2	)	)	PUNCT
ajlm-5	9	3	,	,	PUNCT
ajlm-5	9	4	art	art	NOUN
ajlm-5	9	5	.	.	PUNCT
ajlm-5	10	1	#	#	SYM
ajlm-5	10	2	5	5	NUM
ajlm-5	10	3	,	,	PUNCT
ajlm-5	10	4	7	7	NUM
ajlm-5	10	5	pages	page	NOUN
ajlm-5	10	6	.	.	PUNCT
ajlm-5	11	1	http://dx.doi.org/10.4102/	http://dx.doi.org/10.4102/	NUM
ajlm-5	11	2	ajlm.v1i1.5	ajlm.v1i1.5	PRON
ajlm-5	11	3	copyright	copyright	NOUN
ajlm-5	11	4	notice	notice	NOUN
ajlm-5	11	5	:	:	PUNCT
ajlm-5	11	6	©	©	PROPN
ajlm-5	11	7	2012	2012	NUM
ajlm-5	11	8	.	.	PUNCT
ajlm-5	12	1	the	the	DET
ajlm-5	12	2	authors	author	NOUN
ajlm-5	12	3	.	.	PUNCT
ajlm-5	13	1	licensee	licensee	NOUN
ajlm-5	13	2	:	:	PUNCT
ajlm-5	13	3	aosis	aosis	NOUN
ajlm-5	13	4	openjournals	openjournal	NOUN
ajlm-5	13	5	.	.	PUNCT
ajlm-5	14	1	this	this	PRON
ajlm-5	14	2	is	be	AUX
ajlm-5	14	3	an	an	DET
ajlm-5	14	4	open	open	ADJ
ajlm-5	14	5	access	access	NOUN
ajlm-5	14	6	article	article	NOUN
ajlm-5	14	7	distributed	distribute	VERB
ajlm-5	14	8	under	under	ADP
ajlm-5	14	9	the	the	DET
ajlm-5	14	10	terms	term	NOUN
ajlm-5	14	11	of	of	ADP
ajlm-5	14	12	the	the	DET
ajlm-5	14	13	creative	creative	ADJ
ajlm-5	14	14	commons	common	NOUN
ajlm-5	14	15	attribution	attribution	NOUN
ajlm-5	14	16	license	license	NOUN
ajlm-5	14	17	,	,	PUNCT
ajlm-5	14	18	which	which	PRON
ajlm-5	14	19	permits	permit	VERB
ajlm-5	14	20	unrestricted	unrestricted	ADJ
ajlm-5	14	21	use	use	NOUN
ajlm-5	14	22	,	,	PUNCT
ajlm-5	14	23	distribution	distribution	NOUN
ajlm-5	14	24	,	,	PUNCT
ajlm-5	14	25	and	and	CCONJ
ajlm-5	14	26	reproduction	reproduction	NOUN
ajlm-5	14	27	in	in	ADP
ajlm-5	14	28	any	any	DET
ajlm-5	14	29	medium	medium	NOUN
ajlm-5	14	30	,	,	PUNCT
ajlm-5	14	31	provided	provide	VERB
ajlm-5	14	32	the	the	DET
ajlm-5	14	33	original	original	ADJ
ajlm-5	14	34	work	work	NOUN
ajlm-5	14	35	is	be	AUX
ajlm-5	14	36	properly	properly	ADV
ajlm-5	14	37	cited	cite	VERB
ajlm-5	14	38	.	.	PUNCT
ajlm-5	15	1	immunohaematological	immunohaematological	ADJ
ajlm-5	15	2	reference	reference	NOUN
ajlm-5	15	3	values	value	NOUN
ajlm-5	15	4	for	for	ADP
ajlm-5	15	5	hiv	hiv	NOUN
ajlm-5	15	6	-	-	PUNCT
ajlm-5	15	7	negative	negative	ADJ
ajlm-5	15	8	healthy	healthy	ADJ
ajlm-5	15	9	adults	adult	NOUN
ajlm-5	15	10	in	in	ADP
ajlm-5	15	11	botswana	botswana	PROPN
ajlm-5	15	12	in	in	ADP
ajlm-5	15	13	this	this	DET
ajlm-5	15	14	original	original	ADJ
ajlm-5	15	15	research	research	NOUN
ajlm-5	15	16	...	...	PUNCT
ajlm-5	15	17	open	open	ADJ
ajlm-5	15	18	access	access	NOUN
ajlm-5	15	19	•	•	ADP
ajlm-5	15	20	abstract	abstract	ADJ
ajlm-5	15	21	•	•	NUM
ajlm-5	15	22	introduction	introduction	NOUN
ajlm-5	15	23	•	•	NOUN
ajlm-5	15	24	materials	material	NOUN
ajlm-5	15	25	and	and	CCONJ
ajlm-5	15	26	methods	method	NOUN
ajlm-5	15	27	   	   	SPACE
ajlm-5	15	28	•	•	NUM
ajlm-5	15	29	study	study	NOUN
ajlm-5	15	30	design	design	NOUN
ajlm-5	15	31	,	,	PUNCT
ajlm-5	15	32	setting	set	VERB
ajlm-5	15	33	and	and	CCONJ
ajlm-5	15	34	population	population	NOUN
ajlm-5	15	35	   	   	SPACE
ajlm-5	15	36	•	•	NUM
ajlm-5	15	37	study	study	NOUN
ajlm-5	15	38	procedures	procedure	NOUN
ajlm-5	15	39	•	•	VERB
ajlm-5	15	40	laboratory	laboratory	NOUN
ajlm-5	15	41	procedures	procedure	NOUN
ajlm-5	15	42	   	   	SPACE
ajlm-5	15	43	•	•	NUM
ajlm-5	15	44	blood	blood	NOUN
ajlm-5	15	45	collection	collection	NOUN
ajlm-5	15	46	and	and	CCONJ
ajlm-5	15	47	hiv	hiv	PROPN
ajlm-5	15	48	serology	serology	NOUN
ajlm-5	15	49	   	   	SPACE
ajlm-5	15	50	•	•	NUM
ajlm-5	15	51	flow	flow	NOUN
ajlm-5	15	52	cytometric	cytometric	ADJ
ajlm-5	15	53	analysis	analysis	NOUN
ajlm-5	15	54	   	   	SPACE
ajlm-5	15	55	•	•	CCONJ
ajlm-5	15	56	haematological	haematological	ADJ
ajlm-5	15	57	analysis	analysis	NOUN
ajlm-5	15	58	•	•	ADP
ajlm-5	15	59	ethical	ethical	ADJ
ajlm-5	15	60	considerations	consideration	NOUN
ajlm-5	15	61	   	   	SPACE
ajlm-5	15	62	•	•	NUM
ajlm-5	15	63	statistical	statistical	ADJ
ajlm-5	15	64	analysis	analysis	NOUN
ajlm-5	15	65	•	•	NOUN
ajlm-5	15	66	results	result	VERB
ajlm-5	15	67	•	•	DET
ajlm-5	15	68	discussion	discussion	NOUN
ajlm-5	15	69	   	   	SPACE
ajlm-5	15	70	•	•	NUM
ajlm-5	15	71	limitations	limitation	NOUN
ajlm-5	15	72	of	of	ADP
ajlm-5	15	73	the	the	DET
ajlm-5	15	74	study	study	NOUN
ajlm-5	15	75	•	•	NUM
ajlm-5	15	76	conclusion	conclusion	NOUN
ajlm-5	15	77	•	•	NUM
ajlm-5	15	78	acknowledgements	acknowledgement	NOUN
ajlm-5	15	79	   	   	SPACE
ajlm-5	15	80	•	•	NOUN
ajlm-5	15	81	competing	compete	VERB
ajlm-5	15	82	interests	interest	NOUN
ajlm-5	15	83	   	   	SPACE
ajlm-5	15	84	•	•	NUM
ajlm-5	15	85	authors	author	NOUN
ajlm-5	15	86	’	'	PUNCT
ajlm-5	15	87	contributions	contribution	NOUN
ajlm-5	15	88	•	•	NUM
ajlm-5	15	89	references	reference	NOUN
ajlm-5	15	90	abstract	abstract	ADJ
ajlm-5	15	91	top	top	PROPN
ajlm-5	15	92	↑	↑	PROPN
ajlm-5	15	93	background	background	NOUN
ajlm-5	15	94	:	:	PUNCT
ajlm-5	15	95	clinical	clinical	ADJ
ajlm-5	15	96	laboratories	laboratory	NOUN
ajlm-5	15	97	in	in	ADP
ajlm-5	15	98	botswana	botswana	PROPN
ajlm-5	15	99	have	have	AUX
ajlm-5	15	100	relied	rely	VERB
ajlm-5	15	101	entirely	entirely	ADV
ajlm-5	15	102	on	on	ADP
ajlm-5	15	103	the	the	DET
ajlm-5	15	104	reference	reference	NOUN
ajlm-5	15	105	intervals	interval	NOUN
ajlm-5	15	106	for	for	ADP
ajlm-5	15	107	normal	normal	ADJ
ajlm-5	15	108	immunohaematological	immunohaematological	ADJ
ajlm-5	15	109	values	value	NOUN
ajlm-5	15	110	provided	provide	VERB
ajlm-5	15	111	by	by	ADP
ajlm-5	15	112	manufacturers	manufacturer	NOUN
ajlm-5	15	113	’	’	PART
ajlm-5	15	114	kits	kit	NOUN
ajlm-5	15	115	and	and	CCONJ
ajlm-5	15	116	textbooks.objectives	textbooks.objective	NOUN
ajlm-5	15	117	:	:	PUNCT
ajlm-5	15	118	the	the	DET
ajlm-5	15	119	aim	aim	NOUN
ajlm-5	15	120	of	of	ADP
ajlm-5	15	121	this	this	DET
ajlm-5	15	122	study	study	NOUN
ajlm-5	15	123	was	be	AUX
ajlm-5	15	124	to	to	PART
ajlm-5	15	125	determine	determine	VERB
ajlm-5	15	126	the	the	DET
ajlm-5	15	127	means	mean	NOUN
ajlm-5	15	128	,	,	PUNCT
ajlm-5	15	129	medians	median	NOUN
ajlm-5	15	130	,	,	PUNCT
ajlm-5	15	131	2.5th	2.5th	NUM
ajlm-5	15	132	and	and	CCONJ
ajlm-5	15	133	97.5th	97.5th	ADJ
ajlm-5	15	134	percentile	percentile	ADJ
ajlm-5	15	135	reference	reference	NOUN
ajlm-5	15	136	intervals	interval	NOUN
ajlm-5	15	137	,	,	PUNCT
ajlm-5	15	138	for	for	ADP
ajlm-5	15	139	normal	normal	ADJ
ajlm-5	15	140	immunohaematological	immunohaematological	ADJ
ajlm-5	15	141	values	value	NOUN
ajlm-5	15	142	in	in	ADP
ajlm-5	15	143	healthy	healthy	ADJ
ajlm-5	15	144	adults	adult	NOUN
ajlm-5	15	145	in	in	ADP
ajlm-5	15	146	botswana	botswana	PROPN
ajlm-5	15	147	.	.	PROPN
ajlm-5	16	1	method	method	PROPN
ajlm-5	16	2	:	:	PUNCT
ajlm-5	16	3	a	a	DET
ajlm-5	16	4	total	total	NOUN
ajlm-5	16	5	of	of	ADP
ajlm-5	16	6	261	261	NUM
ajlm-5	16	7	healthy	healthy	ADJ
ajlm-5	16	8	participants	participant	NOUN
ajlm-5	16	9	comprising	comprise	VERB
ajlm-5	16	10	126	126	NUM
ajlm-5	16	11	men	man	NOUN
ajlm-5	16	12	(	(	PUNCT
ajlm-5	16	13	48	48	NUM
ajlm-5	16	14	%	%	NOUN
ajlm-5	16	15	)	)	PUNCT
ajlm-5	16	16	and	and	CCONJ
ajlm-5	16	17	135	135	NUM
ajlm-5	16	18	(	(	PUNCT
ajlm-5	16	19	52	52	NUM
ajlm-5	16	20	%	%	NOUN
ajlm-5	16	21	)	)	PUNCT
ajlm-5	16	22	women	woman	NOUN
ajlm-5	16	23	were	be	AUX
ajlm-5	16	24	enrolled	enrol	VERB
ajlm-5	16	25	in	in	ADP
ajlm-5	16	26	the	the	DET
ajlm-5	16	27	southern	southern	ADJ
ajlm-5	16	28	part	part	NOUN
ajlm-5	16	29	of	of	ADP
ajlm-5	16	30	botswana	botswana	PROPN
ajlm-5	16	31	,	,	PUNCT
ajlm-5	16	32	and	and	CCONJ
ajlm-5	16	33	immunological	immunological	ADJ
ajlm-5	16	34	and	and	CCONJ
ajlm-5	16	35	haematological	haematological	ADJ
ajlm-5	16	36	laboratory	laboratory	NOUN
ajlm-5	16	37	parameters	parameter	NOUN
ajlm-5	16	38	were	be	AUX
ajlm-5	16	39	measured	measure	VERB
ajlm-5	16	40	.	.	PUNCT
ajlm-5	17	1	results	result	NOUN
ajlm-5	17	2	:	:	PUNCT
ajlm-5	17	3	the	the	DET
ajlm-5	17	4	mean	mean	ADJ
ajlm-5	17	5	age	age	NOUN
ajlm-5	17	6	was	be	AUX
ajlm-5	17	7	28.8	28.8	NUM
ajlm-5	17	8	(	(	PUNCT
ajlm-5	17	9	95	95	NUM
ajlm-5	17	10	%	%	NOUN
ajlm-5	17	11	confidence	confidence	NOUN
ajlm-5	17	12	interval	interval	NOUN
ajlm-5	18	1	[	[	X
ajlm-5	18	2	ci	ci	X
ajlm-5	18	3	]	]	X
ajlm-5	18	4	27.7–29.8	27.7–29.8	NUM
ajlm-5	18	5	)	)	PUNCT
ajlm-5	18	6	 	 	SPACE
ajlm-5	18	7	years	year	NOUN
ajlm-5	18	8	,	,	PUNCT
ajlm-5	18	9	with	with	ADP
ajlm-5	18	10	a	a	DET
ajlm-5	18	11	median	median	NOUN
ajlm-5	18	12	of	of	ADP
ajlm-5	18	13	27	27	NUM
ajlm-5	18	14	 	 	SPACE
ajlm-5	18	15	years	year	NOUN
ajlm-5	18	16	and	and	CCONJ
ajlm-5	18	17	a	a	DET
ajlm-5	18	18	range	range	NOUN
ajlm-5	18	19	18–66	18–66	NUM
ajlm-5	18	20	 	 	SPACE
ajlm-5	18	21	years	year	NOUN
ajlm-5	18	22	.	.	PUNCT
ajlm-5	19	1	the	the	DET
ajlm-5	19	2	mean	mean	ADJ
ajlm-5	19	3	haemoglobin	haemoglobin	NOUN
ajlm-5	19	4	level	level	NOUN
ajlm-5	19	5	was	be	AUX
ajlm-5	19	6	significantly	significantly	ADV
ajlm-5	19	7	lower	low	ADJ
ajlm-5	19	8	for	for	ADP
ajlm-5	19	9	women	woman	NOUN
ajlm-5	19	10	(	(	PUNCT
ajlm-5	19	11	12.4	12.4	NUM
ajlm-5	19	12	 	 	SPACE
ajlm-5	19	13	g	g	PROPN
ajlm-5	19	14	/	/	SYM
ajlm-5	19	15	dl	dl	PROPN
ajlm-5	19	16	;	;	PUNCT
ajlm-5	19	17	95	95	NUM
ajlm-5	19	18	%	%	NOUN
ajlm-5	19	19	ci	ci	NOUN
ajlm-5	19	20	12.1	12.1	NUM
ajlm-5	19	21	%	%	NOUN
ajlm-5	19	22	–	–	PUNCT
ajlm-5	19	23	12.7	12.7	NUM
ajlm-5	19	24	%	%	NOUN
ajlm-5	19	25	)	)	PUNCT
ajlm-5	19	26	than	than	ADP
ajlm-5	19	27	men	man	NOUN
ajlm-5	19	28	(	(	PUNCT
ajlm-5	19	29	15.1	15.1	NUM
ajlm-5	19	30	 	 	SPACE
ajlm-5	19	31	g	g	PROPN
ajlm-5	19	32	/	/	SYM
ajlm-5	19	33	dl	dl	PROPN
ajlm-5	19	34	;	;	PUNCT
ajlm-5	19	35	95	95	NUM
ajlm-5	19	36	%	%	NOUN
ajlm-5	19	37	ci	ci	NOUN
ajlm-5	19	38	14.9	14.9	NUM
ajlm-5	19	39	%	%	NOUN
ajlm-5	19	40	–	–	PUNCT
ajlm-5	19	41	15.3	15.3	NUM
ajlm-5	19	42	%	%	NOUN
ajlm-5	19	43	)	)	PUNCT
ajlm-5	19	44	.	.	PUNCT
ajlm-5	20	1	the	the	DET
ajlm-5	20	2	women	woman	NOUN
ajlm-5	20	3	’s	’s	PART
ajlm-5	20	4	haemoglobin	haemoglobin	PROPN
ajlm-5	20	5	reference	reference	NOUN
ajlm-5	20	6	values	value	NOUN
ajlm-5	20	7	(	(	PUNCT
ajlm-5	20	8	9.0	9.0	NUM
ajlm-5	20	9	 	 	SPACE
ajlm-5	20	10	g	g	PROPN
ajlm-5	20	11	/	/	SYM
ajlm-5	20	12	dl	dl	PROPN
ajlm-5	20	13	–	–	PUNCT
ajlm-5	20	14	15.0	15.0	NUM
ajlm-5	20	15	 	 	SPACE
ajlm-5	20	16	g	g	PROPN
ajlm-5	20	17	/	/	SYM
ajlm-5	20	18	dl	dl	NOUN
ajlm-5	20	19	)	)	PUNCT
ajlm-5	20	20	levels	level	NOUN
ajlm-5	20	21	were	be	AUX
ajlm-5	20	22	lower	low	ADJ
ajlm-5	20	23	than	than	SCONJ
ajlm-5	20	24	observed	observe	VERB
ajlm-5	20	25	in	in	ADP
ajlm-5	20	26	predominantly	predominantly	ADV
ajlm-5	20	27	white	white	ADJ
ajlm-5	20	28	populations	population	NOUN
ajlm-5	20	29	(	(	PUNCT
ajlm-5	20	30	12.0	12.0	NUM
ajlm-5	20	31	 	 	SPACE
ajlm-5	20	32	g	g	PROPN
ajlm-5	20	33	/	/	SYM
ajlm-5	20	34	dl	dl	PROPN
ajlm-5	20	35	–	–	PUNCT
ajlm-5	20	36	16.0	16.0	NUM
ajlm-5	20	37	 	 	SPACE
ajlm-5	20	38	g	g	PROPN
ajlm-5	20	39	/	/	SYM
ajlm-5	20	40	dl	dl	PROPN
ajlm-5	20	41	)	)	PUNCT
ajlm-5	20	42	,	,	PUNCT
ajlm-5	20	43	but	but	CCONJ
ajlm-5	20	44	comparable	comparable	ADJ
ajlm-5	20	45	with	with	ADP
ajlm-5	20	46	regional	regional	ADJ
ajlm-5	20	47	consensus	consensus	NOUN
ajlm-5	20	48	reference	reference	NOUN
ajlm-5	20	49	intervals	interval	NOUN
ajlm-5	20	50	(	(	PUNCT
ajlm-5	20	51	9.5	9.5	NUM
ajlm-5	20	52	 	 	SPACE
ajlm-5	20	53	g	g	PROPN
ajlm-5	20	54	/	/	SYM
ajlm-5	20	55	dl	dl	PROPN
ajlm-5	20	56	–	–	PUNCT
ajlm-5	20	57	15.8	15.8	NUM
ajlm-5	20	58	 	 	SPACE
ajlm-5	20	59	g	g	PROPN
ajlm-5	20	60	/	/	SYM
ajlm-5	20	61	dl	dl	PROPN
ajlm-5	20	62	)	)	PUNCT
ajlm-5	20	63	recently	recently	ADV
ajlm-5	20	64	defined	define	VERB
ajlm-5	20	65	for	for	ADP
ajlm-5	20	66	east	east	ADJ
ajlm-5	20	67	and	and	CCONJ
ajlm-5	20	68	southern	southern	PROPN
ajlm-5	20	69	africa	africa	PROPN
ajlm-5	20	70	.	.	PUNCT
ajlm-5	21	1	conclusion	conclusion	NOUN
ajlm-5	21	2	:	:	PUNCT
ajlm-5	21	3	the	the	DET
ajlm-5	21	4	established	establish	VERB
ajlm-5	21	5	values	value	NOUN
ajlm-5	21	6	provide	provide	VERB
ajlm-5	21	7	an	an	DET
ajlm-5	21	8	important	important	ADJ
ajlm-5	21	9	tool	tool	NOUN
ajlm-5	21	10	for	for	ADP
ajlm-5	21	11	patient	patient	ADJ
ajlm-5	21	12	management	management	NOUN
ajlm-5	21	13	and	and	CCONJ
ajlm-5	21	14	could	could	AUX
ajlm-5	21	15	influence	influence	VERB
ajlm-5	21	16	decisions	decision	NOUN
ajlm-5	21	17	on	on	ADP
ajlm-5	21	18	inclusion	inclusion	NOUN
ajlm-5	21	19	of	of	ADP
ajlm-5	21	20	participants	participant	NOUN
ajlm-5	21	21	and	and	CCONJ
ajlm-5	21	22	adverse	adverse	ADJ
ajlm-5	21	23	events	event	NOUN
ajlm-5	21	24	in	in	ADP
ajlm-5	21	25	clinical	clinical	ADJ
ajlm-5	21	26	trials	trial	NOUN
ajlm-5	21	27	conducted	conduct	VERB
ajlm-5	21	28	locally	locally	ADV
ajlm-5	21	29	.	.	PUNCT
ajlm-5	22	1	introduction	introduction	NOUN
ajlm-5	22	2	top	top	PROPN
ajlm-5	22	3	↑	↑	PROPN
ajlm-5	22	4	the	the	DET
ajlm-5	22	5	human	human	ADJ
ajlm-5	22	6	immunodeficiency	immunodeficiency	NOUN
ajlm-5	22	7	virus	virus	NOUN
ajlm-5	22	8	(	(	PUNCT
ajlm-5	22	9	hiv	hiv	PROPN
ajlm-5	22	10	)	)	PUNCT
ajlm-5	22	11	constitutes	constitute	VERB
ajlm-5	22	12	a	a	DET
ajlm-5	22	13	major	major	ADJ
ajlm-5	22	14	public	public	ADJ
ajlm-5	22	15	health	health	NOUN
ajlm-5	22	16	problem	problem	NOUN
ajlm-5	22	17	in	in	ADP
ajlm-5	22	18	botswana	botswana	PROPN
ajlm-5	22	19	with	with	ADP
ajlm-5	22	20	a	a	DET
ajlm-5	22	21	prevalence	prevalence	NOUN
ajlm-5	22	22	of	of	ADP
ajlm-5	22	23	17.6	17.6	NUM
ajlm-5	22	24	%	%	NOUN
ajlm-5	22	25	1	1	NUM
ajlm-5	22	26	in	in	ADP
ajlm-5	22	27	the	the	DET
ajlm-5	22	28	general	general	ADJ
ajlm-5	22	29	population	population	NOUN
ajlm-5	22	30	and	and	CCONJ
ajlm-5	22	31	31.8	31.8	NUM
ajlm-5	22	32	%	%	NOUN
ajlm-5	22	33	amongst	amongst	ADP
ajlm-5	22	34	pregnant	pregnant	PROPN
ajlm-5	22	35	woman.2,3	woman.2,3	PROPN
ajlm-5	22	36	botswana	botswana	PROPN
ajlm-5	22	37	is	be	AUX
ajlm-5	22	38	one	one	NUM
ajlm-5	22	39	of	of	ADP
ajlm-5	22	40	the	the	DET
ajlm-5	22	41	countries	country	NOUN
ajlm-5	22	42	in	in	ADP
ajlm-5	22	43	africa	africa	PROPN
ajlm-5	22	44	that	that	PRON
ajlm-5	22	45	has	have	AUX
ajlm-5	22	46	led	lead	VERB
ajlm-5	22	47	a	a	DET
ajlm-5	22	48	very	very	ADV
ajlm-5	22	49	high	high	ADJ
ajlm-5	22	50	response	response	NOUN
ajlm-5	22	51	to	to	ADP
ajlm-5	22	52	the	the	DET
ajlm-5	22	53	epidemic	epidemic	NOUN
ajlm-5	22	54	through	through	ADP
ajlm-5	22	55	a	a	DET
ajlm-5	22	56	range	range	NOUN
ajlm-5	22	57	of	of	ADP
ajlm-5	22	58	multilevel	multilevel	ADJ
ajlm-5	22	59	interventions	intervention	NOUN
ajlm-5	22	60	,	,	PUNCT
ajlm-5	22	61	including	include	VERB
ajlm-5	22	62	the	the	DET
ajlm-5	22	63	widespread	widespread	ADJ
ajlm-5	22	64	access	access	NOUN
ajlm-5	22	65	to	to	ADP
ajlm-5	22	66	antiretrovirals	antiretroviral	NOUN
ajlm-5	22	67	(	(	PUNCT
ajlm-5	22	68	arvs),4,5	arvs),4,5	NUM
ajlm-5	22	69	and	and	CCONJ
ajlm-5	22	70	has	have	AUX
ajlm-5	22	71	built	build	VERB
ajlm-5	22	72	capacity	capacity	NOUN
ajlm-5	22	73	to	to	PART
ajlm-5	22	74	conduct	conduct	VERB
ajlm-5	22	75	international	international	ADJ
ajlm-5	22	76	prevention	prevention	NOUN
ajlm-5	22	77	,	,	PUNCT
ajlm-5	22	78	treatment	treatment	NOUN
ajlm-5	22	79	and	and	CCONJ
ajlm-5	22	80	vaccine	vaccine	NOUN
ajlm-5	22	81	trials.6	trials.6	PROPN
ajlm-5	22	82	a	a	DET
ajlm-5	22	83	valid	valid	ADJ
ajlm-5	22	84	scientific	scientific	ADJ
ajlm-5	22	85	safety	safety	NOUN
ajlm-5	22	86	evaluation	evaluation	NOUN
ajlm-5	22	87	of	of	ADP
ajlm-5	22	88	arvs	arvs	NOUN
ajlm-5	22	89	and	and	CCONJ
ajlm-5	22	90	hiv	hiv	PROPN
ajlm-5	22	91	vaccines	vaccine	NOUN
ajlm-5	22	92	relies	rely	VERB
ajlm-5	22	93	on	on	ADP
ajlm-5	22	94	the	the	DET
ajlm-5	22	95	availability	availability	NOUN
ajlm-5	22	96	of	of	ADP
ajlm-5	22	97	locally	locally	ADV
ajlm-5	22	98	defined	define	VERB
ajlm-5	22	99	reference	reference	NOUN
ajlm-5	22	100	values	value	NOUN
ajlm-5	22	101	for	for	ADP
ajlm-5	22	102	parameters	parameter	NOUN
ajlm-5	22	103	of	of	ADP
ajlm-5	22	104	clinical	clinical	ADJ
ajlm-5	22	105	interest.7reference	interest.7reference	NOUN
ajlm-5	22	106	intervals	interval	NOUN
ajlm-5	22	107	are	be	AUX
ajlm-5	22	108	essential	essential	ADJ
ajlm-5	22	109	for	for	ADP
ajlm-5	22	110	monitoring	monitor	VERB
ajlm-5	22	111	patho	patho	NOUN
ajlm-5	22	112	-	-	PUNCT
ajlm-5	22	113	physiological	physiological	ADJ
ajlm-5	22	114	changes	change	NOUN
ajlm-5	22	115	after	after	ADP
ajlm-5	22	116	infection	infection	NOUN
ajlm-5	22	117	or	or	CCONJ
ajlm-5	22	118	disease	disease	NOUN
ajlm-5	22	119	states	state	NOUN
ajlm-5	22	120	,	,	PUNCT
ajlm-5	22	121	or	or	CCONJ
ajlm-5	22	122	following	follow	VERB
ajlm-5	22	123	the	the	DET
ajlm-5	22	124	administration	administration	NOUN
ajlm-5	22	125	of	of	ADP
ajlm-5	22	126	drugs	drug	NOUN
ajlm-5	22	127	in	in	ADP
ajlm-5	22	128	therapeutic	therapeutic	ADJ
ajlm-5	22	129	or	or	CCONJ
ajlm-5	22	130	clinical	clinical	ADJ
ajlm-5	22	131	interventions	intervention	NOUN
ajlm-5	22	132	and	and	CCONJ
ajlm-5	22	133	vaccine	vaccine	NOUN
ajlm-5	22	134	studies	study	NOUN
ajlm-5	22	135	.	.	PUNCT
ajlm-5	23	1	several	several	ADJ
ajlm-5	23	2	multicenter	multicenter	ADJ
ajlm-5	23	3	trials	trial	NOUN
ajlm-5	23	4	,	,	PUNCT
ajlm-5	23	5	including	include	VERB
ajlm-5	23	6	phase	phase	NOUN
ajlm-5	23	7	i	i	PRON
ajlm-5	23	8	and/or	and/or	CCONJ
ajlm-5	23	9	phase	phase	NOUN
ajlm-5	23	10	ii	ii	NOUN
ajlm-5	23	11	vaccine	vaccine	NOUN
ajlm-5	23	12	studies	study	NOUN
ajlm-5	23	13	and	and	CCONJ
ajlm-5	23	14	global	global	ADJ
ajlm-5	23	15	use	use	NOUN
ajlm-5	23	16	of	of	ADP
ajlm-5	23	17	arvs	arvs	NOUN
ajlm-5	23	18	,	,	PUNCT
ajlm-5	23	19	have	have	AUX
ajlm-5	23	20	increased	increase	VERB
ajlm-5	23	21	the	the	DET
ajlm-5	23	22	need	need	NOUN
ajlm-5	23	23	for	for	ADP
ajlm-5	23	24	regional	regional	ADJ
ajlm-5	23	25	and	and	CCONJ
ajlm-5	23	26	locally	locally	ADV
ajlm-5	23	27	established	establish	VERB
ajlm-5	23	28	reference	reference	NOUN
ajlm-5	23	29	values.8	values.8	PROPN
ajlm-5	23	30	reference	reference	NOUN
ajlm-5	23	31	values	value	NOUN
ajlm-5	23	32	vary	vary	VERB
ajlm-5	23	33	considerably	considerably	ADV
ajlm-5	23	34	in	in	ADP
ajlm-5	23	35	different	different	ADJ
ajlm-5	23	36	populations	population	NOUN
ajlm-5	23	37	,	,	PUNCT
ajlm-5	23	38	geographical	geographical	ADJ
ajlm-5	23	39	regions	region	NOUN
ajlm-5	23	40	,	,	PUNCT
ajlm-5	23	41	climate	climate	NOUN
ajlm-5	23	42	,	,	PUNCT
ajlm-5	23	43	race	race	NOUN
ajlm-5	23	44	and	and	CCONJ
ajlm-5	23	45	dietary	dietary	ADJ
ajlm-5	23	46	habits.9,10,11,12,13,14,15	habits.9,10,11,12,13,14,15	NUM
ajlm-5	23	47	reference	reference	NOUN
ajlm-5	23	48	intervals	interval	NOUN
ajlm-5	23	49	studies	study	NOUN
ajlm-5	23	50	conducted	conduct	VERB
ajlm-5	23	51	in	in	ADP
ajlm-5	23	52	african	african	ADJ
ajlm-5	23	53	countries	country	NOUN
ajlm-5	23	54	have	have	AUX
ajlm-5	23	55	shown	show	VERB
ajlm-5	23	56	differences	difference	NOUN
ajlm-5	23	57	within	within	ADP
ajlm-5	23	58	populations	population	NOUN
ajlm-5	23	59	and	and	CCONJ
ajlm-5	23	60	sometimes	sometimes	ADV
ajlm-5	23	61	within	within	ADP
ajlm-5	23	62	sub	sub	NOUN
ajlm-5	23	63	-	-	NOUN
ajlm-5	23	64	groups	group	NOUN
ajlm-5	23	65	,	,	PUNCT
ajlm-5	23	66	and	and	CCONJ
ajlm-5	23	67	marked	mark	VERB
ajlm-5	23	68	differences	difference	NOUN
ajlm-5	23	69	with	with	ADP
ajlm-5	23	70	values	value	NOUN
ajlm-5	23	71	from	from	ADP
ajlm-5	23	72	white	white	ADJ
ajlm-5	23	73	populations.8,13,16,17,18	populations.8,13,16,17,18	PROPN
ajlm-5	24	1	these	these	DET
ajlm-5	24	2	studies	study	NOUN
ajlm-5	24	3	have	have	AUX
ajlm-5	24	4	also	also	ADV
ajlm-5	24	5	observed	observe	VERB
ajlm-5	24	6	significant	significant	ADJ
ajlm-5	24	7	differences	difference	NOUN
ajlm-5	24	8	with	with	ADP
ajlm-5	24	9	values	value	NOUN
ajlm-5	24	10	from	from	ADP
ajlm-5	24	11	developed	developed	ADJ
ajlm-5	24	12	countries	country	NOUN
ajlm-5	24	13	,	,	PUNCT
ajlm-5	24	14	in	in	ADP
ajlm-5	24	15	haematologic	haematologic	ADJ
ajlm-5	24	16	parameters	parameter	NOUN
ajlm-5	24	17	such	such	ADJ
ajlm-5	24	18	as	as	ADP
ajlm-5	24	19	haemoglobin	haemoglobin	NOUN
ajlm-5	24	20	and	and	CCONJ
ajlm-5	24	21	absolute	absolute	ADJ
ajlm-5	24	22	neutrophil	neutrophil	NOUN
ajlm-5	24	23	,	,	PUNCT
ajlm-5	24	24	which	which	PRON
ajlm-5	24	25	are	be	AUX
ajlm-5	24	26	normally	normally	ADV
ajlm-5	24	27	used	use	VERB
ajlm-5	24	28	for	for	ADP
ajlm-5	24	29	toxicity	toxicity	NOUN
ajlm-5	24	30	grading	grading	NOUN
ajlm-5	24	31	in	in	ADP
ajlm-5	24	32	clinical	clinical	ADJ
ajlm-5	24	33	trials	trial	NOUN
ajlm-5	24	34	,	,	PUNCT
ajlm-5	24	35	and	and	CCONJ
ajlm-5	24	36	consequently	consequently	ADV
ajlm-5	24	37	have	have	VERB
ajlm-5	24	38	implications	implication	NOUN
ajlm-5	24	39	in	in	ADP
ajlm-5	24	40	patient	patient	ADJ
ajlm-5	24	41	management	management	NOUN
ajlm-5	24	42	and	and	CCONJ
ajlm-5	24	43	the	the	DET
ajlm-5	24	44	conduct	conduct	NOUN
ajlm-5	24	45	of	of	ADP
ajlm-5	24	46	clinical	clinical	ADJ
ajlm-5	24	47	trials.18,19,20,21	trials.18,19,20,21	ADP
ajlm-5	24	48	a	a	DET
ajlm-5	24	49	significant	significant	ADJ
ajlm-5	24	50	number	number	NOUN
ajlm-5	24	51	of	of	ADP
ajlm-5	24	52	potential	potential	ADJ
ajlm-5	24	53	african	african	ADJ
ajlm-5	24	54	volunteers	volunteer	NOUN
ajlm-5	24	55	are	be	AUX
ajlm-5	24	56	excluded	exclude	VERB
ajlm-5	24	57	from	from	ADP
ajlm-5	24	58	participating	participate	VERB
ajlm-5	24	59	in	in	ADP
ajlm-5	24	60	vaccine	vaccine	NOUN
ajlm-5	24	61	trials	trial	NOUN
ajlm-5	24	62	because	because	SCONJ
ajlm-5	24	63	screening	screening	NOUN
ajlm-5	24	64	,	,	PUNCT
ajlm-5	24	65	enrollment	enrollment	NOUN
ajlm-5	24	66	and	and	CCONJ
ajlm-5	24	67	follow	follow	NOUN
ajlm-5	24	68	-	-	PUNCT
ajlm-5	24	69	up	up	ADP
ajlm-5	24	70	monitoring	monitoring	NOUN
ajlm-5	24	71	is	be	AUX
ajlm-5	24	72	mostly	mostly	ADV
ajlm-5	24	73	based	base	VERB
ajlm-5	24	74	on	on	ADP
ajlm-5	24	75	values	value	NOUN
ajlm-5	24	76	derived	derive	VERB
ajlm-5	24	77	from	from	ADP
ajlm-5	24	78	predominantly	predominantly	ADV
ajlm-5	24	79	white	white	ADJ
ajlm-5	24	80	populations	population	NOUN
ajlm-5	24	81	.	.	PUNCT
ajlm-5	25	1	a	a	DET
ajlm-5	25	2	study	study	NOUN
ajlm-5	25	3	in	in	ADP
ajlm-5	25	4	uganda19	uganda19	PROPN
ajlm-5	25	5	documented	document	VERB
ajlm-5	25	6	an	an	DET
ajlm-5	25	7	exclusion	exclusion	NOUN
ajlm-5	25	8	rate	rate	NOUN
ajlm-5	25	9	of	of	ADP
ajlm-5	25	10	as	as	ADV
ajlm-5	25	11	high	high	ADJ
ajlm-5	25	12	as	as	ADP
ajlm-5	25	13	69	69	NUM
ajlm-5	25	14	%	%	NOUN
ajlm-5	25	15	of	of	ADP
ajlm-5	25	16	vaccine	vaccine	NOUN
ajlm-5	25	17	clinical	clinical	ADJ
ajlm-5	25	18	trial	trial	NOUN
ajlm-5	25	19	participants	participant	NOUN
ajlm-5	25	20	because	because	SCONJ
ajlm-5	25	21	of	of	ADP
ajlm-5	25	22	haematologic	haematologic	ADJ
ajlm-5	25	23	abnormalities	abnormality	NOUN
ajlm-5	25	24	,	,	PUNCT
ajlm-5	25	25	83	83	NUM
ajlm-5	25	26	%	%	NOUN
ajlm-5	25	27	of	of	ADP
ajlm-5	25	28	whom	whom	PRON
ajlm-5	25	29	could	could	AUX
ajlm-5	25	30	have	have	AUX
ajlm-5	25	31	been	be	AUX
ajlm-5	25	32	included	include	VERB
ajlm-5	25	33	in	in	ADP
ajlm-5	25	34	the	the	DET
ajlm-5	25	35	studies	study	NOUN
ajlm-5	25	36	if	if	SCONJ
ajlm-5	25	37	local	local	ADJ
ajlm-5	25	38	reference	reference	NOUN
ajlm-5	25	39	ranges	range	NOUN
ajlm-5	25	40	were	be	AUX
ajlm-5	25	41	used	use	VERB
ajlm-5	25	42	.	.	PUNCT
ajlm-5	26	1	kibiya	kibiya	PROPN
ajlm-5	26	2	et	et	PROPN
ajlm-5	26	3	al.8	al.8	PROPN
ajlm-5	26	4	observed	observe	VERB
ajlm-5	26	5	that	that	SCONJ
ajlm-5	26	6	the	the	DET
ajlm-5	26	7	lower	low	ADJ
ajlm-5	26	8	limit	limit	NOUN
ajlm-5	26	9	of	of	ADP
ajlm-5	26	10	neutrophil	neutrophil	ADJ
ajlm-5	26	11	counts	count	NOUN
ajlm-5	26	12	and	and	CCONJ
ajlm-5	26	13	haemoglobin	haemoglobin	PROPN
ajlm-5	26	14	reference	reference	NOUN
ajlm-5	26	15	ranges	range	VERB
ajlm-5	26	16	qualify	qualify	ADJ
ajlm-5	26	17	to	to	PART
ajlm-5	26	18	be	be	AUX
ajlm-5	26	19	graded	grade	VERB
ajlm-5	26	20	as	as	ADP
ajlm-5	26	21	moderate	moderate	ADJ
ajlm-5	26	22	and	and	CCONJ
ajlm-5	26	23	severe	severe	ADJ
ajlm-5	26	24	adverse	adverse	ADJ
ajlm-5	26	25	events	event	NOUN
ajlm-5	26	26	,	,	PUNCT
ajlm-5	26	27	respectively	respectively	ADV
ajlm-5	26	28	,	,	PUNCT
ajlm-5	26	29	according	accord	VERB
ajlm-5	26	30	to	to	ADP
ajlm-5	26	31	the	the	DET
ajlm-5	26	32	division	division	NOUN
ajlm-5	26	33	of	of	ADP
ajlm-5	26	34	aids	aids	PROPN
ajlm-5	26	35	(	(	PUNCT
ajlm-5	26	36	daids	daid	NOUN
ajlm-5	26	37	)	)	PUNCT
ajlm-5	26	38	toxicity	toxicity	NOUN
ajlm-5	26	39	grading	grade	VERB
ajlm-5	26	40	table.22	table.22	NOUN
ajlm-5	26	41	determination	determination	NOUN
ajlm-5	26	42	of	of	ADP
ajlm-5	26	43	the	the	DET
ajlm-5	26	44	cd4	cd4	PROPN
ajlm-5	26	45	+	+	PROPN
ajlm-5	26	46	t	t	PROPN
ajlm-5	26	47	-	-	PUNCT
ajlm-5	26	48	lymphocyte	lymphocyte	NOUN
ajlm-5	26	49	counts	count	NOUN
ajlm-5	26	50	play	play	VERB
ajlm-5	26	51	a	a	DET
ajlm-5	26	52	pivotal	pivotal	ADJ
ajlm-5	26	53	role	role	NOUN
ajlm-5	26	54	on	on	ADP
ajlm-5	26	55	the	the	DET
ajlm-5	26	56	initiation	initiation	NOUN
ajlm-5	26	57	and	and	CCONJ
ajlm-5	26	58	monitoring	monitoring	NOUN
ajlm-5	26	59	of	of	ADP
ajlm-5	26	60	patients	patient	NOUN
ajlm-5	26	61	on	on	ADP
ajlm-5	26	62	highly	highly	ADV
ajlm-5	26	63	active	active	ADJ
ajlm-5	26	64	antiretroviral	antiretroviral	ADJ
ajlm-5	26	65	therapy	therapy	NOUN
ajlm-5	26	66	(	(	PUNCT
ajlm-5	26	67	haart	haart	PROPN
ajlm-5	26	68	)	)	PUNCT
ajlm-5	26	69	;	;	PUNCT
ajlm-5	26	70	hence	hence	ADV
ajlm-5	26	71	the	the	DET
ajlm-5	26	72	urgent	urgent	ADJ
ajlm-5	26	73	need	need	NOUN
ajlm-5	26	74	for	for	ADP
ajlm-5	26	75	establishing	establish	VERB
ajlm-5	26	76	cd4	cd4	PROPN
ajlm-5	26	77	+	+	PROPN
ajlm-5	26	78	lymphocytes	lymphocytes	ADJ
ajlm-5	26	79	reference	reference	NOUN
ajlm-5	26	80	intervals	interval	NOUN
ajlm-5	26	81	for	for	ADP
ajlm-5	26	82	local	local	ADJ
ajlm-5	26	83	populations	population	NOUN
ajlm-5	26	84	.	.	PUNCT
ajlm-5	27	1	some	some	DET
ajlm-5	27	2	studies	study	NOUN
ajlm-5	27	3	have	have	AUX
ajlm-5	27	4	observed	observe	VERB
ajlm-5	27	5	that	that	SCONJ
ajlm-5	27	6	black	black	ADJ
ajlm-5	27	7	people	people	NOUN
ajlm-5	27	8	and	and	CCONJ
ajlm-5	27	9	afro	afro	PROPN
ajlm-5	27	10	–	–	PUNCT
ajlm-5	27	11	caribbean	caribbean	ADJ
ajlm-5	27	12	people	people	NOUN
ajlm-5	27	13	have	have	VERB
ajlm-5	27	14	lower	low	ADJ
ajlm-5	27	15	total	total	ADJ
ajlm-5	27	16	white	white	ADJ
ajlm-5	27	17	cell	cell	NOUN
ajlm-5	27	18	counts	count	NOUN
ajlm-5	27	19	,	,	PUNCT
ajlm-5	27	20	and	and	CCONJ
ajlm-5	27	21	neutrophil	neutrophil	ADJ
ajlm-5	27	22	and	and	CCONJ
ajlm-5	27	23	platelet	platelet	NOUN
ajlm-5	27	24	counts	count	NOUN
ajlm-5	27	25	,	,	PUNCT
ajlm-5	27	26	than	than	SCONJ
ajlm-5	27	27	white	white	ADJ
ajlm-5	27	28	people.9,23,24	people.9,23,24	PROPN
ajlm-5	27	29	immunohaematological	immunohaematological	ADJ
ajlm-5	27	30	reference	reference	NOUN
ajlm-5	27	31	values	value	NOUN
ajlm-5	27	32	for	for	ADP
ajlm-5	27	33	a	a	DET
ajlm-5	27	34	healthy	healthy	ADJ
ajlm-5	27	35	botswanan	botswanan	NOUN
ajlm-5	27	36	population	population	NOUN
ajlm-5	27	37	have	have	AUX
ajlm-5	27	38	never	never	ADV
ajlm-5	27	39	been	be	AUX
ajlm-5	27	40	established	establish	VERB
ajlm-5	27	41	formally	formally	ADV
ajlm-5	27	42	,	,	PUNCT
ajlm-5	27	43	whereas	whereas	SCONJ
ajlm-5	27	44	in	in	ADP
ajlm-5	27	45	many	many	ADJ
ajlm-5	27	46	african	african	ADJ
ajlm-5	27	47	countries	country	NOUN
ajlm-5	27	48	,	,	PUNCT
ajlm-5	27	49	it	it	PRON
ajlm-5	27	50	is	be	AUX
ajlm-5	27	51	common	common	ADJ
ajlm-5	27	52	practice	practice	NOUN
ajlm-5	27	53	to	to	PART
ajlm-5	27	54	use	use	VERB
ajlm-5	27	55	reference	reference	NOUN
ajlm-5	27	56	values	value	NOUN
ajlm-5	27	57	established	establish	VERB
ajlm-5	27	58	in	in	ADP
ajlm-5	27	59	predominantly	predominantly	ADV
ajlm-5	27	60	white	white	ADJ
ajlm-5	27	61	populations	population	NOUN
ajlm-5	27	62	,	,	PUNCT
ajlm-5	27	63	which	which	PRON
ajlm-5	27	64	may	may	AUX
ajlm-5	27	65	not	not	PART
ajlm-5	27	66	be	be	AUX
ajlm-5	27	67	representative	representative	ADJ
ajlm-5	27	68	of	of	ADP
ajlm-5	27	69	the	the	DET
ajlm-5	27	70	botswanan	botswanan	NOUN
ajlm-5	27	71	population	population	NOUN
ajlm-5	27	72	(	(	PUNCT
ajlm-5	27	73	which	which	PRON
ajlm-5	27	74	comprises	comprise	VERB
ajlm-5	27	75	mostly	mostly	ADV
ajlm-5	27	76	black	black	ADJ
ajlm-5	27	77	people	people	NOUN
ajlm-5	27	78	)	)	PUNCT
ajlm-5	27	79	.	.	PUNCT
ajlm-5	28	1	in	in	ADP
ajlm-5	28	2	order	order	NOUN
ajlm-5	28	3	to	to	PART
ajlm-5	28	4	conduct	conduct	VERB
ajlm-5	28	5	investigation	investigation	NOUN
ajlm-5	28	6	drug	drug	NOUN
ajlm-5	28	7	(	(	PUNCT
ajlm-5	28	8	ind	ind	NOUN
ajlm-5	28	9	)	)	PUNCT
ajlm-5	28	10	and	and	CCONJ
ajlm-5	28	11	vaccine	vaccine	NOUN
ajlm-5	28	12	trials	trial	NOUN
ajlm-5	28	13	successfully	successfully	ADV
ajlm-5	28	14	,	,	PUNCT
ajlm-5	28	15	an	an	DET
ajlm-5	28	16	assessment	assessment	NOUN
ajlm-5	28	17	of	of	ADP
ajlm-5	28	18	the	the	DET
ajlm-5	28	19	local	local	ADJ
ajlm-5	28	20	reference	reference	NOUN
ajlm-5	28	21	intervals	interval	NOUN
ajlm-5	28	22	is	be	AUX
ajlm-5	28	23	required.25,26,27	required.25,26,27	NOUN
ajlm-5	28	24	the	the	DET
ajlm-5	28	25	aim	aim	NOUN
ajlm-5	28	26	of	of	ADP
ajlm-5	28	27	this	this	DET
ajlm-5	28	28	study	study	NOUN
ajlm-5	28	29	was	be	AUX
ajlm-5	28	30	to	to	PART
ajlm-5	28	31	establish	establish	VERB
ajlm-5	28	32	the	the	DET
ajlm-5	28	33	immunohaematological	immunohaematological	ADJ
ajlm-5	28	34	reference	reference	NOUN
ajlm-5	28	35	values	value	NOUN
ajlm-5	28	36	in	in	ADP
ajlm-5	28	37	healthy	healthy	ADJ
ajlm-5	28	38	adults	adult	NOUN
ajlm-5	28	39	in	in	ADP
ajlm-5	28	40	botswana	botswana	PROPN
ajlm-5	28	41	following	follow	VERB
ajlm-5	28	42	the	the	DET
ajlm-5	28	43	clinical	clinical	ADJ
ajlm-5	28	44	laboratory	laboratory	NOUN
ajlm-5	28	45	standards	standards	PROPN
ajlm-5	28	46	institute	institute	PROPN
ajlm-5	28	47	(	(	PUNCT
ajlm-5	28	48	clsi	clsi	PROPN
ajlm-5	28	49	)	)	PUNCT
ajlm-5	28	50	(	(	PUNCT
ajlm-5	28	51	formerly	formerly	ADV
ajlm-5	28	52	nccls	nccls	NOUN
ajlm-5	28	53	)	)	PUNCT
ajlm-5	28	54	guidelines28	guidelines28	NOUN
ajlm-5	29	1	in	in	ADP
ajlm-5	29	2	order	order	NOUN
ajlm-5	29	3	to	to	PART
ajlm-5	29	4	improve	improve	VERB
ajlm-5	29	5	patient	patient	ADJ
ajlm-5	29	6	care	care	NOUN
ajlm-5	29	7	,	,	PUNCT
ajlm-5	29	8	the	the	DET
ajlm-5	29	9	participation	participation	NOUN
ajlm-5	29	10	of	of	ADP
ajlm-5	29	11	individuals	individual	NOUN
ajlm-5	29	12	in	in	ADP
ajlm-5	29	13	clinical	clinical	ADJ
ajlm-5	29	14	trials	trial	NOUN
ajlm-5	29	15	and	and	CCONJ
ajlm-5	29	16	the	the	DET
ajlm-5	29	17	evaluation	evaluation	NOUN
ajlm-5	29	18	of	of	ADP
ajlm-5	29	19	adverse	adverse	ADJ
ajlm-5	29	20	events	event	NOUN
ajlm-5	29	21	.	.	PUNCT
ajlm-5	30	1	materials	material	NOUN
ajlm-5	30	2	and	and	CCONJ
ajlm-5	30	3	methods	method	NOUN
ajlm-5	30	4	top	top	PROPN
ajlm-5	30	5	↑	↑	PROPN
ajlm-5	30	6	study	study	NOUN
ajlm-5	30	7	design	design	NOUN
ajlm-5	30	8	,	,	PUNCT
ajlm-5	30	9	setting	set	VERB
ajlm-5	30	10	and	and	CCONJ
ajlm-5	30	11	population	population	NOUN
ajlm-5	30	12	a	a	DET
ajlm-5	30	13	cross	cross	NOUN
ajlm-5	30	14	sectional	sectional	ADJ
ajlm-5	30	15	study	study	NOUN
ajlm-5	30	16	was	be	AUX
ajlm-5	30	17	conducted	conduct	VERB
ajlm-5	30	18	amongst	amongst	ADP
ajlm-5	30	19	healthy	healthy	ADJ
ajlm-5	30	20	adult	adult	NOUN
ajlm-5	30	21	volunteers	volunteer	NOUN
ajlm-5	30	22	that	that	PRON
ajlm-5	30	23	were	be	AUX
ajlm-5	30	24	recruited	recruit	VERB
ajlm-5	30	25	at	at	ADP
ajlm-5	30	26	the	the	DET
ajlm-5	30	27	voluntary	voluntary	ADJ
ajlm-5	30	28	counselling	counselling	NOUN
ajlm-5	30	29	and	and	CCONJ
ajlm-5	30	30	testing	testing	NOUN
ajlm-5	30	31	center	center	NOUN
ajlm-5	30	32	(	(	PUNCT
ajlm-5	30	33	vct	vct	NOUN
ajlm-5	30	34	)	)	PUNCT
ajlm-5	30	35	known	know	VERB
ajlm-5	30	36	as	as	ADP
ajlm-5	30	37	tebelopele	tebelopele	PROPN
ajlm-5	30	38	(	(	PUNCT
ajlm-5	30	39	a	a	DET
ajlm-5	30	40	setswana	setswana	NOUN
ajlm-5	30	41	name	name	NOUN
ajlm-5	30	42	that	that	PRON
ajlm-5	30	43	means	mean	VERB
ajlm-5	30	44	‘	'	PUNCT
ajlm-5	30	45	foresight	foresight	NOUN
ajlm-5	30	46	’	'	PUNCT
ajlm-5	30	47	)	)	PUNCT
ajlm-5	30	48	from	from	ADP
ajlm-5	30	49	around	around	ADP
ajlm-5	30	50	gaborone	gaborone	PROPN
ajlm-5	30	51	,	,	PUNCT
ajlm-5	30	52	the	the	DET
ajlm-5	30	53	capital	capital	NOUN
ajlm-5	30	54	city	city	NOUN
ajlm-5	30	55	of	of	ADP
ajlm-5	30	56	botswana	botswana	PROPN
ajlm-5	30	57	.	.	PUNCT
ajlm-5	31	1	potential	potential	ADJ
ajlm-5	31	2	volunteers	volunteer	NOUN
ajlm-5	31	3	who	who	PRON
ajlm-5	31	4	tested	test	VERB
ajlm-5	31	5	hiv	hiv	PROPN
ajlm-5	31	6	-	-	PUNCT
ajlm-5	31	7	negative	negative	ADJ
ajlm-5	31	8	in	in	ADP
ajlm-5	31	9	a	a	DET
ajlm-5	31	10	parallel	parallel	ADJ
ajlm-5	31	11	testing	testing	NOUN
ajlm-5	31	12	algorithm	algorithm	NOUN
ajlm-5	31	13	that	that	PRON
ajlm-5	31	14	used	use	VERB
ajlm-5	31	15	determine	determine	VERB
ajlm-5	31	16	hiv-1/2	hiv-1/2	PROPN
ajlm-5	31	17	(	(	PUNCT
ajlm-5	31	18	abbott	abbott	PROPN
ajlm-5	31	19	laboratories	laboratory	NOUN
ajlm-5	31	20	,	,	PUNCT
ajlm-5	31	21	il	il	PROPN
ajlm-5	31	22	,	,	PUNCT
ajlm-5	31	23	usa	usa	PROPN
ajlm-5	31	24	)	)	PUNCT
ajlm-5	31	25	and	and	CCONJ
ajlm-5	31	26	unigold	unigold	ADJ
ajlm-5	31	27	hiv	hiv	PROPN
ajlm-5	31	28	(	(	PUNCT
ajlm-5	31	29	trinity	trinity	NOUN
ajlm-5	31	30	biotech	biotech	NOUN
ajlm-5	31	31	,	,	PUNCT
ajlm-5	31	32	ireland	ireland	NOUN
ajlm-5	31	33	)	)	PUNCT
ajlm-5	31	34	rapid	rapid	ADJ
ajlm-5	31	35	test	test	NOUN
ajlm-5	31	36	kits	kit	NOUN
ajlm-5	31	37	,	,	PUNCT
ajlm-5	31	38	were	be	AUX
ajlm-5	31	39	recruited	recruit	VERB
ajlm-5	31	40	into	into	ADP
ajlm-5	31	41	the	the	DET
ajlm-5	31	42	study	study	NOUN
ajlm-5	31	43	.	.	PUNCT
ajlm-5	32	1	the	the	DET
ajlm-5	32	2	rapid	rapid	ADJ
ajlm-5	32	3	hiv	hiv	PROPN
ajlm-5	32	4	results	result	NOUN
ajlm-5	32	5	were	be	AUX
ajlm-5	32	6	confirmed	confirm	VERB
ajlm-5	32	7	in	in	ADP
ajlm-5	32	8	the	the	DET
ajlm-5	32	9	laboratory	laboratory	NOUN
ajlm-5	32	10	by	by	ADP
ajlm-5	32	11	using	use	VERB
ajlm-5	32	12	two	two	NUM
ajlm-5	32	13	enzyme	enzyme	NOUN
ajlm-5	32	14	-	-	PUNCT
ajlm-5	32	15	linked	link	VERB
ajlm-5	32	16	immunosorbent	immunosorbent	NOUN
ajlm-5	32	17	assays	assay	NOUN
ajlm-5	32	18	as	as	ADP
ajlm-5	32	19	per	per	ADP
ajlm-5	32	20	national	national	ADJ
ajlm-5	32	21	guidelines	guideline	NOUN
ajlm-5	32	22	.	.	PUNCT
ajlm-5	33	1	study	study	NOUN
ajlm-5	33	2	procedures	procedure	NOUN
ajlm-5	33	3	potential	potential	ADJ
ajlm-5	33	4	apparently	apparently	ADV
ajlm-5	33	5	healthy	healthy	ADJ
ajlm-5	33	6	hiv	hiv	PROPN
ajlm-5	33	7	-	-	PUNCT
ajlm-5	33	8	negative	negative	ADJ
ajlm-5	33	9	volunteers	volunteer	NOUN
ajlm-5	33	10	who	who	PRON
ajlm-5	33	11	consented	consent	VERB
ajlm-5	33	12	to	to	PART
ajlm-5	33	13	participate	participate	VERB
ajlm-5	33	14	in	in	ADP
ajlm-5	33	15	the	the	DET
ajlm-5	33	16	study	study	NOUN
ajlm-5	33	17	were	be	AUX
ajlm-5	33	18	included	include	VERB
ajlm-5	33	19	.	.	PUNCT
ajlm-5	34	1	a	a	DET
ajlm-5	34	2	brief	brief	ADJ
ajlm-5	34	3	screening	screening	NOUN
ajlm-5	34	4	questionnaire	questionnaire	NOUN
ajlm-5	34	5	was	be	AUX
ajlm-5	34	6	administered	administer	VERB
ajlm-5	34	7	by	by	ADP
ajlm-5	34	8	experienced	experienced	ADJ
ajlm-5	34	9	study	study	NOUN
ajlm-5	34	10	nurses	nurse	NOUN
ajlm-5	34	11	.	.	PUNCT
ajlm-5	35	1	the	the	DET
ajlm-5	35	2	questionnaire	questionnaire	NOUN
ajlm-5	35	3	was	be	AUX
ajlm-5	35	4	designed	design	VERB
ajlm-5	35	5	using	use	VERB
ajlm-5	35	6	the	the	DET
ajlm-5	35	7	clinical	clinical	ADJ
ajlm-5	35	8	laboratory	laboratory	NOUN
ajlm-5	35	9	standards	standard	NOUN
ajlm-5	35	10	institute	institute	PROPN
ajlm-5	35	11	(	(	PUNCT
ajlm-5	35	12	clsi	clsi	PROPN
ajlm-5	35	13	)	)	PUNCT
ajlm-5	35	14	guidelines28	guidelines28	NOUN
ajlm-5	35	15	(	(	PUNCT
ajlm-5	35	16	formerly	formerly	ADV
ajlm-5	35	17	nccls	nccls	NOUN
ajlm-5	35	18	)	)	PUNCT
ajlm-5	35	19	and	and	CCONJ
ajlm-5	35	20	the	the	DET
ajlm-5	35	21	following	follow	VERB
ajlm-5	35	22	categories	category	NOUN
ajlm-5	35	23	were	be	AUX
ajlm-5	35	24	excluded	exclude	VERB
ajlm-5	35	25	:	:	PUNCT
ajlm-5	35	26	•	•	NUM
ajlm-5	35	27	pregnant	pregnant	ADJ
ajlm-5	35	28	•	•	NOUN
ajlm-5	35	29	breastfeeding	breastfeed	VERB
ajlm-5	35	30	•	•	NUM
ajlm-5	35	31	patients	patient	NOUN
ajlm-5	35	32	who	who	PRON
ajlm-5	35	33	had	have	AUX
ajlm-5	35	34	been	be	AUX
ajlm-5	35	35	inpatients	inpatient	NOUN
ajlm-5	35	36	in	in	ADP
ajlm-5	35	37	a	a	DET
ajlm-5	35	38	hospital	hospital	NOUN
ajlm-5	35	39	or	or	CCONJ
ajlm-5	35	40	who	who	PRON
ajlm-5	35	41	had	have	AUX
ajlm-5	35	42	been	be	AUX
ajlm-5	35	43	subjectively	subjectively	ADV
ajlm-5	35	44	ill	ill	ADJ
ajlm-5	35	45	during	during	ADP
ajlm-5	35	46	the	the	DET
ajlm-5	35	47	last	last	ADJ
ajlm-5	35	48	month	month	NOUN
ajlm-5	35	49	•	•	ADP
ajlm-5	35	50	patients	patient	NOUN
ajlm-5	35	51	receiving	receive	VERB
ajlm-5	35	52	medical	medical	ADJ
ajlm-5	35	53	treatment	treatment	NOUN
ajlm-5	35	54	•	•	NOUN
ajlm-5	35	55	patients	patient	NOUN
ajlm-5	35	56	who	who	PRON
ajlm-5	35	57	had	have	VERB
ajlm-5	35	58	a	a	DET
ajlm-5	35	59	recent	recent	ADJ
ajlm-5	35	60	or	or	CCONJ
ajlm-5	35	61	recurrent	recurrent	ADJ
ajlm-5	35	62	infection	infection	NOUN
ajlm-5	35	63	,	,	PUNCT
ajlm-5	35	64	including	include	VERB
ajlm-5	35	65	hiv	hiv	PROPN
ajlm-5	35	66	and	and	CCONJ
ajlm-5	35	67	malaria	malaria	ADJ
ajlm-5	35	68	•	•	NOUN
ajlm-5	35	69	patients	patient	NOUN
ajlm-5	35	70	who	who	PRON
ajlm-5	35	71	had	have	AUX
ajlm-5	35	72	smoked	smoke	VERB
ajlm-5	35	73	in	in	ADP
ajlm-5	35	74	the	the	DET
ajlm-5	35	75	hour	hour	NOUN
ajlm-5	35	76	before	before	SCONJ
ajlm-5	35	77	blood	blood	NOUN
ajlm-5	35	78	was	be	AUX
ajlm-5	35	79	drawn	draw	VERB
ajlm-5	35	80	•	•	NUM
ajlm-5	35	81	patients	patient	NOUN
ajlm-5	35	82	who	who	PRON
ajlm-5	35	83	had	have	AUX
ajlm-5	35	84	donated	donate	VERB
ajlm-5	35	85	blood	blood	NOUN
ajlm-5	35	86	in	in	ADP
ajlm-5	35	87	the	the	DET
ajlm-5	35	88	preceding	precede	VERB
ajlm-5	35	89	month	month	NOUN
ajlm-5	35	90	.	.	PUNCT
ajlm-5	36	1	participants	participant	NOUN
ajlm-5	36	2	had	have	VERB
ajlm-5	36	3	access	access	NOUN
ajlm-5	36	4	to	to	ADP
ajlm-5	36	5	their	their	PRON
ajlm-5	36	6	hiv	hiv	NOUN
ajlm-5	36	7	-	-	PUNCT
ajlm-5	36	8	testing	testing	NOUN
ajlm-5	36	9	results	result	NOUN
ajlm-5	36	10	through	through	ADP
ajlm-5	36	11	voluntary	voluntary	ADJ
ajlm-5	36	12	counselling	counselling	NOUN
ajlm-5	36	13	and	and	CCONJ
ajlm-5	36	14	testing	testing	NOUN
ajlm-5	36	15	protocol	protocol	NOUN
ajlm-5	36	16	,	,	PUNCT
ajlm-5	36	17	and	and	CCONJ
ajlm-5	36	18	obtained	obtain	VERB
ajlm-5	36	19	all	all	DET
ajlm-5	36	20	other	other	ADJ
ajlm-5	36	21	results	result	NOUN
ajlm-5	36	22	through	through	ADP
ajlm-5	36	23	a	a	DET
ajlm-5	36	24	registered	register	VERB
ajlm-5	36	25	physician	physician	NOUN
ajlm-5	36	26	for	for	ADP
ajlm-5	36	27	review	review	NOUN
ajlm-5	36	28	and	and	CCONJ
ajlm-5	36	29	referral	referral	NOUN
ajlm-5	36	30	to	to	ADP
ajlm-5	36	31	appropriate	appropriate	ADJ
ajlm-5	36	32	care	care	NOUN
ajlm-5	36	33	.	.	PUNCT
ajlm-5	37	1	participants	participant	NOUN
ajlm-5	37	2	with	with	ADP
ajlm-5	37	3	underlying	underlie	VERB
ajlm-5	37	4	clinical	clinical	ADJ
ajlm-5	37	5	conditions	condition	NOUN
ajlm-5	37	6	were	be	AUX
ajlm-5	37	7	excluded	exclude	VERB
ajlm-5	37	8	from	from	ADP
ajlm-5	37	9	the	the	DET
ajlm-5	37	10	analysis	analysis	NOUN
ajlm-5	37	11	as	as	ADV
ajlm-5	37	12	well	well	ADV
ajlm-5	37	13	.	.	PUNCT
ajlm-5	38	1	laboratory	laboratory	NOUN
ajlm-5	38	2	procedures	procedure	NOUN
ajlm-5	38	3	top	top	VERB
ajlm-5	38	4	↑	↑	NOUN
ajlm-5	38	5	blood	blood	NOUN
ajlm-5	38	6	collection	collection	NOUN
ajlm-5	38	7	and	and	CCONJ
ajlm-5	38	8	hiv	hiv	PROPN
ajlm-5	38	9	serology	serology	NOUN
ajlm-5	38	10	approximately	approximately	ADV
ajlm-5	38	11	15	15	NUM
ajlm-5	38	12	 	 	SPACE
ajlm-5	38	13	ml	ml	NOUN
ajlm-5	38	14	whole	whole	ADJ
ajlm-5	38	15	blood	blood	NOUN
ajlm-5	38	16	was	be	AUX
ajlm-5	38	17	collected	collect	VERB
ajlm-5	38	18	from	from	ADP
ajlm-5	38	19	the	the	DET
ajlm-5	38	20	cubital	cubital	NOUN
ajlm-5	38	21	vein	vein	VERB
ajlm-5	38	22	with	with	ADP
ajlm-5	38	23	a	a	DET
ajlm-5	38	24	vacutainer	vacutainer	ADJ
ajlm-5	38	25	system	system	NOUN
ajlm-5	38	26	in	in	ADP
ajlm-5	38	27	k3edta	k3edta	PROPN
ajlm-5	38	28	.	.	PUNCT
ajlm-5	39	1	samples	sample	NOUN
ajlm-5	39	2	were	be	AUX
ajlm-5	39	3	analysed	analyse	VERB
ajlm-5	39	4	on	on	ADP
ajlm-5	39	5	the	the	DET
ajlm-5	39	6	day	day	NOUN
ajlm-5	39	7	of	of	ADP
ajlm-5	39	8	collection	collection	NOUN
ajlm-5	39	9	.	.	PUNCT
ajlm-5	40	1	hiv	hiv	PROPN
ajlm-5	40	2	status	status	NOUN
ajlm-5	40	3	was	be	AUX
ajlm-5	40	4	further	far	ADV
ajlm-5	40	5	confirmed	confirm	VERB
ajlm-5	40	6	in	in	ADP
ajlm-5	40	7	plasma	plasma	NOUN
ajlm-5	40	8	from	from	ADP
ajlm-5	40	9	the	the	DET
ajlm-5	40	10	samples	sample	NOUN
ajlm-5	40	11	by	by	ADP
ajlm-5	40	12	using	use	VERB
ajlm-5	40	13	an	an	DET
ajlm-5	40	14	enzyme	enzyme	NOUN
ajlm-5	40	15	-	-	PUNCT
ajlm-5	40	16	linked	link	VERB
ajlm-5	40	17	immunosorbent	immunosorbent	NOUN
ajlm-5	40	18	assays	assay	NOUN
ajlm-5	40	19	vironostika	vironostika	VERB
ajlm-5	40	20	hiv	hiv	PROPN
ajlm-5	40	21	uniform	uniform	PROPN
ajlm-5	40	22	ii	ii	PROPN
ajlm-5	40	23	plus	plus	CCONJ
ajlm-5	40	24	o	o	PROPN
ajlm-5	40	25	(	(	PUNCT
ajlm-5	40	26	biomérieux	biomérieux	PROPN
ajlm-5	40	27	france	france	PROPN
ajlm-5	40	28	,	,	PUNCT
ajlm-5	40	29	marcy	marcy	PROPN
ajlm-5	40	30	l’etoile	l’etoile	PROPN
ajlm-5	40	31	,	,	PUNCT
ajlm-5	40	32	france	france	PROPN
ajlm-5	40	33	)	)	PUNCT
ajlm-5	40	34	and	and	CCONJ
ajlm-5	40	35	murex	murex	PROPN
ajlm-5	41	1	hiv-1.2.o	hiv-1.2.o	PROPN
ajlm-5	41	2	murex	murex	PROPN
ajlm-5	41	3	(	(	PUNCT
ajlm-5	41	4	biotech	biotech	NOUN
ajlm-5	41	5	,	,	PUNCT
ajlm-5	41	6	dartford	dartford	PROPN
ajlm-5	41	7	,	,	PUNCT
ajlm-5	41	8	uk	uk	PROPN
ajlm-5	41	9	)	)	PUNCT
ajlm-5	41	10	according	accord	VERB
ajlm-5	41	11	to	to	ADP
ajlm-5	41	12	manufacturer	manufacturer	NOUN
ajlm-5	41	13	’s	’s	PART
ajlm-5	41	14	instructions	instruction	NOUN
ajlm-5	41	15	.	.	PUNCT
ajlm-5	42	1	a	a	DET
ajlm-5	42	2	parallel	parallel	ADJ
ajlm-5	42	3	algorithm	algorithm	NOUN
ajlm-5	42	4	was	be	AUX
ajlm-5	42	5	applied	apply	VERB
ajlm-5	42	6	and	and	CCONJ
ajlm-5	42	7	the	the	DET
ajlm-5	42	8	tests	test	NOUN
ajlm-5	42	9	were	be	AUX
ajlm-5	42	10	performed	perform	VERB
ajlm-5	42	11	at	at	ADP
ajlm-5	42	12	the	the	DET
ajlm-5	42	13	botswana	botswana	PROPN
ajlm-5	42	14	harvard	harvard	PROPN
ajlm-5	42	15	hiv	hiv	PROPN
ajlm-5	42	16	reference	reference	PROPN
ajlm-5	42	17	laboratory	laboratory	NOUN
ajlm-5	42	18	,	,	PUNCT
ajlm-5	42	19	following	follow	VERB
ajlm-5	42	20	national	national	ADJ
ajlm-5	42	21	guidelines	guideline	NOUN
ajlm-5	42	22	that	that	PRON
ajlm-5	42	23	included	include	VERB
ajlm-5	42	24	confirmation	confirmation	NOUN
ajlm-5	42	25	with	with	ADP
ajlm-5	42	26	western	western	ADJ
ajlm-5	42	27	blot	blot	NOUN
ajlm-5	42	28	or	or	CCONJ
ajlm-5	42	29	dna	dna	PROPN
ajlm-5	42	30	pcr	pcr	PROPN
ajlm-5	42	31	for	for	ADP
ajlm-5	42	32	all	all	DET
ajlm-5	42	33	discordant	discordant	ADJ
ajlm-5	42	34	results	result	NOUN
ajlm-5	42	35	.	.	PUNCT
ajlm-5	43	1	flow	flow	VERB
ajlm-5	43	2	cytometric	cytometric	ADJ
ajlm-5	43	3	analysis	analysis	NOUN
ajlm-5	43	4	t	t	PROPN
ajlm-5	43	5	-	-	PUNCT
ajlm-5	43	6	lymphocyte	lymphocyte	ADJ
ajlm-5	43	7	subsets	subset	NOUN
ajlm-5	43	8	were	be	AUX
ajlm-5	43	9	analysed	analyse	VERB
ajlm-5	43	10	on	on	ADP
ajlm-5	43	11	a	a	DET
ajlm-5	43	12	facscalibur	facscalibur	NOUN
ajlm-5	43	13	flow	flow	NOUN
ajlm-5	43	14	cytometer	cytometer	NOUN
ajlm-5	43	15	(	(	PUNCT
ajlm-5	43	16	becton	becton	PROPN
ajlm-5	43	17	dickinson	dickinson	PROPN
ajlm-5	43	18	immunocytometry	immunocytometry	NOUN
ajlm-5	43	19	systems	system	NOUN
ajlm-5	43	20	,	,	PUNCT
ajlm-5	43	21	san	san	PROPN
ajlm-5	43	22	jose	jose	PROPN
ajlm-5	43	23	,	,	PUNCT
ajlm-5	43	24	california	california	PROPN
ajlm-5	43	25	)	)	PUNCT
ajlm-5	43	26	by	by	ADP
ajlm-5	43	27	using	use	VERB
ajlm-5	43	28	a	a	DET
ajlm-5	43	29	four	four	NUM
ajlm-5	43	30	-	-	PUNCT
ajlm-5	43	31	colour	colour	NOUN
ajlm-5	43	32	immunofluorescence	immunofluorescence	NOUN
ajlm-5	43	33	reagent	reagent	NOUN
ajlm-5	43	34	(	(	PUNCT
ajlm-5	43	35	bd	bd	AUX
ajlm-5	43	36	multitest	multitest	AUX
ajlm-5	43	37	cd3	cd3	VERB
ajlm-5	43	38	fluorescein	fluorescein	ADJ
ajlm-5	43	39	isothiocyanate	isothiocyanate	NOUN
ajlm-5	44	1	[	[	X
ajlm-5	44	2	fitc]/cd8	fitc]/cd8	PROPN
ajlm-5	44	3	,	,	PUNCT
ajlm-5	44	4	phycoerythrin	phycoerythrin	NOUN
ajlm-5	45	1	[	[	X
ajlm-5	45	2	pe]/cd45	pe]/cd45	ADJ
ajlm-5	45	3	,	,	PUNCT
ajlm-5	45	4	peridinin	peridinin	ADJ
ajlm-5	45	5	chlorophyll	chlorophyll	NOUN
ajlm-5	45	6	protein	protein	NOUN
ajlm-5	45	7	[	[	X
ajlm-5	45	8	percp]/cd4	percp]/cd4	PROPN
ajlm-5	45	9	,	,	PUNCT
ajlm-5	45	10	allophycocyanin	allophycocyanin	PROPN
ajlm-5	46	1	[	[	X
ajlm-5	46	2	apc	apc	PROPN
ajlm-5	46	3	]	]	X
ajlm-5	46	4	)	)	PUNCT
ajlm-5	46	5	,	,	PUNCT
ajlm-5	46	6	and	and	CCONJ
ajlm-5	46	7	trucount	trucount	PROPN
ajlm-5	46	8	tubes	tube	NOUN
ajlm-5	46	9	according	accord	VERB
ajlm-5	46	10	to	to	ADP
ajlm-5	46	11	the	the	DET
ajlm-5	46	12	manufacturer	manufacturer	NOUN
ajlm-5	46	13	’s	’s	PART
ajlm-5	46	14	instructions	instruction	NOUN
ajlm-5	46	15	.	.	PUNCT
ajlm-5	47	1	the	the	DET
ajlm-5	47	2	list	list	NOUN
ajlm-5	47	3	-	-	PUNCT
ajlm-5	47	4	mode	mode	NOUN
ajlm-5	47	5	data	datum	NOUN
ajlm-5	47	6	was	be	AUX
ajlm-5	47	7	acquired	acquire	VERB
ajlm-5	47	8	and	and	CCONJ
ajlm-5	47	9	analysed	analyse	VERB
ajlm-5	47	10	with	with	ADP
ajlm-5	47	11	multiset	multiset	ADJ
ajlm-5	47	12	software	software	NOUN
ajlm-5	47	13	(	(	PUNCT
ajlm-5	47	14	becton	becton	PROPN
ajlm-5	47	15	dickinson	dickinson	PROPN
ajlm-5	47	16	immunocytometry	immunocytometry	NOUN
ajlm-5	47	17	systems	system	NOUN
ajlm-5	47	18	)	)	PUNCT
ajlm-5	47	19	.	.	PUNCT
ajlm-5	48	1	the	the	DET
ajlm-5	48	2	instrument	instrument	NOUN
ajlm-5	48	3	used	use	VERB
ajlm-5	48	4	was	be	AUX
ajlm-5	48	5	validated	validate	VERB
ajlm-5	48	6	prior	prior	ADV
ajlm-5	48	7	to	to	ADP
ajlm-5	48	8	use	use	NOUN
ajlm-5	48	9	and	and	CCONJ
ajlm-5	48	10	it	it	PRON
ajlm-5	48	11	was	be	AUX
ajlm-5	48	12	monitored	monitor	VERB
ajlm-5	48	13	daily	daily	ADV
ajlm-5	48	14	with	with	ADP
ajlm-5	48	15	trucount	trucount	PROPN
ajlm-5	48	16	controls	control	NOUN
ajlm-5	48	17	materials	material	NOUN
ajlm-5	48	18	;	;	PUNCT
ajlm-5	48	19	it	it	PRON
ajlm-5	48	20	was	be	AUX
ajlm-5	48	21	also	also	ADV
ajlm-5	48	22	enrolled	enrol	VERB
ajlm-5	48	23	in	in	ADP
ajlm-5	48	24	an	an	DET
ajlm-5	48	25	external	external	ADJ
ajlm-5	48	26	quality	quality	NOUN
ajlm-5	48	27	assurance	assurance	NOUN
ajlm-5	48	28	scheme	scheme	NOUN
ajlm-5	48	29	by	by	ADP
ajlm-5	48	30	the	the	DET
ajlm-5	48	31	united	united	PROPN
ajlm-5	48	32	kingdom	kingdom	PROPN
ajlm-5	48	33	external	external	ADJ
ajlm-5	48	34	quality	quality	NOUN
ajlm-5	48	35	assessment	assessment	NOUN
ajlm-5	48	36	scheme	scheme	NOUN
ajlm-5	48	37	(	(	PUNCT
ajlm-5	48	38	ukneqas	ukneqas	NOUN
ajlm-5	48	39	)	)	PUNCT
ajlm-5	48	40	.	.	PUNCT
ajlm-5	49	1	analysis	analysis	NOUN
ajlm-5	49	2	was	be	AUX
ajlm-5	49	3	conducted	conduct	VERB
ajlm-5	49	4	by	by	ADP
ajlm-5	49	5	trained	train	VERB
ajlm-5	49	6	and	and	CCONJ
ajlm-5	49	7	competent	competent	ADJ
ajlm-5	49	8	personnel	personnel	NOUN
ajlm-5	49	9	.	.	PUNCT
ajlm-5	50	1	haematological	haematological	ADJ
ajlm-5	50	2	analysis	analysis	NOUN
ajlm-5	50	3	haematology	haematology	NOUN
ajlm-5	50	4	parameters	parameter	NOUN
ajlm-5	50	5	were	be	AUX
ajlm-5	50	6	determined	determine	VERB
ajlm-5	50	7	from	from	ADP
ajlm-5	50	8	whole	whole	ADJ
ajlm-5	50	9	blood	blood	NOUN
ajlm-5	50	10	by	by	ADP
ajlm-5	50	11	using	use	VERB
ajlm-5	50	12	the	the	DET
ajlm-5	50	13	sysmex	sysmex	NOUN
ajlm-5	50	14	xe-2100	xe-2100	NOUN
ajlm-5	50	15	(	(	PUNCT
ajlm-5	50	16	sysmex	sysmex	NOUN
ajlm-5	50	17	,	,	PUNCT
ajlm-5	50	18	kobe	kobe	PROPN
ajlm-5	50	19	,	,	PUNCT
ajlm-5	50	20	japan	japan	PROPN
ajlm-5	50	21	)	)	PUNCT
ajlm-5	50	22	,	,	PUNCT
ajlm-5	50	23	according	accord	VERB
ajlm-5	50	24	to	to	ADP
ajlm-5	50	25	the	the	DET
ajlm-5	50	26	manufacturer	manufacturer	NOUN
ajlm-5	50	27	’s	’s	PART
ajlm-5	50	28	instructions	instruction	NOUN
ajlm-5	50	29	.	.	PUNCT
ajlm-5	51	1	the	the	DET
ajlm-5	51	2	xe-2100	xe-2100	PROPN
ajlm-5	51	3	is	be	AUX
ajlm-5	51	4	capable	capable	ADJ
ajlm-5	51	5	of	of	ADP
ajlm-5	51	6	measuring	measure	VERB
ajlm-5	51	7	32	32	NUM
ajlm-5	51	8	parameters	parameter	NOUN
ajlm-5	51	9	,	,	PUNCT
ajlm-5	51	10	including	include	VERB
ajlm-5	51	11	the	the	DET
ajlm-5	51	12	white	white	ADJ
ajlm-5	51	13	blood	blood	NOUN
ajlm-5	51	14	cell	cell	NOUN
ajlm-5	51	15	(	(	PUNCT
ajlm-5	51	16	wbc	wbc	PROPN
ajlm-5	51	17	)	)	PUNCT
ajlm-5	51	18	5	5	NUM
ajlm-5	51	19	-	-	PUNCT
ajlm-5	51	20	part	part	NOUN
ajlm-5	51	21	differential	differential	NOUN
ajlm-5	51	22	into	into	ADP
ajlm-5	51	23	lymphocytes	lymphocyte	NOUN
ajlm-5	51	24	,	,	PUNCT
ajlm-5	51	25	monocytes	monocyte	NOUN
ajlm-5	51	26	,	,	PUNCT
ajlm-5	51	27	eosinophils	eosinophil	NOUN
ajlm-5	51	28	,	,	PUNCT
ajlm-5	51	29	neutrophils	neutrophil	NOUN
ajlm-5	51	30	and	and	CCONJ
ajlm-5	51	31	basophils	basophils	PROPN
ajlm-5	51	32	.	.	PUNCT
ajlm-5	52	1	it	it	PRON
ajlm-5	52	2	also	also	ADV
ajlm-5	52	3	provides	provide	VERB
ajlm-5	52	4	a	a	DET
ajlm-5	52	5	14	14	NUM
ajlm-5	52	6	-	-	PUNCT
ajlm-5	52	7	parameter	parameter	NOUN
ajlm-5	52	8	haemogram	haemogram	PROPN
ajlm-5	52	9	,	,	PUNCT
ajlm-5	52	10	as	as	ADV
ajlm-5	52	11	well	well	ADV
ajlm-5	52	12	as	as	ADP
ajlm-5	52	13	an	an	DET
ajlm-5	52	14	integral	integral	ADJ
ajlm-5	52	15	reticulocyte	reticulocyte	NOUN
ajlm-5	52	16	analysis	analysis	NOUN
ajlm-5	52	17	that	that	PRON
ajlm-5	52	18	includes	include	VERB
ajlm-5	52	19	an	an	DET
ajlm-5	52	20	immature	immature	ADJ
ajlm-5	52	21	reticulocyte	reticulocyte	NOUN
ajlm-5	52	22	fraction	fraction	NOUN
ajlm-5	52	23	,	,	PUNCT
ajlm-5	52	24	a	a	DET
ajlm-5	52	25	nucleated	nucleated	ADJ
ajlm-5	52	26	red	red	ADJ
ajlm-5	52	27	blood	blood	NOUN
ajlm-5	52	28	cell	cell	NOUN
ajlm-5	52	29	(	(	PUNCT
ajlm-5	52	30	nrbc	nrbc	NOUN
ajlm-5	52	31	)	)	PUNCT
ajlm-5	52	32	count	count	VERB
ajlm-5	52	33	and	and	CCONJ
ajlm-5	52	34	calculated	calculated	ADJ
ajlm-5	52	35	parameters	parameter	NOUN
ajlm-5	52	36	.	.	PUNCT
ajlm-5	53	1	these	these	DET
ajlm-5	53	2	calculated	calculate	VERB
ajlm-5	53	3	parameters	parameter	NOUN
ajlm-5	53	4	are	be	AUX
ajlm-5	53	5	,	,	PUNCT
ajlm-5	53	6	the	the	DET
ajlm-5	53	7	mean	mean	ADJ
ajlm-5	53	8	corpuscular	corpuscular	NOUN
ajlm-5	53	9	volume	volume	NOUN
ajlm-5	53	10	(	(	PUNCT
ajlm-5	53	11	mcv	mcv	PROPN
ajlm-5	53	12	)	)	PUNCT
ajlm-5	53	13	(	(	PUNCT
ajlm-5	53	14	fl	fl	NOUN
ajlm-5	53	15	)	)	PUNCT
ajlm-5	53	16	,	,	PUNCT
ajlm-5	53	17	the	the	DET
ajlm-5	53	18	corpuscular	corpuscular	ADJ
ajlm-5	53	19	haemoglobin	haemoglobin	NOUN
ajlm-5	53	20	(	(	PUNCT
ajlm-5	53	21	mch	mch	PROPN
ajlm-5	53	22	)	)	PUNCT
ajlm-5	53	23	(	(	PUNCT
ajlm-5	53	24	pg	pg	NOUN
ajlm-5	53	25	)	)	PUNCT
ajlm-5	53	26	,	,	PUNCT
ajlm-5	53	27	the	the	DET
ajlm-5	53	28	mean	mean	ADJ
ajlm-5	53	29	corpuscular	corpuscular	ADJ
ajlm-5	53	30	haemoglobin	haemoglobin	NOUN
ajlm-5	53	31	concentration	concentration	NOUN
ajlm-5	53	32	(	(	PUNCT
ajlm-5	53	33	mchc	mchc	NOUN
ajlm-5	53	34	)	)	PUNCT
ajlm-5	53	35	(	(	PUNCT
ajlm-5	53	36	g	g	PROPN
ajlm-5	53	37	/	/	SYM
ajlm-5	53	38	dl	dl	NOUN
ajlm-5	53	39	)	)	PUNCT
ajlm-5	53	40	,	,	PUNCT
ajlm-5	53	41	and	and	CCONJ
ajlm-5	53	42	the	the	DET
ajlm-5	53	43	rbc	rbc	PROPN
ajlm-5	53	44	distribution	distribution	NOUN
ajlm-5	53	45	width	width	NOUN
ajlm-5	53	46	by	by	ADP
ajlm-5	53	47	standard	standard	ADJ
ajlm-5	53	48	deviation	deviation	NOUN
ajlm-5	53	49	(	(	PUNCT
ajlm-5	53	50	rdw	rdw	X
ajlm-5	53	51	-	-	PUNCT
ajlm-5	53	52	sd	sd	NOUN
ajlm-5	53	53	)	)	PUNCT
ajlm-5	53	54	(	(	PUNCT
ajlm-5	53	55	fl	fl	NOUN
ajlm-5	53	56	)	)	PUNCT
ajlm-5	53	57	.	.	PUNCT
ajlm-5	54	1	the	the	DET
ajlm-5	54	2	accuracy	accuracy	NOUN
ajlm-5	54	3	and	and	CCONJ
ajlm-5	54	4	precision	precision	NOUN
ajlm-5	54	5	of	of	ADP
ajlm-5	54	6	the	the	DET
ajlm-5	54	7	instrument	instrument	NOUN
ajlm-5	54	8	was	be	AUX
ajlm-5	54	9	monitored	monitor	VERB
ajlm-5	54	10	daily	daily	ADV
ajlm-5	54	11	by	by	ADP
ajlm-5	54	12	using	use	VERB
ajlm-5	54	13	commercial	commercial	ADJ
ajlm-5	54	14	quality	quality	NOUN
ajlm-5	54	15	control	control	NOUN
ajlm-5	54	16	materials	material	NOUN
ajlm-5	54	17	,	,	PUNCT
ajlm-5	54	18	as	as	ADV
ajlm-5	54	19	well	well	ADV
ajlm-5	54	20	as	as	ADV
ajlm-5	54	21	quarterly	quarterly	ADV
ajlm-5	54	22	through	through	ADP
ajlm-5	54	23	enrollment	enrollment	NOUN
ajlm-5	54	24	in	in	ADP
ajlm-5	54	25	an	an	DET
ajlm-5	54	26	external	external	ADJ
ajlm-5	54	27	quality	quality	NOUN
ajlm-5	54	28	assurance	assurance	NOUN
ajlm-5	54	29	scheme	scheme	NOUN
ajlm-5	54	30	by	by	ADP
ajlm-5	54	31	the	the	DET
ajlm-5	54	32	college	college	PROPN
ajlm-5	54	33	of	of	ADP
ajlm-5	54	34	american	american	ADJ
ajlm-5	54	35	pathologists	pathologist	NOUN
ajlm-5	54	36	(	(	PUNCT
ajlm-5	54	37	cap	cap	NOUN
ajlm-5	54	38	)	)	PUNCT
ajlm-5	54	39	.	.	PUNCT
ajlm-5	55	1	trained	train	VERB
ajlm-5	55	2	and	and	CCONJ
ajlm-5	55	3	competent	competent	ADJ
ajlm-5	55	4	personnel	personnel	NOUN
ajlm-5	55	5	performed	perform	VERB
ajlm-5	55	6	the	the	DET
ajlm-5	55	7	analysis	analysis	NOUN
ajlm-5	55	8	.	.	PUNCT
ajlm-5	56	1	ethical	ethical	ADJ
ajlm-5	56	2	considerations	consideration	NOUN
ajlm-5	56	3	top	top	ADJ
ajlm-5	56	4	↑	↑	PROPN
ajlm-5	56	5	the	the	DET
ajlm-5	56	6	study	study	NOUN
ajlm-5	56	7	was	be	AUX
ajlm-5	56	8	approved	approve	VERB
ajlm-5	56	9	by	by	ADP
ajlm-5	56	10	the	the	DET
ajlm-5	56	11	health	health	NOUN
ajlm-5	56	12	research	research	PROPN
ajlm-5	56	13	and	and	CCONJ
ajlm-5	56	14	development	development	NOUN
ajlm-5	56	15	committee	committee	PROPN
ajlm-5	56	16	(	(	PUNCT
ajlm-5	56	17	hrdc	hrdc	NOUN
ajlm-5	56	18	)	)	PUNCT
ajlm-5	56	19	of	of	ADP
ajlm-5	56	20	the	the	DET
ajlm-5	56	21	ministry	ministry	PROPN
ajlm-5	56	22	of	of	ADP
ajlm-5	56	23	health	health	PROPN
ajlm-5	56	24	in	in	ADP
ajlm-5	56	25	botswana	botswana	PROPN
ajlm-5	56	26	.	.	PROPN
ajlm-5	57	1	written	write	VERB
ajlm-5	57	2	informed	informed	ADJ
ajlm-5	57	3	consent	consent	NOUN
ajlm-5	57	4	was	be	AUX
ajlm-5	57	5	obtained	obtain	VERB
ajlm-5	57	6	from	from	ADP
ajlm-5	57	7	participants	participant	NOUN
ajlm-5	57	8	prior	prior	ADV
ajlm-5	57	9	to	to	ADP
ajlm-5	57	10	their	their	PRON
ajlm-5	57	11	enrollment	enrollment	NOUN
ajlm-5	57	12	.	.	PUNCT
ajlm-5	58	1	those	those	DET
ajlm-5	58	2	people	people	NOUN
ajlm-5	58	3	found	find	VERB
ajlm-5	58	4	to	to	PART
ajlm-5	58	5	be	be	AUX
ajlm-5	58	6	hiv	hiv	NOUN
ajlm-5	58	7	-	-	PUNCT
ajlm-5	58	8	positive	positive	ADJ
ajlm-5	58	9	were	be	AUX
ajlm-5	58	10	excluded	exclude	VERB
ajlm-5	58	11	from	from	ADP
ajlm-5	58	12	the	the	DET
ajlm-5	58	13	study	study	NOUN
ajlm-5	58	14	,	,	PUNCT
ajlm-5	58	15	and	and	CCONJ
ajlm-5	58	16	referred	refer	VERB
ajlm-5	58	17	for	for	ADP
ajlm-5	58	18	hiv	hiv	PROPN
ajlm-5	58	19	care	care	NOUN
ajlm-5	58	20	and	and	CCONJ
ajlm-5	58	21	treatment	treatment	NOUN
ajlm-5	58	22	clinics	clinic	NOUN
ajlm-5	58	23	for	for	ADP
ajlm-5	58	24	further	further	ADJ
ajlm-5	58	25	management	management	NOUN
ajlm-5	58	26	.	.	PUNCT
ajlm-5	59	1	cd4	cd4	PROPN
ajlm-5	59	2	and	and	CCONJ
ajlm-5	59	3	haematology	haematology	NOUN
ajlm-5	59	4	results	result	NOUN
ajlm-5	59	5	that	that	PRON
ajlm-5	59	6	were	be	AUX
ajlm-5	59	7	obtained	obtain	VERB
ajlm-5	59	8	,	,	PUNCT
ajlm-5	59	9	were	be	AUX
ajlm-5	59	10	offered	offer	VERB
ajlm-5	59	11	free	free	ADJ
ajlm-5	59	12	of	of	ADP
ajlm-5	59	13	charge	charge	NOUN
ajlm-5	59	14	as	as	ADP
ajlm-5	59	15	per	per	ADP
ajlm-5	59	16	the	the	DET
ajlm-5	59	17	botswanan	botswanan	NOUN
ajlm-5	59	18	guidelines	guideline	NOUN
ajlm-5	59	19	.	.	PUNCT
ajlm-5	60	1	statistical	statistical	ADJ
ajlm-5	60	2	analysis	analysis	NOUN
ajlm-5	60	3	reference	reference	NOUN
ajlm-5	60	4	intervals	interval	NOUN
ajlm-5	60	5	were	be	AUX
ajlm-5	60	6	calculated	calculate	VERB
ajlm-5	60	7	according	accord	VERB
ajlm-5	60	8	to	to	ADP
ajlm-5	60	9	the	the	DET
ajlm-5	60	10	clsi	clsi	NOUN
ajlm-5	60	11	guidelines	guideline	NOUN
ajlm-5	60	12	document	document	NOUN
ajlm-5	60	13	c28	c28	NOUN
ajlm-5	60	14	-	-	PUNCT
ajlm-5	60	15	a2	a2	NOUN
ajlm-5	60	16	28	28	NUM
ajlm-5	60	17	by	by	ADP
ajlm-5	60	18	applying	apply	VERB
ajlm-5	60	19	non	non	ADJ
ajlm-5	60	20	-	-	ADJ
ajlm-5	60	21	parametric	parametric	ADJ
ajlm-5	60	22	methods	method	NOUN
ajlm-5	60	23	.	.	PUNCT
ajlm-5	61	1	the	the	DET
ajlm-5	61	2	medians	median	NOUN
ajlm-5	61	3	were	be	AUX
ajlm-5	61	4	calculated	calculate	VERB
ajlm-5	61	5	and	and	CCONJ
ajlm-5	61	6	reference	reference	NOUN
ajlm-5	61	7	values	value	NOUN
ajlm-5	61	8	were	be	AUX
ajlm-5	61	9	determined	determine	VERB
ajlm-5	61	10	as	as	ADP
ajlm-5	61	11	the	the	DET
ajlm-5	61	12	2.5th	2.5th	PROPN
ajlm-5	61	13	and	and	CCONJ
ajlm-5	61	14	97.5th	97.5th	ADJ
ajlm-5	61	15	percentiles	percentile	NOUN
ajlm-5	61	16	,	,	PUNCT
ajlm-5	61	17	respectively	respectively	ADV
ajlm-5	61	18	,	,	PUNCT
ajlm-5	61	19	of	of	ADP
ajlm-5	61	20	the	the	DET
ajlm-5	61	21	distribution	distribution	NOUN
ajlm-5	61	22	of	of	ADP
ajlm-5	61	23	reference	reference	NOUN
ajlm-5	61	24	values	value	NOUN
ajlm-5	61	25	.	.	PUNCT
ajlm-5	62	1	the	the	DET
ajlm-5	62	2	mean	mean	ADJ
ajlm-5	62	3	,	,	PUNCT
ajlm-5	62	4	median	median	ADJ
ajlm-5	62	5	,	,	PUNCT
ajlm-5	62	6	and	and	CCONJ
ajlm-5	62	7	standard	standard	ADJ
ajlm-5	62	8	deviation	deviation	NOUN
ajlm-5	62	9	values	value	NOUN
ajlm-5	62	10	were	be	AUX
ajlm-5	62	11	calculated	calculate	VERB
ajlm-5	62	12	for	for	ADP
ajlm-5	62	13	each	each	DET
ajlm-5	62	14	immunohaematological	immunohaematological	ADJ
ajlm-5	62	15	parameter	parameter	NOUN
ajlm-5	62	16	.	.	PUNCT
ajlm-5	63	1	we	we	PRON
ajlm-5	63	2	used	use	VERB
ajlm-5	63	3	confidence	confidence	NOUN
ajlm-5	63	4	ratio	ratio	NOUN
ajlm-5	63	5	,	,	PUNCT
ajlm-5	63	6	which	which	PRON
ajlm-5	63	7	is	be	AUX
ajlm-5	63	8	the	the	DET
ajlm-5	63	9	ratio	ratio	NOUN
ajlm-5	63	10	of	of	ADP
ajlm-5	63	11	(	(	PUNCT
ajlm-5	63	12	average	average	ADJ
ajlm-5	63	13	confidence	confidence	NOUN
ajlm-5	63	14	interval	interval	NOUN
ajlm-5	63	15	width	width	NOUN
ajlm-5	63	16	)	)	PUNCT
ajlm-5	63	17	 	 	SPACE
ajlm-5	63	18	to	to	ADP
ajlm-5	63	19	 	 	SPACE
ajlm-5	63	20	(	(	PUNCT
ajlm-5	63	21	reference	reference	NOUN
ajlm-5	63	22	interval	interval	NOUN
ajlm-5	63	23	)	)	PUNCT
ajlm-5	63	24	,	,	PUNCT
ajlm-5	63	25	as	as	SCONJ
ajlm-5	63	26	described	describe	VERB
ajlm-5	63	27	by	by	ADP
ajlm-5	63	28	rhoads,29	rhoads,29	NOUN
ajlm-5	63	29	to	to	PART
ajlm-5	63	30	evaluate	evaluate	VERB
ajlm-5	63	31	the	the	DET
ajlm-5	63	32	impact	impact	NOUN
ajlm-5	63	33	of	of	ADP
ajlm-5	63	34	the	the	DET
ajlm-5	63	35	sample	sample	NOUN
ajlm-5	63	36	size	size	NOUN
ajlm-5	63	37	.	.	PUNCT
ajlm-5	64	1	clsi	clsi	NOUN
ajlm-5	64	2	recommends	recommend	VERB
ajlm-5	64	3	a	a	DET
ajlm-5	64	4	minimum	minimum	NOUN
ajlm-5	64	5	of	of	ADP
ajlm-5	64	6	120	120	NUM
ajlm-5	64	7	healthy	healthy	ADJ
ajlm-5	64	8	patients	patient	NOUN
ajlm-5	64	9	per	per	ADP
ajlm-5	64	10	group	group	NOUN
ajlm-5	64	11	.	.	PUNCT
ajlm-5	65	1	the	the	DET
ajlm-5	65	2	non	non	ADJ
ajlm-5	65	3	-	-	ADJ
ajlm-5	65	4	parametric	parametric	ADJ
ajlm-5	65	5	mann	mann	PROPN
ajlm-5	65	6	-	-	PUNCT
ajlm-5	65	7	whitney	whitney	PROPN
ajlm-5	65	8	u	u	PROPN
ajlm-5	65	9	test	test	NOUN
ajlm-5	65	10	was	be	AUX
ajlm-5	65	11	used	use	VERB
ajlm-5	65	12	to	to	PART
ajlm-5	65	13	determine	determine	VERB
ajlm-5	65	14	any	any	DET
ajlm-5	65	15	statistically	statistically	ADJ
ajlm-5	65	16	differences	difference	NOUN
ajlm-5	65	17	between	between	ADP
ajlm-5	65	18	laboratory	laboratory	NOUN
ajlm-5	65	19	values	value	NOUN
ajlm-5	65	20	for	for	ADP
ajlm-5	65	21	men	man	NOUN
ajlm-5	65	22	and	and	CCONJ
ajlm-5	65	23	women	woman	NOUN
ajlm-5	65	24	.	.	PUNCT
ajlm-5	66	1	p	p	X
ajlm-5	66	2	-	-	PUNCT
ajlm-5	66	3	values	value	NOUN
ajlm-5	66	4	 	 	SPACE
ajlm-5	66	5	<	<	AUX
ajlm-5	66	6	 	 	SPACE
ajlm-5	66	7	0.05	0.05	NUM
ajlm-5	66	8	were	be	AUX
ajlm-5	66	9	considered	consider	VERB
ajlm-5	66	10	significant	significant	ADJ
ajlm-5	66	11	.	.	PUNCT
ajlm-5	67	1	all	all	DET
ajlm-5	67	2	statistical	statistical	ADJ
ajlm-5	67	3	analyses	analysis	NOUN
ajlm-5	67	4	were	be	AUX
ajlm-5	67	5	carried	carry	VERB
ajlm-5	67	6	out	out	ADP
ajlm-5	67	7	with	with	ADP
ajlm-5	67	8	ep	ep	PROPN
ajlm-5	67	9	evaluator	evaluator	NOUN
ajlm-5	67	10	release	release	NOUN
ajlm-5	67	11	8	8	NUM
ajlm-5	67	12	(	(	PUNCT
ajlm-5	67	13	david	david	PROPN
ajlm-5	67	14	g.	g.	PROPN
ajlm-5	67	15	rhoads	rhoads	PROPN
ajlm-5	67	16	and	and	CCONJ
ajlm-5	67	17	associates	associates	PROPN
ajlm-5	67	18	,	,	PUNCT
ajlm-5	67	19	kennett	kennett	PROPN
ajlm-5	67	20	square	square	PROPN
ajlm-5	67	21	,	,	PUNCT
ajlm-5	67	22	pennsylvania	pennsylvania	PROPN
ajlm-5	67	23	,	,	PUNCT
ajlm-5	67	24	usa	usa	PROPN
ajlm-5	67	25	)	)	PUNCT
ajlm-5	67	26	and	and	CCONJ
ajlm-5	67	27	stata	stata	VERB
ajlm-5	67	28	11.0	11.0	NUM
ajlm-5	67	29	(	(	PUNCT
ajlm-5	67	30	satacorp	satacorp	PROPN
ajlm-5	67	31	,	,	PUNCT
ajlm-5	67	32	college	college	NOUN
ajlm-5	67	33	park	park	PROPN
ajlm-5	67	34	,	,	PUNCT
ajlm-5	67	35	texas	texas	PROPN
ajlm-5	67	36	,	,	PUNCT
ajlm-5	67	37	usa	usa	PROPN
ajlm-5	67	38	)	)	PUNCT
ajlm-5	67	39	.	.	PUNCT
ajlm-5	68	1	results	result	VERB
ajlm-5	68	2	top	top	ADJ
ajlm-5	68	3	↑	↑	NOUN
ajlm-5	68	4	screening	screening	NOUN
ajlm-5	68	5	and	and	CCONJ
ajlm-5	68	6	enrollment	enrollment	NOUN
ajlm-5	68	7	started	start	VERB
ajlm-5	68	8	in	in	ADP
ajlm-5	68	9	may	may	PROPN
ajlm-5	68	10	2008	2008	NUM
ajlm-5	68	11	and	and	CCONJ
ajlm-5	68	12	ended	end	VERB
ajlm-5	68	13	in	in	ADP
ajlm-5	68	14	june	june	PROPN
ajlm-5	68	15	2008	2008	NUM
ajlm-5	68	16	.	.	PUNCT
ajlm-5	69	1	a	a	DET
ajlm-5	69	2	total	total	NOUN
ajlm-5	69	3	of	of	ADP
ajlm-5	69	4	294	294	NUM
ajlm-5	69	5	individuals	individual	NOUN
ajlm-5	69	6	were	be	AUX
ajlm-5	69	7	screened	screen	VERB
ajlm-5	69	8	:	:	PUNCT
ajlm-5	69	9	145	145	NUM
ajlm-5	69	10	men	man	NOUN
ajlm-5	69	11	(	(	PUNCT
ajlm-5	69	12	49	49	NUM
ajlm-5	69	13	%	%	NOUN
ajlm-5	69	14	)	)	PUNCT
ajlm-5	69	15	and	and	CCONJ
ajlm-5	69	16	149	149	NUM
ajlm-5	69	17	women	woman	NOUN
ajlm-5	69	18	(	(	PUNCT
ajlm-5	69	19	51	51	NUM
ajlm-5	69	20	%	%	NOUN
ajlm-5	69	21	)	)	PUNCT
ajlm-5	69	22	.	.	PUNCT
ajlm-5	70	1	a	a	DET
ajlm-5	70	2	total	total	NOUN
ajlm-5	70	3	of	of	ADP
ajlm-5	70	4	33	33	NUM
ajlm-5	70	5	(	(	PUNCT
ajlm-5	70	6	11.2	11.2	NUM
ajlm-5	70	7	%	%	NOUN
ajlm-5	70	8	)	)	PUNCT
ajlm-5	70	9	of	of	ADP
ajlm-5	70	10	screened	screen	VERB
ajlm-5	70	11	volunteers	volunteer	NOUN
ajlm-5	70	12	were	be	AUX
ajlm-5	70	13	excluded	exclude	VERB
ajlm-5	70	14	,	,	PUNCT
ajlm-5	70	15	following	follow	VERB
ajlm-5	70	16	enrollment	enrollment	NOUN
ajlm-5	70	17	based	base	VERB
ajlm-5	70	18	on	on	ADP
ajlm-5	70	19	defined	define	VERB
ajlm-5	70	20	exclusion	exclusion	NOUN
ajlm-5	70	21	criteria	criterion	NOUN
ajlm-5	70	22	.	.	PUNCT
ajlm-5	71	1	the	the	DET
ajlm-5	71	2	remaining	remain	VERB
ajlm-5	71	3	261	261	NUM
ajlm-5	71	4	participants	participant	NOUN
ajlm-5	71	5	’	'	PUNCT
ajlm-5	71	6	samples	sample	NOUN
ajlm-5	71	7	were	be	AUX
ajlm-5	71	8	included	include	VERB
ajlm-5	71	9	in	in	ADP
ajlm-5	71	10	the	the	DET
ajlm-5	71	11	study	study	NOUN
ajlm-5	71	12	,	,	PUNCT
ajlm-5	71	13	and	and	CCONJ
ajlm-5	71	14	comprised	comprise	VERB
ajlm-5	71	15	135	135	NUM
ajlm-5	71	16	women	woman	NOUN
ajlm-5	71	17	(	(	PUNCT
ajlm-5	71	18	51	51	NUM
ajlm-5	71	19	%	%	NOUN
ajlm-5	71	20	)	)	PUNCT
ajlm-5	71	21	and	and	CCONJ
ajlm-5	71	22	126	126	NUM
ajlm-5	71	23	men	man	NOUN
ajlm-5	71	24	(	(	PUNCT
ajlm-5	71	25	49	49	NUM
ajlm-5	71	26	%	%	NOUN
ajlm-5	71	27	)	)	PUNCT
ajlm-5	71	28	.	.	PUNCT
ajlm-5	72	1	the	the	DET
ajlm-5	72	2	mean	mean	ADJ
ajlm-5	72	3	age	age	NOUN
ajlm-5	72	4	was	be	AUX
ajlm-5	72	5	28.8	28.8	NUM
ajlm-5	72	6	(	(	PUNCT
ajlm-5	72	7	95	95	NUM
ajlm-5	72	8	%	%	NOUN
ajlm-5	72	9	ci	ci	NOUN
ajlm-5	72	10	,	,	PUNCT
ajlm-5	72	11	27.7–29.8	27.7–29.8	NUM
ajlm-5	72	12	)	)	PUNCT
ajlm-5	72	13	 	 	SPACE
ajlm-5	72	14	years	year	NOUN
ajlm-5	72	15	,	,	PUNCT
ajlm-5	72	16	with	with	ADP
ajlm-5	72	17	a	a	DET
ajlm-5	72	18	median	median	NOUN
ajlm-5	72	19	of	of	ADP
ajlm-5	72	20	27	27	NUM
ajlm-5	72	21	and	and	CCONJ
ajlm-5	72	22	a	a	DET
ajlm-5	72	23	range	range	NOUN
ajlm-5	72	24	18–66	18–66	NUM
ajlm-5	72	25	 	 	SPACE
ajlm-5	72	26	years.in	years.in	PRON
ajlm-5	72	27	our	our	PRON
ajlm-5	72	28	results	result	NOUN
ajlm-5	72	29	(	(	PUNCT
ajlm-5	72	30	table	table	NOUN
ajlm-5	72	31	1	1	NUM
ajlm-5	72	32	and	and	CCONJ
ajlm-5	72	33	table	table	NOUN
ajlm-5	72	34	2	2	NUM
ajlm-5	72	35	)	)	PUNCT
ajlm-5	72	36	we	we	PRON
ajlm-5	72	37	show	show	VERB
ajlm-5	72	38	the	the	DET
ajlm-5	72	39	means	mean	NOUN
ajlm-5	72	40	,	,	PUNCT
ajlm-5	72	41	medians	median	NOUN
ajlm-5	72	42	and	and	CCONJ
ajlm-5	72	43	95th	95th	ADJ
ajlm-5	72	44	percentile	percentile	ADJ
ajlm-5	72	45	reference	reference	NOUN
ajlm-5	72	46	values	value	NOUN
ajlm-5	72	47	,	,	PUNCT
ajlm-5	72	48	according	accord	VERB
ajlm-5	72	49	to	to	ADP
ajlm-5	72	50	gender	gender	NOUN
ajlm-5	72	51	,	,	PUNCT
ajlm-5	72	52	for	for	ADP
ajlm-5	72	53	cd4	cd4	PROPN
ajlm-5	72	54	+	+	PROPN
ajlm-5	72	55	and	and	CCONJ
ajlm-5	72	56	cd8	cd8	PROPN
ajlm-5	72	57	+	+	PROPN
ajlm-5	72	58	t	t	PROPN
ajlm-5	72	59	-	-	PUNCT
ajlm-5	72	60	lymphocytes	lymphocyte	VERB
ajlm-5	72	61	absolute	absolute	ADJ
ajlm-5	72	62	values	value	NOUN
ajlm-5	72	63	and	and	CCONJ
ajlm-5	72	64	percentages	percentage	NOUN
ajlm-5	72	65	.	.	PUNCT
ajlm-5	73	1	the	the	DET
ajlm-5	73	2	median	median	ADJ
ajlm-5	73	3	cd4	cd4	PROPN
ajlm-5	73	4	cell	cell	NOUN
ajlm-5	73	5	count	count	NOUN
ajlm-5	73	6	in	in	ADP
ajlm-5	73	7	the	the	DET
ajlm-5	73	8	women	woman	NOUN
ajlm-5	73	9	(	(	PUNCT
ajlm-5	73	10	924	924	NUM
ajlm-5	73	11	cells	cell	NOUN
ajlm-5	73	12	/	/	SYM
ajlm-5	73	13	mm3	mm3	PROPN
ajlm-5	73	14	)	)	PUNCT
ajlm-5	73	15	was	be	AUX
ajlm-5	73	16	significant	significant	ADV
ajlm-5	73	17	higher	high	ADJ
ajlm-5	73	18	than	than	ADP
ajlm-5	73	19	in	in	ADP
ajlm-5	73	20	the	the	DET
ajlm-5	73	21	men	man	NOUN
ajlm-5	73	22	(	(	PUNCT
ajlm-5	73	23	744	744	NUM
ajlm-5	73	24	cells	cell	NOUN
ajlm-5	73	25	/	/	SYM
ajlm-5	73	26	mm3	mm3	NOUN
ajlm-5	73	27	)	)	PUNCT
ajlm-5	73	28	,	,	PUNCT
ajlm-5	73	29	with	with	ADP
ajlm-5	73	30	p	p	X
ajlm-5	73	31	 	 	SPACE
ajlm-5	73	32	<	<	X
ajlm-5	73	33	 	 	SPACE
ajlm-5	73	34	0.05	0.05	NUM
ajlm-5	73	35	.	.	PUNCT
ajlm-5	74	1	the	the	DET
ajlm-5	74	2	calculated	calculate	VERB
ajlm-5	74	3	combined	combined	ADJ
ajlm-5	74	4	reference	reference	NOUN
ajlm-5	74	5	intervals	interval	NOUN
ajlm-5	74	6	for	for	ADP
ajlm-5	74	7	cd4	cd4	PROPN
ajlm-5	74	8	+	+	PROPN
ajlm-5	74	9	and	and	CCONJ
ajlm-5	74	10	cd8	cd8	PROPN
ajlm-5	74	11	+	+	PROPN
ajlm-5	74	12	t	t	PROPN
ajlm-5	74	13	-	-	PUNCT
ajlm-5	74	14	lymphocytes	lymphocyte	NOUN
ajlm-5	74	15	were	be	AUX
ajlm-5	74	16	261	261	NUM
ajlm-5	74	17	 	 	SPACE
ajlm-5	74	18	cells	cell	NOUN
ajlm-5	74	19	/	/	SYM
ajlm-5	74	20	mm3	mm3	PROPN
ajlm-5	74	21	–	–	PUNCT
ajlm-5	74	22	1667	1667	NUM
ajlm-5	74	23	 	 	SPACE
ajlm-5	74	24	cells	cell	NOUN
ajlm-5	74	25	/	/	SYM
ajlm-5	74	26	mm3	mm3	NOUN
ajlm-5	74	27	and	and	CCONJ
ajlm-5	74	28	261	261	NUM
ajlm-5	74	29	 	 	SPACE
ajlm-5	74	30	cells	cell	NOUN
ajlm-5	74	31	/	/	SYM
ajlm-5	74	32	mm3	mm3	PROPN
ajlm-5	74	33	–	–	PUNCT
ajlm-5	74	34	1538	1538	NUM
ajlm-5	74	35	 	 	SPACE
ajlm-5	74	36	cells	cell	NOUN
ajlm-5	74	37	/	/	SYM
ajlm-5	74	38	mm3	mm3	NOUN
ajlm-5	74	39	for	for	ADP
ajlm-5	74	40	men	man	NOUN
ajlm-5	74	41	,	,	PUNCT
ajlm-5	74	42	and	and	CCONJ
ajlm-5	74	43	268	268	NUM
ajlm-5	74	44	 	 	SPACE
ajlm-5	74	45	cells	cell	NOUN
ajlm-5	74	46	/	/	SYM
ajlm-5	74	47	mm3	mm3	PROPN
ajlm-5	74	48	–	–	PUNCT
ajlm-5	74	49	1667	1667	NUM
ajlm-5	74	50	 	 	SPACE
ajlm-5	74	51	cells	cell	NOUN
ajlm-5	74	52	/	/	SYM
ajlm-5	74	53	mm3	mm3	NOUN
ajlm-5	74	54	for	for	ADP
ajlm-5	74	55	women	woman	NOUN
ajlm-5	74	56	(	(	PUNCT
ajlm-5	74	57	table	table	NOUN
ajlm-5	74	58	1	1	NUM
ajlm-5	74	59	)	)	PUNCT
ajlm-5	74	60	.	.	PUNCT
ajlm-5	75	1	the	the	DET
ajlm-5	75	2	reference	reference	NOUN
ajlm-5	75	3	intervals	interval	NOUN
ajlm-5	75	4	for	for	ADP
ajlm-5	75	5	cd8	cd8	PROPN
ajlm-5	75	6	+	+	PROPN
ajlm-5	75	7	t	t	PROPN
ajlm-5	75	8	-	-	PUNCT
ajlm-5	75	9	lymphocytes	lymphocyte	NOUN
ajlm-5	75	10	(	(	PUNCT
ajlm-5	75	11	table	table	NOUN
ajlm-5	75	12	2	2	NUM
ajlm-5	75	13	)	)	PUNCT
ajlm-5	75	14	were	be	AUX
ajlm-5	75	15	comparable	comparable	ADJ
ajlm-5	75	16	to	to	ADP
ajlm-5	75	17	those	those	PRON
ajlm-5	75	18	obtained	obtain	VERB
ajlm-5	75	19	from	from	ADP
ajlm-5	75	20	a	a	DET
ajlm-5	75	21	blood	blood	NOUN
ajlm-5	75	22	donor	donor	NOUN
ajlm-5	75	23	population	population	NOUN
ajlm-5	75	24	.	.	PUNCT
ajlm-5	76	1	the	the	DET
ajlm-5	76	2	study	study	NOUN
ajlm-5	76	3	furthermore	furthermore	ADV
ajlm-5	76	4	shows	show	VERB
ajlm-5	76	5	that	that	SCONJ
ajlm-5	76	6	the	the	DET
ajlm-5	76	7	cd4	cd4	PROPN
ajlm-5	76	8	%	%	NOUN
ajlm-5	76	9	and	and	CCONJ
ajlm-5	76	10	cd8	cd8	PROPN
ajlm-5	76	11	%	%	NOUN
ajlm-5	76	12	reference	reference	NOUN
ajlm-5	76	13	intervals	interval	NOUN
ajlm-5	76	14	for	for	ADP
ajlm-5	76	15	women	woman	NOUN
ajlm-5	76	16	were	be	AUX
ajlm-5	76	17	27–63	27–63	NUM
ajlm-5	76	18	,	,	PUNCT
ajlm-5	76	19	for	for	ADP
ajlm-5	76	20	men	man	NOUN
ajlm-5	76	21	27–60	27–60	NUM
ajlm-5	76	22	,	,	PUNCT
ajlm-5	76	23	and	and	CCONJ
ajlm-5	76	24	for	for	ADP
ajlm-5	76	25	both	both	DET
ajlm-5	76	26	sexes	sex	NOUN
ajlm-5	76	27	27–63	27–63	NUM
ajlm-5	76	28	(	(	PUNCT
ajlm-5	76	29	table	table	NOUN
ajlm-5	76	30	3	3	NUM
ajlm-5	76	31	)	)	PUNCT
ajlm-5	76	32	.	.	PUNCT
ajlm-5	77	1	the	the	DET
ajlm-5	77	2	cd8	cd8	PROPN
ajlm-5	77	3	%	%	PROPN
ajlm-5	77	4	reference	reference	NOUN
ajlm-5	77	5	intervals	interval	NOUN
ajlm-5	77	6	were	be	AUX
ajlm-5	77	7	12–46	12–46	NUM
ajlm-5	77	8	for	for	ADP
ajlm-5	77	9	women	woman	NOUN
ajlm-5	77	10	,	,	PUNCT
ajlm-5	77	11	11–45	11–45	NUM
ajlm-5	77	12	for	for	ADP
ajlm-5	77	13	men	man	NOUN
ajlm-5	77	14	,	,	PUNCT
ajlm-5	77	15	and	and	CCONJ
ajlm-5	77	16	11–46	11–46	NUM
ajlm-5	77	17	for	for	ADP
ajlm-5	77	18	both	both	DET
ajlm-5	77	19	sexes	sex	NOUN
ajlm-5	77	20	.	.	PUNCT
ajlm-5	78	1	the	the	DET
ajlm-5	78	2	absolute	absolute	PROPN
ajlm-5	78	3	cd4	cd4	PROPN
ajlm-5	78	4	and	and	CCONJ
ajlm-5	78	5	cd8	cd8	PROPN
ajlm-5	78	6	values	value	NOUN
ajlm-5	78	7	for	for	ADP
ajlm-5	78	8	botswana	botswana	PROPN
ajlm-5	78	9	were	be	AUX
ajlm-5	78	10	lower	low	ADJ
ajlm-5	78	11	than	than	ADP
ajlm-5	78	12	for	for	ADP
ajlm-5	78	13	most	most	ADJ
ajlm-5	78	14	african	african	ADJ
ajlm-5	78	15	countries	country	NOUN
ajlm-5	78	16	(	(	PUNCT
ajlm-5	78	17	table	table	NOUN
ajlm-5	78	18	4	4	NUM
ajlm-5	78	19	)	)	PUNCT
ajlm-5	78	20	.	.	PUNCT
ajlm-5	79	1	table	table	NOUN
ajlm-5	79	2	1	1	NUM
ajlm-5	79	3	:	:	PUNCT
ajlm-5	79	4	cd4	cd4	PROPN
ajlm-5	79	5	+	+	NOUN
ajlm-5	79	6	cell	cell	NOUN
ajlm-5	79	7	counts	count	NOUN
ajlm-5	79	8	for	for	ADP
ajlm-5	79	9	healthy	healthy	ADJ
ajlm-5	79	10	hiv	hiv	PROPN
ajlm-5	79	11	-	-	PUNCT
ajlm-5	79	12	negative	negative	ADJ
ajlm-5	79	13	adults	adult	NOUN
ajlm-5	79	14	in	in	ADP
ajlm-5	79	15	botswana	botswana	PROPN
ajlm-5	79	16	.	.	PUNCT
ajlm-5	79	17	table	table	NOUN
ajlm-5	80	1	2	2	NUM
ajlm-5	80	2	:	:	PUNCT
ajlm-5	80	3	cd8	cd8	PROPN
ajlm-5	80	4	+	+	PROPN
ajlm-5	80	5	cells	cell	NOUN
ajlm-5	80	6	counts	count	VERB
ajlm-5	80	7	for	for	ADP
ajlm-5	80	8	healthy	healthy	ADJ
ajlm-5	80	9	hiv	hiv	PROPN
ajlm-5	80	10	-	-	PUNCT
ajlm-5	80	11	negative	negative	ADJ
ajlm-5	80	12	adults	adult	NOUN
ajlm-5	80	13	in	in	ADP
ajlm-5	80	14	botswana	botswana	PROPN
ajlm-5	80	15	.	.	PUNCT
ajlm-5	80	16	table	table	PROPN
ajlm-5	81	1	3	3	NUM
ajlm-5	81	2	:	:	PUNCT
ajlm-5	81	3	cd4	cd4	PROPN
ajlm-5	81	4	%	%	NOUN
ajlm-5	81	5	and	and	CCONJ
ajlm-5	81	6	cd8	cd8	PROPN
ajlm-5	81	7	%	%	NOUN
ajlm-5	81	8	cells	cell	NOUN
ajlm-5	81	9	counts	count	VERB
ajlm-5	81	10	for	for	ADP
ajlm-5	81	11	healthy	healthy	ADJ
ajlm-5	81	12	hiv	hiv	PROPN
ajlm-5	81	13	-	-	PUNCT
ajlm-5	81	14	negative	negative	ADJ
ajlm-5	81	15	adults	adult	NOUN
ajlm-5	81	16	in	in	ADP
ajlm-5	81	17	botswana	botswana	PROPN
ajlm-5	81	18	.	.	PUNCT
ajlm-5	81	19	table	table	NOUN
ajlm-5	81	20	4	4	NUM
ajlm-5	81	21	:	:	PUNCT
ajlm-5	81	22	comparison	comparison	NOUN
ajlm-5	81	23	of	of	ADP
ajlm-5	81	24	ratio	ratio	NOUN
ajlm-5	81	25	of	of	ADP
ajlm-5	81	26	cd4	cd4	PROPN
ajlm-5	81	27	+	+	PROPN
ajlm-5	81	28	to	to	ADP
ajlm-5	81	29	cd8	cd8	PROPN
ajlm-5	81	30	+	+	PROPN
ajlm-5	81	31	and	and	CCONJ
ajlm-5	81	32	absolute	absolute	ADJ
ajlm-5	81	33	cd4	cd4	PROPN
ajlm-5	81	34	+	+	PROPN
ajlm-5	81	35	,	,	PUNCT
ajlm-5	81	36	cd8	cd8	PROPN
ajlm-5	81	37	+	+	ADJ
ajlm-5	81	38	and	and	CCONJ
ajlm-5	81	39	lymphocyte	lymphocyte	ADJ
ajlm-5	81	40	counts	count	NOUN
ajlm-5	81	41	between	between	ADP
ajlm-5	81	42	different	different	ADJ
ajlm-5	81	43	populations	population	NOUN
ajlm-5	81	44	.	.	PUNCT
ajlm-5	82	1	our	our	PRON
ajlm-5	82	2	research	research	NOUN
ajlm-5	82	3	shows	show	VERB
ajlm-5	82	4	the	the	DET
ajlm-5	82	5	reference	reference	NOUN
ajlm-5	82	6	intervals	interval	NOUN
ajlm-5	82	7	for	for	ADP
ajlm-5	82	8	the	the	DET
ajlm-5	82	9	haematological	haematological	ADJ
ajlm-5	82	10	parameters	parameter	NOUN
ajlm-5	82	11	(	(	PUNCT
ajlm-5	82	12	mean	mean	VERB
ajlm-5	82	13	;	;	PUNCT
ajlm-5	82	14	mean	mean	PROPN
ajlm-5	82	15	s.d	s.d	PROPN
ajlm-5	82	16	;	;	PUNCT
ajlm-5	82	17	and	and	CCONJ
ajlm-5	82	18	95	95	NUM
ajlm-5	82	19	%	%	NOUN
ajlm-5	82	20	ci	ci	NOUN
ajlm-5	82	21	for	for	ADP
ajlm-5	82	22	mean	mean	ADJ
ajlm-5	82	23	,	,	PUNCT
ajlm-5	82	24	median	median	ADJ
ajlm-5	82	25	,	,	PUNCT
ajlm-5	82	26	range	range	NOUN
ajlm-5	82	27	2.5th	2.5th	PROPN
ajlm-5	82	28	to	to	ADP
ajlm-5	82	29	97.5th	97.5th	PROPN
ajlm-5	82	30	percentile	percentile	NOUN
ajlm-5	82	31	)	)	PUNCT
ajlm-5	82	32	partitioned	partition	VERB
ajlm-5	82	33	by	by	ADP
ajlm-5	82	34	gender	gender	NOUN
ajlm-5	82	35	(	(	PUNCT
ajlm-5	82	36	table	table	NOUN
ajlm-5	82	37	5	5	NUM
ajlm-5	82	38	and	and	CCONJ
ajlm-5	82	39	table	table	NOUN
ajlm-5	82	40	6	6	NUM
ajlm-5	82	41	)	)	PUNCT
ajlm-5	82	42	.	.	PUNCT
ajlm-5	83	1	the	the	DET
ajlm-5	83	2	red	red	ADJ
ajlm-5	83	3	blood	blood	NOUN
ajlm-5	83	4	cell	cell	NOUN
ajlm-5	83	5	(	(	PUNCT
ajlm-5	83	6	rbc	rbc	PROPN
ajlm-5	83	7	)	)	PUNCT
ajlm-5	83	8	parameters	parameter	NOUN
ajlm-5	83	9	(	(	PUNCT
ajlm-5	83	10	median	median	PROPN
ajlm-5	83	11	haemoglobin	haemoglobin	PROPN
ajlm-5	83	12	,	,	PUNCT
ajlm-5	83	13	haematocrit	haematocrit	PROPN
ajlm-5	83	14	,	,	PUNCT
ajlm-5	83	15	and	and	CCONJ
ajlm-5	83	16	rbc	rbc	PROPN
ajlm-5	83	17	)	)	PUNCT
ajlm-5	83	18	and	and	CCONJ
ajlm-5	83	19	wbc	wbc	PROPN
ajlm-5	83	20	were	be	AUX
ajlm-5	83	21	statistically	statistically	ADV
ajlm-5	83	22	different	different	ADJ
ajlm-5	83	23	according	accord	VERB
ajlm-5	83	24	to	to	ADP
ajlm-5	83	25	gender	gender	NOUN
ajlm-5	83	26	(	(	PUNCT
ajlm-5	83	27	p	p	X
ajlm-5	83	28	 	 	SPACE
ajlm-5	83	29	<	<	X
ajlm-5	83	30	 	 	SPACE
ajlm-5	83	31	0.05	0.05	NUM
ajlm-5	83	32	)	)	PUNCT
ajlm-5	83	33	.	.	PUNCT
ajlm-5	84	1	there	there	PRON
ajlm-5	84	2	were	be	VERB
ajlm-5	84	3	;	;	PUNCT
ajlm-5	84	4	however	however	ADV
ajlm-5	84	5	,	,	PUNCT
ajlm-5	84	6	no	no	DET
ajlm-5	84	7	gender	gender	NOUN
ajlm-5	84	8	-	-	PUNCT
ajlm-5	84	9	specific	specific	ADJ
ajlm-5	84	10	differences	difference	NOUN
ajlm-5	84	11	observed	observe	VERB
ajlm-5	84	12	for	for	ADP
ajlm-5	84	13	some	some	DET
ajlm-5	84	14	white	white	ADJ
ajlm-5	84	15	blood	blood	NOUN
ajlm-5	84	16	cell	cell	NOUN
ajlm-5	84	17	(	(	PUNCT
ajlm-5	84	18	wbc	wbc	PROPN
ajlm-5	84	19	)	)	PUNCT
ajlm-5	84	20	subsets	subset	NOUN
ajlm-5	84	21	(	(	PUNCT
ajlm-5	84	22	neutrophils	neutrophil	NOUN
ajlm-5	84	23	,	,	PUNCT
ajlm-5	84	24	eosinophils	eosinophil	NOUN
ajlm-5	84	25	,	,	PUNCT
ajlm-5	84	26	lymphocytes	lymphocyte	NOUN
ajlm-5	84	27	,	,	PUNCT
ajlm-5	84	28	reticulocytes	reticulocyte	NOUN
ajlm-5	84	29	and	and	CCONJ
ajlm-5	84	30	basophils	basophils	PROPN
ajlm-5	84	31	)	)	PUNCT
ajlm-5	84	32	,	,	PUNCT
ajlm-5	84	33	except	except	SCONJ
ajlm-5	84	34	for	for	ADP
ajlm-5	84	35	monocytes	monocyte	NOUN
ajlm-5	84	36	(	(	PUNCT
ajlm-5	84	37	p	p	NOUN
ajlm-5	84	38	 	 	SPACE
ajlm-5	84	39	=	=	NOUN
ajlm-5	84	40	 	 	SPACE
ajlm-5	84	41	0.0089	0.0089	NUM
ajlm-5	84	42	)	)	PUNCT
ajlm-5	84	43	.	.	PUNCT
ajlm-5	85	1	our	our	PRON
ajlm-5	85	2	research	research	NOUN
ajlm-5	85	3	also	also	ADV
ajlm-5	85	4	shows	show	VERB
ajlm-5	85	5	haematological	haematological	ADJ
ajlm-5	85	6	reference	reference	NOUN
ajlm-5	85	7	intervals	interval	NOUN
ajlm-5	85	8	from	from	ADP
ajlm-5	85	9	this	this	DET
ajlm-5	85	10	study	study	NOUN
ajlm-5	85	11	and	and	CCONJ
ajlm-5	85	12	those	those	PRON
ajlm-5	85	13	from	from	ADP
ajlm-5	85	14	certain	certain	ADJ
ajlm-5	85	15	african	african	ADJ
ajlm-5	85	16	countries14,16,18,19	countries14,16,18,19	PROPN
ajlm-5	85	17	and	and	CCONJ
ajlm-5	85	18	non	non	ADJ
ajlm-5	85	19	-	-	ADJ
ajlm-5	85	20	african	african	ADJ
ajlm-5	85	21	populations	population	NOUN
ajlm-5	85	22	(	(	PUNCT
ajlm-5	85	23	table	table	NOUN
ajlm-5	85	24	7).30	7).30	PRON
ajlm-5	85	25	the	the	DET
ajlm-5	85	26	haemoglobin	haemoglobin	PROPN
ajlm-5	85	27	reference	reference	NOUN
ajlm-5	85	28	intervals	interval	NOUN
ajlm-5	85	29	were	be	AUX
ajlm-5	85	30	generally	generally	ADV
ajlm-5	85	31	higher	high	ADJ
ajlm-5	85	32	than	than	ADP
ajlm-5	85	33	in	in	ADP
ajlm-5	85	34	east	east	PROPN
ajlm-5	85	35	africa	africa	PROPN
ajlm-5	85	36	,	,	PUNCT
ajlm-5	85	37	but	but	CCONJ
ajlm-5	85	38	lower	low	ADJ
ajlm-5	85	39	than	than	ADP
ajlm-5	85	40	those	those	PRON
ajlm-5	85	41	from	from	ADP
ajlm-5	85	42	ethiopia	ethiopia	PROPN
ajlm-5	85	43	and	and	CCONJ
ajlm-5	85	44	us	we	PRON
ajlm-5	85	45	-	-	PUNCT
ajlm-5	85	46	based	base	VERB
ajlm-5	85	47	comparison	comparison	NOUN
ajlm-5	85	48	populations	population	NOUN
ajlm-5	85	49	.	.	PUNCT
ajlm-5	86	1	table	table	NOUN
ajlm-5	86	2	5	5	NUM
ajlm-5	86	3	:	:	PUNCT
ajlm-5	86	4	means	mean	NOUN
ajlm-5	86	5	,	,	PUNCT
ajlm-5	86	6	medians	median	NOUN
ajlm-5	86	7	and	and	CCONJ
ajlm-5	86	8	95th	95th	ADJ
ajlm-5	86	9	percentile	percentile	ADJ
ajlm-5	86	10	reference	reference	NOUN
ajlm-5	86	11	intervals	interval	NOUN
ajlm-5	86	12	for	for	ADP
ajlm-5	86	13	haematological	haematological	ADJ
ajlm-5	86	14	parameters	parameter	NOUN
ajlm-5	86	15	for	for	ADP
ajlm-5	86	16	261	261	NUM
ajlm-5	86	17	hiv	hiv	PROPN
ajlm-5	86	18	-	-	PUNCT
ajlm-5	86	19	negative	negative	ADJ
ajlm-5	86	20	adults	adult	NOUN
ajlm-5	86	21	in	in	ADP
ajlm-5	86	22	botswana	botswana	PROPN
ajlm-5	86	23	.	.	PUNCT
ajlm-5	86	24	table	table	PROPN
ajlm-5	86	25	6	6	NUM
ajlm-5	86	26	:	:	PUNCT
ajlm-5	86	27	means	mean	NOUN
ajlm-5	86	28	,	,	PUNCT
ajlm-5	86	29	medians	median	NOUN
ajlm-5	86	30	and	and	CCONJ
ajlm-5	86	31	95th	95th	ADJ
ajlm-5	86	32	percentile	percentile	ADJ
ajlm-5	86	33	reference	reference	NOUN
ajlm-5	86	34	intervals	interval	NOUN
ajlm-5	86	35	of	of	ADP
ajlm-5	86	36	white	white	ADJ
ajlm-5	86	37	blood	blood	NOUN
ajlm-5	86	38	cell	cell	NOUN
ajlm-5	86	39	subset	subset	VERB
ajlm-5	86	40	percentages	percentage	NOUN
ajlm-5	86	41	for	for	ADP
ajlm-5	86	42	261	261	NUM
ajlm-5	86	43	hiv	hiv	PROPN
ajlm-5	86	44	-	-	PUNCT
ajlm-5	86	45	negative	negative	ADJ
ajlm-5	86	46	adults	adult	NOUN
ajlm-5	86	47	in	in	ADP
ajlm-5	86	48	botswana	botswana	PROPN
ajlm-5	86	49	.	.	PUNCT
ajlm-5	87	1	table	table	PROPN
ajlm-5	87	2	7	7	NUM
ajlm-5	87	3	:	:	PUNCT
ajlm-5	87	4	comparison	comparison	NOUN
ajlm-5	87	5	of	of	ADP
ajlm-5	87	6	haematological	haematological	ADJ
ajlm-5	87	7	parameters	parameter	NOUN
ajlm-5	87	8	between	between	ADP
ajlm-5	87	9	different	different	ADJ
ajlm-5	87	10	populations	population	NOUN
ajlm-5	87	11	.	.	PUNCT
ajlm-5	88	1	discussion	discussion	NOUN
ajlm-5	88	2	top	top	PROPN
ajlm-5	88	3	↑	↑	PROPN
ajlm-5	88	4	the	the	DET
ajlm-5	88	5	reference	reference	NOUN
ajlm-5	88	6	intervals	interval	NOUN
ajlm-5	88	7	for	for	ADP
ajlm-5	88	8	immunohaematological	immunohaematological	ADJ
ajlm-5	88	9	and	and	CCONJ
ajlm-5	88	10	clinical	clinical	ADJ
ajlm-5	88	11	chemistry	chemistry	NOUN
ajlm-5	88	12	parameters	parameter	NOUN
ajlm-5	88	13	,	,	PUNCT
ajlm-5	88	14	which	which	PRON
ajlm-5	88	15	may	may	AUX
ajlm-5	88	16	serve	serve	VERB
ajlm-5	88	17	as	as	ADP
ajlm-5	88	18	botswanan	botswanan	NOUN
ajlm-5	88	19	standards	standard	NOUN
ajlm-5	88	20	for	for	ADP
ajlm-5	88	21	the	the	DET
ajlm-5	88	22	interpretation	interpretation	NOUN
ajlm-5	88	23	of	of	ADP
ajlm-5	88	24	laboratory	laboratory	NOUN
ajlm-5	88	25	results	result	NOUN
ajlm-5	88	26	,	,	PUNCT
ajlm-5	88	27	were	be	AUX
ajlm-5	88	28	established	establish	VERB
ajlm-5	88	29	from	from	ADP
ajlm-5	88	30	260	260	NUM
ajlm-5	88	31	hiv	hiv	PROPN
ajlm-5	88	32	-	-	PUNCT
ajlm-5	88	33	negative	negative	ADJ
ajlm-5	88	34	participants	participant	NOUN
ajlm-5	88	35	(	(	PUNCT
ajlm-5	88	36	134	134	NUM
ajlm-5	88	37	women	woman	NOUN
ajlm-5	88	38	[	[	X
ajlm-5	88	39	52	52	NUM
ajlm-5	88	40	%	%	NOUN
ajlm-5	88	41	]	]	PUNCT
ajlm-5	88	42	and	and	CCONJ
ajlm-5	88	43	126	126	NUM
ajlm-5	88	44	men	man	NOUN
ajlm-5	88	45	[	[	X
ajlm-5	88	46	48	48	NUM
ajlm-5	88	47	%	%	NOUN
ajlm-5	88	48	]	]	PUNCT
ajlm-5	88	49	)	)	PUNCT
ajlm-5	88	50	aged	aged	ADJ
ajlm-5	88	51	18–66	18–66	NUM
ajlm-5	88	52	years	year	NOUN
ajlm-5	88	53	,	,	PUNCT
ajlm-5	88	54	from	from	ADP
ajlm-5	88	55	around	around	ADP
ajlm-5	88	56	gaborone	gaborone	PROPN
ajlm-5	88	57	.	.	PUNCT
ajlm-5	89	1	as	as	SCONJ
ajlm-5	89	2	expected	expect	VERB
ajlm-5	89	3	,	,	PUNCT
ajlm-5	89	4	the	the	DET
ajlm-5	89	5	percentage	percentage	NOUN
ajlm-5	89	6	cd4	cd4	NOUN
ajlm-5	89	7	+	+	PROPN
ajlm-5	89	8	and	and	CCONJ
ajlm-5	89	9	cd8	cd8	PROPN
ajlm-5	89	10	+	+	PROPN
ajlm-5	89	11	t	t	PROPN
ajlm-5	89	12	-	-	PUNCT
ajlm-5	89	13	lymphocytes	lymphocyte	NOUN
ajlm-5	89	14	varied	varied	ADJ
ajlm-5	89	15	less	less	ADV
ajlm-5	89	16	between	between	ADP
ajlm-5	89	17	women	woman	NOUN
ajlm-5	89	18	and	and	CCONJ
ajlm-5	89	19	men	man	NOUN
ajlm-5	89	20	.	.	PUNCT
ajlm-5	90	1	malone	malone	NOUN
ajlm-5	90	2	et	et	PROPN
ajlm-5	90	3	al.31	al.31	PROPN
ajlm-5	90	4	reported	report	VERB
ajlm-5	90	5	large	large	ADJ
ajlm-5	90	6	fluctuations	fluctuation	NOUN
ajlm-5	90	7	in	in	ADP
ajlm-5	90	8	repeated	repeat	VERB
ajlm-5	90	9	cd4	cd4	PROPN
ajlm-5	90	10	+	+	NOUN
ajlm-5	90	11	cell	cell	NOUN
ajlm-5	90	12	counts	count	NOUN
ajlm-5	90	13	in	in	ADP
ajlm-5	90	14	hiv	hiv	PROPN
ajlm-5	90	15	-	-	PUNCT
ajlm-5	90	16	positive	positive	ADJ
ajlm-5	90	17	patients	patient	NOUN
ajlm-5	90	18	and	and	CCONJ
ajlm-5	90	19	can	can	AUX
ajlm-5	90	20	be	be	AUX
ajlm-5	90	21	explained	explain	VERB
ajlm-5	90	22	,	,	PUNCT
ajlm-5	90	23	in	in	ADP
ajlm-5	90	24	part	part	NOUN
ajlm-5	90	25	,	,	PUNCT
ajlm-5	90	26	by	by	ADP
ajlm-5	90	27	cd4	cd4	PROPN
ajlm-5	90	28	+	+	PROPN
ajlm-5	90	29	cell	cell	NOUN
ajlm-5	90	30	count	count	NOUN
ajlm-5	90	31	diurnal	diurnal	ADJ
ajlm-5	90	32	cycle	cycle	NOUN
ajlm-5	90	33	,	,	PUNCT
ajlm-5	90	34	and	and	CCONJ
ajlm-5	90	35	also	also	ADV
ajlm-5	90	36	by	by	ADP
ajlm-5	90	37	high	high	ADJ
ajlm-5	90	38	variability	variability	NOUN
ajlm-5	90	39	in	in	ADP
ajlm-5	90	40	total	total	ADJ
ajlm-5	90	41	lymphocyte	lymphocyte	ADJ
ajlm-5	90	42	counts	count	NOUN
ajlm-5	90	43	.	.	PUNCT
ajlm-5	91	1	hiv	hiv	PROPN
ajlm-5	91	2	-	-	PUNCT
ajlm-5	91	3	negative	negative	ADJ
ajlm-5	91	4	women	woman	NOUN
ajlm-5	91	5	have	have	VERB
ajlm-5	91	6	a	a	DET
ajlm-5	91	7	higher	high	ADJ
ajlm-5	91	8	average	average	ADJ
ajlm-5	91	9	cd4	cd4	PROPN
ajlm-5	91	10	+	+	PROPN
ajlm-5	91	11	t	t	PROPN
ajlm-5	91	12	-	-	PUNCT
ajlm-5	91	13	lymphocytes	lymphocyte	NOUN
ajlm-5	91	14	count	count	NOUN
ajlm-5	91	15	than	than	ADP
ajlm-5	91	16	men	man	NOUN
ajlm-5	91	17	,	,	PUNCT
ajlm-5	91	18	which	which	PRON
ajlm-5	91	19	confirms	confirm	VERB
ajlm-5	91	20	the	the	DET
ajlm-5	91	21	findings	finding	NOUN
ajlm-5	91	22	of	of	ADP
ajlm-5	91	23	bussmann	bussmann	PROPN
ajlm-5	91	24	et	et	PROPN
ajlm-5	91	25	al.32	al.32	VERB
ajlm-5	91	26	the	the	DET
ajlm-5	91	27	cd4	cd4	PROPN
ajlm-5	91	28	cell	cell	NOUN
ajlm-5	91	29	counts	count	NOUN
ajlm-5	91	30	are	be	AUX
ajlm-5	91	31	lower	low	ADJ
ajlm-5	91	32	in	in	ADP
ajlm-5	91	33	botswana	botswana	PROPN
ajlm-5	91	34	than	than	ADP
ajlm-5	91	35	those	those	PRON
ajlm-5	91	36	observed	observe	VERB
ajlm-5	91	37	in	in	ADP
ajlm-5	91	38	east	east	PROPN
ajlm-5	91	39	africa	africa	PROPN
ajlm-5	91	40	and	and	CCONJ
ajlm-5	91	41	usa	usa	PROPN
ajlm-5	91	42	.	.	PROPN
ajlm-5	92	1	this	this	PRON
ajlm-5	92	2	has	have	VERB
ajlm-5	92	3	obvious	obvious	ADJ
ajlm-5	92	4	implications	implication	NOUN
ajlm-5	92	5	on	on	ADP
ajlm-5	92	6	the	the	DET
ajlm-5	92	7	clinical	clinical	ADJ
ajlm-5	92	8	staging	staging	NOUN
ajlm-5	92	9	of	of	ADP
ajlm-5	92	10	aids	aid	NOUN
ajlm-5	92	11	and	and	CCONJ
ajlm-5	92	12	the	the	DET
ajlm-5	92	13	assessment	assessment	NOUN
ajlm-5	92	14	for	for	ADP
ajlm-5	92	15	disease	disease	NOUN
ajlm-5	92	16	progression.the	progression.the	DET
ajlm-5	92	17	significant	significant	ADJ
ajlm-5	92	18	gender	gender	NOUN
ajlm-5	92	19	difference	difference	NOUN
ajlm-5	92	20	in	in	ADP
ajlm-5	92	21	red	red	ADJ
ajlm-5	92	22	blood	blood	NOUN
ajlm-5	92	23	cell	cell	NOUN
ajlm-5	92	24	count	count	NOUN
ajlm-5	92	25	,	,	PUNCT
ajlm-5	92	26	haemoglobin	haemoglobin	NOUN
ajlm-5	92	27	and	and	CCONJ
ajlm-5	92	28	haematocrit	haematocrit	PROPN
ajlm-5	92	29	,	,	PUNCT
ajlm-5	92	30	agrees	agree	VERB
ajlm-5	92	31	with	with	ADP
ajlm-5	92	32	other	other	ADJ
ajlm-5	92	33	studies16	studies16	NOUN
ajlm-5	92	34	and	and	CCONJ
ajlm-5	92	35	with	with	ADP
ajlm-5	92	36	the	the	DET
ajlm-5	92	37	well	well	ADV
ajlm-5	92	38	-	-	PUNCT
ajlm-5	92	39	established	establish	VERB
ajlm-5	92	40	fact	fact	NOUN
ajlm-5	92	41	that	that	SCONJ
ajlm-5	92	42	men	man	NOUN
ajlm-5	92	43	have	have	AUX
ajlm-5	92	44	higher	high	ADJ
ajlm-5	92	45	values	value	NOUN
ajlm-5	92	46	for	for	ADP
ajlm-5	92	47	the	the	DET
ajlm-5	92	48	red	red	ADJ
ajlm-5	92	49	blood	blood	NOUN
ajlm-5	92	50	cell	cell	NOUN
ajlm-5	92	51	parameters	parameter	NOUN
ajlm-5	92	52	than	than	ADP
ajlm-5	92	53	women	woman	NOUN
ajlm-5	92	54	,	,	PUNCT
ajlm-5	92	55	partly	partly	ADV
ajlm-5	92	56	because	because	SCONJ
ajlm-5	92	57	of	of	ADP
ajlm-5	92	58	the	the	DET
ajlm-5	92	59	influence	influence	NOUN
ajlm-5	92	60	of	of	ADP
ajlm-5	92	61	the	the	DET
ajlm-5	92	62	hormone	hormone	NOUN
ajlm-5	92	63	androgen	androgen	NOUN
ajlm-5	92	64	on	on	ADP
ajlm-5	92	65	erythropoiesis	erythropoiesis	NOUN
ajlm-5	92	66	,	,	PUNCT
ajlm-5	92	67	and	and	CCONJ
ajlm-5	92	68	partly	partly	ADV
ajlm-5	92	69	because	because	SCONJ
ajlm-5	92	70	of	of	ADP
ajlm-5	92	71	menstrual	menstrual	ADJ
ajlm-5	92	72	loss	loss	NOUN
ajlm-5	92	73	.	.	PUNCT
ajlm-5	93	1	the	the	DET
ajlm-5	93	2	red	red	ADJ
ajlm-5	93	3	blood	blood	NOUN
ajlm-5	93	4	cell	cell	NOUN
ajlm-5	93	5	parameters	parameter	NOUN
ajlm-5	93	6	for	for	ADP
ajlm-5	93	7	the	the	DET
ajlm-5	93	8	botswanan	botswanan	NOUN
ajlm-5	93	9	population	population	NOUN
ajlm-5	93	10	were	be	AUX
ajlm-5	93	11	within	within	ADP
ajlm-5	93	12	the	the	DET
ajlm-5	93	13	intervals	interval	NOUN
ajlm-5	93	14	for	for	ADP
ajlm-5	93	15	the	the	DET
ajlm-5	93	16	ethiopian	ethiopian	ADJ
ajlm-5	93	17	population	population	NOUN
ajlm-5	93	18	,	,	PUNCT
ajlm-5	93	19	even	even	ADV
ajlm-5	93	20	though	though	SCONJ
ajlm-5	93	21	the	the	DET
ajlm-5	93	22	expectation	expectation	NOUN
ajlm-5	93	23	was	be	AUX
ajlm-5	93	24	that	that	SCONJ
ajlm-5	93	25	altitude	altitude	NOUN
ajlm-5	93	26	induces	induce	NOUN
ajlm-5	93	27	erythropoiesis	erythropoiesis	NOUN
ajlm-5	93	28	,	,	PUNCT
ajlm-5	93	29	which	which	PRON
ajlm-5	93	30	has	have	AUX
ajlm-5	93	31	accounted	account	VERB
ajlm-5	93	32	for	for	ADP
ajlm-5	93	33	the	the	DET
ajlm-5	93	34	red	red	ADJ
ajlm-5	93	35	blood	blood	NOUN
ajlm-5	93	36	cell	cell	NOUN
ajlm-5	93	37	parameters	parameter	NOUN
ajlm-5	93	38	of	of	ADP
ajlm-5	93	39	ethiopia	ethiopia	PROPN
ajlm-5	93	40	that	that	PRON
ajlm-5	93	41	were	be	AUX
ajlm-5	93	42	consistently	consistently	ADV
ajlm-5	93	43	higher	high	ADJ
ajlm-5	93	44	than	than	ADP
ajlm-5	93	45	those	those	PRON
ajlm-5	93	46	of	of	ADP
ajlm-5	93	47	many	many	ADJ
ajlm-5	93	48	other	other	ADJ
ajlm-5	93	49	african	african	ADJ
ajlm-5	93	50	countries.16	countries.16	PROPN
ajlm-5	93	51	the	the	DET
ajlm-5	93	52	median	median	ADJ
ajlm-5	93	53	haemoglobin	haemoglobin	NOUN
ajlm-5	93	54	level	level	NOUN
ajlm-5	93	55	was	be	AUX
ajlm-5	93	56	significantly	significantly	ADV
ajlm-5	93	57	lower	low	ADJ
ajlm-5	93	58	for	for	ADP
ajlm-5	93	59	women	woman	NOUN
ajlm-5	93	60	than	than	ADP
ajlm-5	93	61	for	for	ADP
ajlm-5	93	62	men	man	NOUN
ajlm-5	93	63	,	,	PUNCT
ajlm-5	93	64	which	which	PRON
ajlm-5	93	65	is	be	AUX
ajlm-5	93	66	consistent	consistent	ADJ
ajlm-5	93	67	with	with	ADP
ajlm-5	93	68	previous	previous	ADJ
ajlm-5	93	69	findings.8,9,21,27	findings.8,9,21,27	NOUN
ajlm-5	93	70	the	the	DET
ajlm-5	93	71	female	female	ADJ
ajlm-5	93	72	haemoglobin	haemoglobin	NOUN
ajlm-5	93	73	reference	reference	NOUN
ajlm-5	93	74	value	value	NOUN
ajlm-5	93	75	(	(	PUNCT
ajlm-5	93	76	9.0	9.0	NUM
ajlm-5	93	77	 	 	SPACE
ajlm-5	93	78	g	g	PROPN
ajlm-5	93	79	/	/	SYM
ajlm-5	93	80	dl	dl	PROPN
ajlm-5	93	81	to	to	ADP
ajlm-5	93	82	15.0	15.0	NUM
ajlm-5	93	83	 	 	SPACE
ajlm-5	93	84	g	g	PROPN
ajlm-5	93	85	/	/	SYM
ajlm-5	93	86	dl	dl	NOUN
ajlm-5	93	87	)	)	PUNCT
ajlm-5	93	88	levels	level	NOUN
ajlm-5	93	89	were	be	AUX
ajlm-5	93	90	lower	low	ADJ
ajlm-5	93	91	than	than	SCONJ
ajlm-5	93	92	observed	observe	VERB
ajlm-5	93	93	in	in	ADP
ajlm-5	93	94	predominantly	predominantly	ADV
ajlm-5	93	95	white	white	ADJ
ajlm-5	93	96	populations	population	NOUN
ajlm-5	93	97	(	(	PUNCT
ajlm-5	93	98	12.0	12.0	NUM
ajlm-5	93	99	 	 	SPACE
ajlm-5	93	100	g	g	PROPN
ajlm-5	93	101	/	/	SYM
ajlm-5	93	102	dl	dl	PROPN
ajlm-5	93	103	to	to	ADP
ajlm-5	93	104	16.0	16.0	NUM
ajlm-5	93	105	 	 	SPACE
ajlm-5	93	106	g	g	PROPN
ajlm-5	93	107	/	/	SYM
ajlm-5	93	108	dl	dl	PROPN
ajlm-5	93	109	)	)	PUNCT
ajlm-5	93	110	,	,	PUNCT
ajlm-5	93	111	but	but	CCONJ
ajlm-5	93	112	comparable	comparable	ADJ
ajlm-5	93	113	with	with	ADP
ajlm-5	93	114	east	east	ADJ
ajlm-5	93	115	african	african	ADJ
ajlm-5	93	116	and	and	CCONJ
ajlm-5	93	117	southern	southern	ADJ
ajlm-5	93	118	african	african	ADJ
ajlm-5	93	119	regional	regional	ADJ
ajlm-5	93	120	consensus	consensus	NOUN
ajlm-5	93	121	reference	reference	NOUN
ajlm-5	93	122	intervals	interval	NOUN
ajlm-5	93	123	(	(	PUNCT
ajlm-5	93	124	9.5	9.5	NUM
ajlm-5	93	125	 	 	SPACE
ajlm-5	93	126	g	g	PROPN
ajlm-5	93	127	/	/	SYM
ajlm-5	93	128	dl	dl	PROPN
ajlm-5	93	129	to	to	ADP
ajlm-5	93	130	15.8	15.8	NUM
ajlm-5	93	131	 	 	SPACE
ajlm-5	93	132	g	g	PROPN
ajlm-5	93	133	/	/	SYM
ajlm-5	93	134	dl	dl	PROPN
ajlm-5	93	135	)	)	PUNCT
ajlm-5	93	136	recently	recently	ADV
ajlm-5	93	137	defined	define	VERB
ajlm-5	93	138	for	for	ADP
ajlm-5	93	139	east	east	ADJ
ajlm-5	93	140	and	and	CCONJ
ajlm-5	93	141	southern	southern	PROPN
ajlm-5	93	142	africa	africa	PROPN
ajlm-5	93	143	.	.	PUNCT
ajlm-5	94	1	the	the	DET
ajlm-5	94	2	division	division	NOUN
ajlm-5	94	3	of	of	ADP
ajlm-5	94	4	aids	aids	PROPN
ajlm-5	94	5	(	(	PUNCT
ajlm-5	94	6	daids	daid	NOUN
ajlm-5	94	7	)	)	PUNCT
ajlm-5	94	8	has	have	VERB
ajlm-5	94	9	haematological	haematological	ADJ
ajlm-5	94	10	criteria	criterion	NOUN
ajlm-5	94	11	for	for	ADP
ajlm-5	94	12	grading	grade	VERB
ajlm-5	94	13	the	the	DET
ajlm-5	94	14	severity	severity	NOUN
ajlm-5	94	15	of	of	ADP
ajlm-5	94	16	potential	potential	ADJ
ajlm-5	94	17	vaccine	vaccine	NOUN
ajlm-5	94	18	-	-	PUNCT
ajlm-5	94	19	related	relate	VERB
ajlm-5	94	20	adverse	adverse	ADJ
ajlm-5	94	21	events.22	events.22	NOUN
ajlm-5	94	22	white	white	ADJ
ajlm-5	94	23	blood	blood	NOUN
ajlm-5	94	24	cell	cell	NOUN
ajlm-5	94	25	and	and	CCONJ
ajlm-5	94	26	platelet	platelet	NOUN
ajlm-5	94	27	counts	count	NOUN
ajlm-5	94	28	,	,	PUNCT
ajlm-5	94	29	and	and	CCONJ
ajlm-5	94	30	haemoglobin	haemoglobin	PROPN
ajlm-5	94	31	levels	level	NOUN
ajlm-5	94	32	are	be	AUX
ajlm-5	94	33	used	use	VERB
ajlm-5	94	34	as	as	ADP
ajlm-5	94	35	inclusion	inclusion	NOUN
ajlm-5	94	36	and/or	and/or	CCONJ
ajlm-5	94	37	exclusion	exclusion	NOUN
ajlm-5	94	38	criteria	criterion	NOUN
ajlm-5	94	39	in	in	ADP
ajlm-5	94	40	many	many	ADJ
ajlm-5	94	41	clinical	clinical	ADJ
ajlm-5	94	42	trials	trial	NOUN
ajlm-5	94	43	.	.	PUNCT
ajlm-5	95	1	the	the	DET
ajlm-5	95	2	lower	low	ADJ
ajlm-5	95	3	limit	limit	NOUN
ajlm-5	95	4	of	of	ADP
ajlm-5	95	5	botswana	botswana	PROPN
ajlm-5	95	6	’s	’s	PART
ajlm-5	95	7	normal	normal	ADJ
ajlm-5	95	8	female	female	ADJ
ajlm-5	95	9	reference	reference	NOUN
ajlm-5	95	10	range	range	NOUN
ajlm-5	95	11	for	for	ADP
ajlm-5	95	12	haemoglobin	haemoglobin	NOUN
ajlm-5	95	13	qualifies	qualify	VERB
ajlm-5	95	14	as	as	ADP
ajlm-5	95	15	a	a	DET
ajlm-5	95	16	moderate	moderate	ADJ
ajlm-5	95	17	adverse	adverse	ADJ
ajlm-5	95	18	event	event	NOUN
ajlm-5	95	19	and	and	CCONJ
ajlm-5	95	20	a	a	DET
ajlm-5	95	21	significant	significant	ADJ
ajlm-5	95	22	proportion	proportion	NOUN
ajlm-5	95	23	of	of	ADP
ajlm-5	95	24	the	the	DET
ajlm-5	95	25	woman	woman	NOUN
ajlm-5	95	26	may	may	AUX
ajlm-5	95	27	not	not	PART
ajlm-5	95	28	qualify	qualify	VERB
ajlm-5	95	29	to	to	PART
ajlm-5	95	30	be	be	AUX
ajlm-5	95	31	enrolled	enrol	VERB
ajlm-5	95	32	for	for	ADP
ajlm-5	95	33	phase	phase	NOUN
ajlm-5	95	34	i	i	PRON
ajlm-5	95	35	and/or	and/or	CCONJ
ajlm-5	95	36	phase	phase	NOUN
ajlm-5	95	37	ii	ii	NOUN
ajlm-5	95	38	vaccine	vaccine	NOUN
ajlm-5	95	39	trials	trial	NOUN
ajlm-5	95	40	.	.	PUNCT
ajlm-5	96	1	the	the	DET
ajlm-5	96	2	methodologies	methodology	NOUN
ajlm-5	96	3	in	in	ADP
ajlm-5	96	4	this	this	DET
ajlm-5	96	5	study	study	NOUN
ajlm-5	96	6	are	be	AUX
ajlm-5	96	7	commonly	commonly	ADV
ajlm-5	96	8	used	use	VERB
ajlm-5	96	9	,	,	PUNCT
ajlm-5	96	10	and	and	CCONJ
ajlm-5	96	11	should	should	AUX
ajlm-5	96	12	serve	serve	VERB
ajlm-5	96	13	well	well	ADV
ajlm-5	96	14	as	as	ADP
ajlm-5	96	15	guidelines	guideline	NOUN
ajlm-5	96	16	for	for	ADP
ajlm-5	96	17	the	the	DET
ajlm-5	96	18	represented	represent	VERB
ajlm-5	96	19	population	population	NOUN
ajlm-5	96	20	.	.	PUNCT
ajlm-5	97	1	laboratories	laboratory	NOUN
ajlm-5	97	2	that	that	PRON
ajlm-5	97	3	wish	wish	VERB
ajlm-5	97	4	to	to	PART
ajlm-5	97	5	adopt	adopt	VERB
ajlm-5	97	6	these	these	DET
ajlm-5	97	7	reference	reference	NOUN
ajlm-5	97	8	intervals	interval	NOUN
ajlm-5	97	9	should	should	AUX
ajlm-5	97	10	explore	explore	VERB
ajlm-5	97	11	any	any	DET
ajlm-5	97	12	differences	difference	NOUN
ajlm-5	97	13	in	in	ADP
ajlm-5	97	14	methodology	methodology	NOUN
ajlm-5	97	15	,	,	PUNCT
ajlm-5	97	16	and	and	CCONJ
ajlm-5	97	17	should	should	AUX
ajlm-5	97	18	verify	verify	VERB
ajlm-5	97	19	the	the	DET
ajlm-5	97	20	transference	transference	NOUN
ajlm-5	97	21	and	and	CCONJ
ajlm-5	97	22	appropriateness	appropriateness	NOUN
ajlm-5	97	23	of	of	ADP
ajlm-5	97	24	the	the	DET
ajlm-5	97	25	reference	reference	NOUN
ajlm-5	97	26	intervals	interval	NOUN
ajlm-5	97	27	to	to	ADP
ajlm-5	97	28	their	their	PRON
ajlm-5	97	29	laboratory	laboratory	NOUN
ajlm-5	97	30	.	.	PUNCT
ajlm-5	98	1	limitations	limitation	NOUN
ajlm-5	98	2	of	of	ADP
ajlm-5	98	3	the	the	DET
ajlm-5	98	4	study	study	NOUN
ajlm-5	98	5	although	although	SCONJ
ajlm-5	98	6	this	this	DET
ajlm-5	98	7	study	study	NOUN
ajlm-5	98	8	meets	meet	VERB
ajlm-5	98	9	the	the	DET
ajlm-5	98	10	minimum	minimum	ADJ
ajlm-5	98	11	clsi	clsi	NOUN
ajlm-5	98	12	requirements	requirement	NOUN
ajlm-5	98	13	for	for	ADP
ajlm-5	98	14	establishing	establish	VERB
ajlm-5	98	15	valid	valid	ADJ
ajlm-5	98	16	reference	reference	NOUN
ajlm-5	98	17	intervals	interval	NOUN
ajlm-5	98	18	,	,	PUNCT
ajlm-5	98	19	it	it	PRON
ajlm-5	98	20	is	be	AUX
ajlm-5	98	21	be	be	AUX
ajlm-5	98	22	important	important	ADJ
ajlm-5	98	23	to	to	PART
ajlm-5	98	24	explore	explore	VERB
ajlm-5	98	25	further	further	ADJ
ajlm-5	98	26	geographic	geographic	ADJ
ajlm-5	98	27	and	and	CCONJ
ajlm-5	98	28	ethic	ethic	ADJ
ajlm-5	98	29	differences	difference	NOUN
ajlm-5	98	30	that	that	PRON
ajlm-5	98	31	may	may	AUX
ajlm-5	98	32	exist	exist	VERB
ajlm-5	98	33	within	within	ADP
ajlm-5	98	34	the	the	DET
ajlm-5	98	35	botswanan	botswanan	NOUN
ajlm-5	98	36	population	population	NOUN
ajlm-5	98	37	.	.	PUNCT
ajlm-5	99	1	one	one	NUM
ajlm-5	99	2	limitation	limitation	NOUN
ajlm-5	99	3	of	of	ADP
ajlm-5	99	4	our	our	PRON
ajlm-5	99	5	study	study	NOUN
ajlm-5	99	6	is	be	AUX
ajlm-5	99	7	that	that	SCONJ
ajlm-5	99	8	,	,	PUNCT
ajlm-5	99	9	despite	despite	SCONJ
ajlm-5	99	10	our	our	PRON
ajlm-5	99	11	efforts	effort	NOUN
ajlm-5	99	12	to	to	PART
ajlm-5	99	13	include	include	VERB
ajlm-5	99	14	only	only	ADJ
ajlm-5	99	15	healthy	healthy	ADJ
ajlm-5	99	16	subjects	subject	NOUN
ajlm-5	99	17	,	,	PUNCT
ajlm-5	99	18	the	the	DET
ajlm-5	99	19	use	use	NOUN
ajlm-5	99	20	of	of	ADP
ajlm-5	99	21	a	a	DET
ajlm-5	99	22	questionnaire	questionnaire	NOUN
ajlm-5	99	23	,	,	PUNCT
ajlm-5	99	24	as	as	ADV
ajlm-5	99	25	well	well	ADV
ajlm-5	99	26	as	as	ADP
ajlm-5	99	27	hiv	hiv	PROPN
ajlm-5	99	28	screening	screening	NOUN
ajlm-5	99	29	and	and	CCONJ
ajlm-5	99	30	a	a	DET
ajlm-5	99	31	review	review	NOUN
ajlm-5	99	32	by	by	ADP
ajlm-5	99	33	a	a	DET
ajlm-5	99	34	physician	physician	NOUN
ajlm-5	99	35	,	,	PUNCT
ajlm-5	99	36	it	it	PRON
ajlm-5	99	37	was	be	AUX
ajlm-5	99	38	not	not	PART
ajlm-5	99	39	feasible	feasible	ADJ
ajlm-5	99	40	to	to	PART
ajlm-5	99	41	screen	screen	VERB
ajlm-5	99	42	for	for	ADP
ajlm-5	99	43	all	all	DET
ajlm-5	99	44	medical	medical	ADJ
ajlm-5	99	45	conditions	condition	NOUN
ajlm-5	99	46	that	that	PRON
ajlm-5	99	47	might	might	AUX
ajlm-5	99	48	have	have	AUX
ajlm-5	99	49	influenced	influence	VERB
ajlm-5	99	50	the	the	DET
ajlm-5	99	51	laboratory	laboratory	NOUN
ajlm-5	99	52	results	result	NOUN
ajlm-5	99	53	.	.	PUNCT
ajlm-5	100	1	for	for	ADP
ajlm-5	100	2	instance	instance	NOUN
ajlm-5	100	3	,	,	PUNCT
ajlm-5	100	4	participants	participant	NOUN
ajlm-5	100	5	were	be	AUX
ajlm-5	100	6	not	not	PART
ajlm-5	100	7	examined	examine	VERB
ajlm-5	100	8	for	for	ADP
ajlm-5	100	9	other	other	ADJ
ajlm-5	100	10	infections	infection	NOUN
ajlm-5	100	11	such	such	ADJ
ajlm-5	100	12	as	as	ADP
ajlm-5	100	13	respiratory	respiratory	ADJ
ajlm-5	100	14	infections	infection	NOUN
ajlm-5	100	15	,	,	PUNCT
ajlm-5	100	16	recent	recent	ADJ
ajlm-5	100	17	transient	transient	ADJ
ajlm-5	100	18	gastroenteritis	gastroenteritis	NOUN
ajlm-5	100	19	and	and	CCONJ
ajlm-5	100	20	sexually	sexually	ADV
ajlm-5	100	21	transmitted	transmit	VERB
ajlm-5	100	22	infections	infection	NOUN
ajlm-5	100	23	.	.	PUNCT
ajlm-5	101	1	all	all	DET
ajlm-5	101	2	participants	participant	NOUN
ajlm-5	101	3	were	be	AUX
ajlm-5	101	4	adults	adult	NOUN
ajlm-5	101	5	drawn	draw	VERB
ajlm-5	101	6	from	from	ADP
ajlm-5	101	7	voluntary	voluntary	ADJ
ajlm-5	101	8	counselling	counselling	NOUN
ajlm-5	101	9	and	and	CCONJ
ajlm-5	101	10	testing	testing	NOUN
ajlm-5	101	11	facilities	facility	NOUN
ajlm-5	101	12	.	.	PUNCT
ajlm-5	102	1	when	when	SCONJ
ajlm-5	102	2	reporting	reporting	NOUN
ajlm-5	102	3	reference	reference	NOUN
ajlm-5	102	4	values	value	NOUN
ajlm-5	102	5	,	,	PUNCT
ajlm-5	102	6	the	the	DET
ajlm-5	102	7	actual	actual	ADJ
ajlm-5	102	8	representativeness	representativeness	NOUN
ajlm-5	102	9	of	of	ADP
ajlm-5	102	10	the	the	DET
ajlm-5	102	11	data	data	NOUN
ajlm-5	102	12	is	be	AUX
ajlm-5	102	13	an	an	DET
ajlm-5	102	14	important	important	ADJ
ajlm-5	102	15	concern	concern	NOUN
ajlm-5	102	16	for	for	ADP
ajlm-5	102	17	the	the	DET
ajlm-5	102	18	underlying	underlie	VERB
ajlm-5	102	19	population	population	NOUN
ajlm-5	102	20	.	.	PUNCT
ajlm-5	103	1	as	as	ADP
ajlm-5	103	2	in	in	ADP
ajlm-5	103	3	most	most	ADJ
ajlm-5	103	4	studies	study	NOUN
ajlm-5	103	5	,	,	PUNCT
ajlm-5	103	6	we	we	PRON
ajlm-5	103	7	can	can	AUX
ajlm-5	103	8	not	not	PART
ajlm-5	103	9	totally	totally	ADV
ajlm-5	103	10	exclude	exclude	VERB
ajlm-5	103	11	the	the	DET
ajlm-5	103	12	possibility	possibility	NOUN
ajlm-5	103	13	that	that	SCONJ
ajlm-5	103	14	there	there	PRON
ajlm-5	103	15	is	be	VERB
ajlm-5	103	16	some	some	DET
ajlm-5	103	17	sampling	sample	VERB
ajlm-5	103	18	bias	bias	NOUN
ajlm-5	103	19	because	because	SCONJ
ajlm-5	103	20	of	of	ADP
ajlm-5	103	21	use	use	NOUN
ajlm-5	103	22	of	of	ADP
ajlm-5	103	23	a	a	DET
ajlm-5	103	24	self	self	NOUN
ajlm-5	103	25	-	-	PUNCT
ajlm-5	103	26	selecting	select	VERB
ajlm-5	103	27	population	population	NOUN
ajlm-5	103	28	.	.	PUNCT
ajlm-5	104	1	our	our	PRON
ajlm-5	104	2	analysis	analysis	NOUN
ajlm-5	104	3	excluded	exclude	VERB
ajlm-5	104	4	participants	participant	NOUN
ajlm-5	104	5	who	who	PRON
ajlm-5	104	6	showed	show	VERB
ajlm-5	104	7	any	any	DET
ajlm-5	104	8	signs	sign	NOUN
ajlm-5	104	9	or	or	CCONJ
ajlm-5	104	10	symptoms	symptom	NOUN
ajlm-5	104	11	of	of	ADP
ajlm-5	104	12	disease	disease	NOUN
ajlm-5	104	13	,	,	PUNCT
ajlm-5	104	14	however	however	ADV
ajlm-5	104	15	,	,	PUNCT
ajlm-5	104	16	and	and	CCONJ
ajlm-5	104	17	it	it	PRON
ajlm-5	104	18	is	be	AUX
ajlm-5	104	19	thus	thus	ADV
ajlm-5	104	20	likely	likely	ADJ
ajlm-5	104	21	that	that	SCONJ
ajlm-5	104	22	our	our	PRON
ajlm-5	104	23	data	datum	NOUN
ajlm-5	104	24	are	be	AUX
ajlm-5	104	25	representative	representative	ADJ
ajlm-5	104	26	of	of	ADP
ajlm-5	104	27	healthy	healthy	ADJ
ajlm-5	104	28	adults	adult	NOUN
ajlm-5	104	29	from	from	ADP
ajlm-5	104	30	the	the	DET
ajlm-5	104	31	southern	southern	ADJ
ajlm-5	104	32	region	region	NOUN
ajlm-5	104	33	of	of	ADP
ajlm-5	104	34	botswana	botswana	PROPN
ajlm-5	104	35	.	.	PUNCT
ajlm-5	105	1	gaborone	gaborone	PROPN
ajlm-5	105	2	is	be	AUX
ajlm-5	105	3	the	the	DET
ajlm-5	105	4	capital	capital	NOUN
ajlm-5	105	5	city	city	NOUN
ajlm-5	105	6	of	of	ADP
ajlm-5	105	7	botswana	botswana	PROPN
ajlm-5	105	8	and	and	CCONJ
ajlm-5	105	9	has	have	VERB
ajlm-5	105	10	a	a	DET
ajlm-5	105	11	diversity	diversity	NOUN
ajlm-5	105	12	of	of	ADP
ajlm-5	105	13	ethnic	ethnic	ADJ
ajlm-5	105	14	groups	group	NOUN
ajlm-5	105	15	;	;	PUNCT
ajlm-5	105	16	consequently	consequently	ADV
ajlm-5	105	17	,	,	PUNCT
ajlm-5	105	18	reference	reference	NOUN
ajlm-5	105	19	values	value	NOUN
ajlm-5	105	20	from	from	ADP
ajlm-5	105	21	this	this	DET
ajlm-5	105	22	region	region	NOUN
ajlm-5	105	23	are	be	AUX
ajlm-5	105	24	not	not	PART
ajlm-5	105	25	likely	likely	ADJ
ajlm-5	105	26	to	to	PART
ajlm-5	105	27	make	make	VERB
ajlm-5	105	28	a	a	DET
ajlm-5	105	29	significant	significant	ADJ
ajlm-5	105	30	clinical	clinical	ADJ
ajlm-5	105	31	difference	difference	NOUN
ajlm-5	105	32	.	.	PUNCT
ajlm-5	106	1	because	because	SCONJ
ajlm-5	106	2	of	of	ADP
ajlm-5	106	3	access	access	NOUN
ajlm-5	106	4	to	to	ADP
ajlm-5	106	5	a	a	DET
ajlm-5	106	6	reference	reference	NOUN
ajlm-5	106	7	laboratory	laboratory	NOUN
ajlm-5	106	8	working	work	VERB
ajlm-5	106	9	under	under	ADP
ajlm-5	106	10	iso	iso	NOUN
ajlm-5	106	11	and	and	CCONJ
ajlm-5	106	12	gclp	gclp	ADJ
ajlm-5	106	13	standards	standard	NOUN
ajlm-5	106	14	,	,	PUNCT
ajlm-5	106	15	it	it	PRON
ajlm-5	106	16	was	be	AUX
ajlm-5	106	17	not	not	PART
ajlm-5	106	18	easy	easy	ADJ
ajlm-5	106	19	to	to	PART
ajlm-5	106	20	include	include	VERB
ajlm-5	106	21	regions	region	NOUN
ajlm-5	106	22	that	that	PRON
ajlm-5	106	23	are	be	AUX
ajlm-5	106	24	further	far	ADV
ajlm-5	106	25	away	away	ADV
ajlm-5	106	26	from	from	ADP
ajlm-5	106	27	the	the	DET
ajlm-5	106	28	capital	capital	NOUN
ajlm-5	106	29	city	city	NOUN
ajlm-5	106	30	,	,	PUNCT
ajlm-5	106	31	but	but	CCONJ
ajlm-5	106	32	this	this	DET
ajlm-5	106	33	data	data	NOUN
ajlm-5	106	34	is	be	AUX
ajlm-5	106	35	still	still	ADV
ajlm-5	106	36	considered	consider	VERB
ajlm-5	106	37	to	to	PART
ajlm-5	106	38	be	be	AUX
ajlm-5	106	39	a	a	DET
ajlm-5	106	40	very	very	ADV
ajlm-5	106	41	important	important	ADJ
ajlm-5	106	42	baseline	baseline	NOUN
ajlm-5	106	43	for	for	ADP
ajlm-5	106	44	similar	similar	ADJ
ajlm-5	106	45	future	future	ADJ
ajlm-5	106	46	studies	study	NOUN
ajlm-5	106	47	.	.	PUNCT
ajlm-5	107	1	the	the	DET
ajlm-5	107	2	data	datum	NOUN
ajlm-5	107	3	are	be	AUX
ajlm-5	107	4	also	also	ADV
ajlm-5	107	5	immediately	immediately	ADV
ajlm-5	107	6	applicable	applicable	ADJ
ajlm-5	107	7	in	in	ADP
ajlm-5	107	8	studies	study	NOUN
ajlm-5	107	9	and	and	CCONJ
ajlm-5	107	10	clinical	clinical	ADJ
ajlm-5	107	11	care	care	NOUN
ajlm-5	107	12	that	that	PRON
ajlm-5	107	13	is	be	AUX
ajlm-5	107	14	an	an	DET
ajlm-5	107	15	improvement	improvement	NOUN
ajlm-5	107	16	over	over	ADP
ajlm-5	107	17	the	the	DET
ajlm-5	107	18	current	current	ADJ
ajlm-5	107	19	practice	practice	NOUN
ajlm-5	107	20	of	of	ADP
ajlm-5	107	21	using	use	VERB
ajlm-5	107	22	reference	reference	NOUN
ajlm-5	107	23	values	value	NOUN
ajlm-5	107	24	derived	derive	VERB
ajlm-5	107	25	from	from	ADP
ajlm-5	107	26	elsewhere	elsewhere	ADV
ajlm-5	107	27	.	.	PUNCT
ajlm-5	108	1	conclusion	conclusion	NOUN
ajlm-5	108	2	top	top	PROPN
ajlm-5	108	3	↑	↑	PROPN
ajlm-5	108	4	this	this	PRON
ajlm-5	108	5	is	be	AUX
ajlm-5	108	6	the	the	DET
ajlm-5	108	7	first	first	ADJ
ajlm-5	108	8	study	study	NOUN
ajlm-5	108	9	in	in	ADP
ajlm-5	108	10	botswana	botswana	PROPN
ajlm-5	108	11	to	to	PART
ajlm-5	108	12	document	document	VERB
ajlm-5	108	13	haematological	haematological	ADJ
ajlm-5	108	14	reference	reference	NOUN
ajlm-5	108	15	intervals	interval	NOUN
ajlm-5	108	16	for	for	ADP
ajlm-5	108	17	healthy	healthy	ADJ
ajlm-5	108	18	adults	adult	NOUN
ajlm-5	108	19	.	.	PUNCT
ajlm-5	109	1	our	our	PRON
ajlm-5	109	2	study	study	NOUN
ajlm-5	109	3	shows	show	VERB
ajlm-5	109	4	that	that	SCONJ
ajlm-5	109	5	clinical	clinical	ADJ
ajlm-5	109	6	reference	reference	NOUN
ajlm-5	109	7	values	value	NOUN
ajlm-5	109	8	developed	develop	VERB
ajlm-5	109	9	within	within	ADP
ajlm-5	109	10	the	the	DET
ajlm-5	109	11	region	region	NOUN
ajlm-5	109	12	are	be	AUX
ajlm-5	109	13	more	more	ADV
ajlm-5	109	14	appropriate	appropriate	ADJ
ajlm-5	109	15	for	for	ADP
ajlm-5	109	16	the	the	DET
ajlm-5	109	17	botswanan	botswanan	NOUN
ajlm-5	109	18	population	population	NOUN
ajlm-5	109	19	than	than	ADP
ajlm-5	109	20	those	those	PRON
ajlm-5	109	21	adopted	adopt	VERB
ajlm-5	109	22	from	from	ADP
ajlm-5	109	23	developed	developed	ADJ
ajlm-5	109	24	countries	country	NOUN
ajlm-5	109	25	.	.	PUNCT
ajlm-5	110	1	the	the	DET
ajlm-5	110	2	established	establish	VERB
ajlm-5	110	3	values	value	NOUN
ajlm-5	110	4	provide	provide	VERB
ajlm-5	110	5	an	an	DET
ajlm-5	110	6	important	important	ADJ
ajlm-5	110	7	tool	tool	NOUN
ajlm-5	110	8	for	for	ADP
ajlm-5	110	9	patient	patient	ADJ
ajlm-5	110	10	management	management	NOUN
ajlm-5	110	11	and	and	CCONJ
ajlm-5	110	12	could	could	AUX
ajlm-5	110	13	influence	influence	VERB
ajlm-5	110	14	decisions	decision	NOUN
ajlm-5	110	15	on	on	ADP
ajlm-5	110	16	the	the	DET
ajlm-5	110	17	inclusion	inclusion	NOUN
ajlm-5	110	18	of	of	ADP
ajlm-5	110	19	participants	participant	NOUN
ajlm-5	110	20	,	,	PUNCT
ajlm-5	110	21	as	as	ADV
ajlm-5	110	22	well	well	ADV
ajlm-5	110	23	as	as	ADP
ajlm-5	110	24	the	the	DET
ajlm-5	110	25	management	management	NOUN
ajlm-5	110	26	of	of	ADP
ajlm-5	110	27	adverse	adverse	ADJ
ajlm-5	110	28	events	event	NOUN
ajlm-5	110	29	.	.	PUNCT
ajlm-5	111	1	it	it	PRON
ajlm-5	111	2	could	could	AUX
ajlm-5	111	3	also	also	ADV
ajlm-5	111	4	improve	improve	VERB
ajlm-5	111	5	scientific	scientific	ADJ
ajlm-5	111	6	validity	validity	NOUN
ajlm-5	111	7	in	in	ADP
ajlm-5	111	8	clinical	clinical	ADJ
ajlm-5	111	9	trials	trial	NOUN
ajlm-5	111	10	that	that	PRON
ajlm-5	111	11	are	be	AUX
ajlm-5	111	12	conducted	conduct	VERB
ajlm-5	111	13	locally	locally	ADV
ajlm-5	111	14	and	and	CCONJ
ajlm-5	111	15	regionally	regionally	ADV
ajlm-5	111	16	.	.	PUNCT
ajlm-5	112	1	acknowledgements	acknowledgement	NOUN
ajlm-5	112	2	top	top	PROPN
ajlm-5	112	3	↑	↑	NOUN
ajlm-5	112	4	the	the	DET
ajlm-5	112	5	authors	author	NOUN
ajlm-5	112	6	would	would	AUX
ajlm-5	112	7	like	like	VERB
ajlm-5	112	8	to	to	PART
ajlm-5	112	9	thank	thank	VERB
ajlm-5	112	10	the	the	DET
ajlm-5	112	11	participants	participant	NOUN
ajlm-5	112	12	of	of	ADP
ajlm-5	112	13	this	this	DET
ajlm-5	112	14	study	study	NOUN
ajlm-5	112	15	for	for	ADP
ajlm-5	112	16	their	their	PRON
ajlm-5	112	17	time	time	NOUN
ajlm-5	112	18	and	and	CCONJ
ajlm-5	112	19	patience	patience	NOUN
ajlm-5	112	20	.	.	PUNCT
ajlm-5	113	1	the	the	DET
ajlm-5	113	2	authors	author	NOUN
ajlm-5	113	3	also	also	ADV
ajlm-5	113	4	extend	extend	VERB
ajlm-5	113	5	their	their	PRON
ajlm-5	113	6	gratitude	gratitude	NOUN
ajlm-5	113	7	to	to	ADP
ajlm-5	113	8	the	the	DET
ajlm-5	113	9	voluntary	voluntary	ADJ
ajlm-5	113	10	counselling	counselling	NOUN
ajlm-5	113	11	and	and	CCONJ
ajlm-5	113	12	testing	testing	NOUN
ajlm-5	113	13	(	(	PUNCT
ajlm-5	113	14	vct	vct	NOUN
ajlm-5	113	15	)	)	PUNCT
ajlm-5	113	16	management	management	NOUN
ajlm-5	113	17	for	for	ADP
ajlm-5	113	18	availing	avail	VERB
ajlm-5	113	19	the	the	DET
ajlm-5	113	20	use	use	NOUN
ajlm-5	113	21	of	of	ADP
ajlm-5	113	22	their	their	PRON
ajlm-5	113	23	facilities	facility	NOUN
ajlm-5	113	24	for	for	ADP
ajlm-5	113	25	the	the	DET
ajlm-5	113	26	recruitment	recruitment	NOUN
ajlm-5	113	27	of	of	ADP
ajlm-5	113	28	the	the	DET
ajlm-5	113	29	study	study	NOUN
ajlm-5	113	30	participants	participant	NOUN
ajlm-5	113	31	.	.	PUNCT
ajlm-5	114	1	in	in	ADP
ajlm-5	114	2	addition	addition	NOUN
ajlm-5	114	3	,	,	PUNCT
ajlm-5	114	4	the	the	DET
ajlm-5	114	5	authors	author	NOUN
ajlm-5	114	6	would	would	AUX
ajlm-5	114	7	like	like	VERB
ajlm-5	114	8	to	to	PART
ajlm-5	114	9	thank	thank	VERB
ajlm-5	114	10	the	the	DET
ajlm-5	114	11	ministry	ministry	PROPN
ajlm-5	114	12	of	of	ADP
ajlm-5	114	13	health	health	PROPN
ajlm-5	114	14	and	and	CCONJ
ajlm-5	114	15	botswana	botswana	PROPN
ajlm-5	114	16	harvard	harvard	PROPN
ajlm-5	114	17	partnership	partnership	PROPN
ajlm-5	114	18	for	for	ADP
ajlm-5	114	19	supporting	support	VERB
ajlm-5	114	20	the	the	DET
ajlm-5	114	21	study	study	NOUN
ajlm-5	114	22	.	.	PUNCT
ajlm-5	115	1	the	the	DET
ajlm-5	115	2	project	project	NOUN
ajlm-5	115	3	was	be	AUX
ajlm-5	115	4	also	also	ADV
ajlm-5	115	5	supported	support	VERB
ajlm-5	115	6	by	by	ADP
ajlm-5	115	7	grant	grant	NOUN
ajlm-5	115	8	number	number	NOUN
ajlm-5	115	9	u01ai069456	u01ai069456	PROPN
ajlm-5	115	10	from	from	ADP
ajlm-5	115	11	the	the	DET
ajlm-5	115	12	national	national	PROPN
ajlm-5	115	13	institute	institute	PROPN
ajlm-5	115	14	of	of	ADP
ajlm-5	115	15	allergy	allergy	PROPN
ajlm-5	115	16	and	and	CCONJ
ajlm-5	115	17	infectious	infectious	ADJ
ajlm-5	115	18	diseases	disease	NOUN
ajlm-5	115	19	.	.	PUNCT
ajlm-5	116	1	the	the	DET
ajlm-5	116	2	content	content	NOUN
ajlm-5	116	3	is	be	AUX
ajlm-5	116	4	solely	solely	ADV
ajlm-5	116	5	the	the	DET
ajlm-5	116	6	responsibility	responsibility	NOUN
ajlm-5	116	7	of	of	ADP
ajlm-5	116	8	the	the	DET
ajlm-5	116	9	authors	author	NOUN
ajlm-5	116	10	and	and	CCONJ
ajlm-5	116	11	does	do	AUX
ajlm-5	116	12	not	not	PART
ajlm-5	116	13	necessarily	necessarily	ADV
ajlm-5	116	14	represent	represent	VERB
ajlm-5	116	15	the	the	DET
ajlm-5	116	16	official	official	ADJ
ajlm-5	116	17	views	view	NOUN
ajlm-5	116	18	of	of	ADP
ajlm-5	116	19	the	the	DET
ajlm-5	116	20	national	national	PROPN
ajlm-5	116	21	institute	institute	PROPN
ajlm-5	116	22	of	of	ADP
ajlm-5	116	23	allergy	allergy	PROPN
ajlm-5	116	24	and	and	CCONJ
ajlm-5	116	25	infectious	infectious	ADJ
ajlm-5	116	26	diseases	disease	NOUN
ajlm-5	116	27	or	or	CCONJ
ajlm-5	116	28	the	the	DET
ajlm-5	116	29	national	national	PROPN
ajlm-5	116	30	institutes	institutes	PROPN
ajlm-5	116	31	of	of	ADP
ajlm-5	116	32	health	health	NOUN
ajlm-5	116	33	.	.	PUNCT
ajlm-5	117	1	competing	compete	VERB
ajlm-5	117	2	interests	interest	NOUN
ajlm-5	117	3	the	the	DET
ajlm-5	117	4	authors	author	NOUN
ajlm-5	117	5	declare	declare	VERB
ajlm-5	117	6	that	that	SCONJ
ajlm-5	117	7	they	they	PRON
ajlm-5	117	8	have	have	VERB
ajlm-5	117	9	no	no	DET
ajlm-5	117	10	financial	financial	ADJ
ajlm-5	117	11	or	or	CCONJ
ajlm-5	117	12	personal	personal	ADJ
ajlm-5	117	13	relationship(s	relationship(s	NOUN
ajlm-5	117	14	)	)	PUNCT
ajlm-5	117	15	which	which	PRON
ajlm-5	117	16	may	may	AUX
ajlm-5	117	17	have	have	AUX
ajlm-5	117	18	influenced	influence	VERB
ajlm-5	117	19	them	they	PRON
ajlm-5	117	20	inappropriately	inappropriately	ADV
ajlm-5	117	21	in	in	ADP
ajlm-5	117	22	writing	write	VERB
ajlm-5	117	23	this	this	DET
ajlm-5	117	24	article	article	NOUN
ajlm-5	117	25	.	.	PUNCT
ajlm-5	118	1	authors	author	NOUN
ajlm-5	118	2	’	’	PART
ajlm-5	118	3	contributions	contribution	NOUN
ajlm-5	118	4	m.	m.	NOUN
ajlm-5	118	5	mine	mine	NOUN
ajlm-5	118	6	(	(	PUNCT
ajlm-5	118	7	national	national	ADJ
ajlm-5	118	8	health	health	NOUN
ajlm-5	118	9	laboratory	laboratory	PROPN
ajlm-5	118	10	)	)	PUNCT
ajlm-5	118	11	,	,	PUNCT
ajlm-5	118	12	v.n	v.n	PROPN
ajlm-5	118	13	.	.	PUNCT
ajlm-5	118	14	(	(	PUNCT
ajlm-5	118	15	harvard	harvard	PROPN
ajlm-5	118	16	school	school	NOUN
ajlm-5	118	17	of	of	ADP
ajlm-5	118	18	public	public	ADJ
ajlm-5	118	19	health	health	NOUN
ajlm-5	118	20	)	)	PUNCT
ajlm-5	118	21	,	,	PUNCT
ajlm-5	118	22	r.	r.	PROPN
ajlm-5	118	23	marlink	marlink	PROPN
ajlm-5	118	24	(	(	PUNCT
ajlm-5	118	25	harvard	harvard	PROPN
ajlm-5	118	26	school	school	NOUN
ajlm-5	118	27	of	of	ADP
ajlm-5	118	28	public	public	ADJ
ajlm-5	118	29	health	health	NOUN
ajlm-5	118	30	)	)	PUNCT
ajlm-5	118	31	and	and	CCONJ
ajlm-5	118	32	m.e	m.e	PROPN
ajlm-5	118	33	.	.	PROPN
ajlm-5	118	34	(	(	PUNCT
ajlm-5	118	35	harvard	harvard	PROPN
ajlm-5	118	36	school	school	NOUN
ajlm-5	118	37	of	of	ADP
ajlm-5	118	38	public	public	ADJ
ajlm-5	118	39	health	health	NOUN
ajlm-5	118	40	)	)	PUNCT
ajlm-5	118	41	conceived	conceive	VERB
ajlm-5	118	42	and	and	CCONJ
ajlm-5	118	43	designed	design	VERB
ajlm-5	118	44	the	the	DET
ajlm-5	118	45	study	study	NOUN
ajlm-5	118	46	,	,	PUNCT
ajlm-5	118	47	and	and	CCONJ
ajlm-5	118	48	m.	m.	NOUN
ajlm-5	118	49	mine	mine	PROPN
ajlm-5	118	50	,	,	PUNCT
ajlm-5	118	51	s.	s.	PROPN
ajlm-5	118	52	moyo	moyo	PROPN
ajlm-5	118	53	(	(	PUNCT
ajlm-5	118	54	bhp	bhp	PROPN
ajlm-5	118	55	princess	princess	PROPN
ajlm-5	118	56	marina	marina	PROPN
ajlm-5	118	57	hospital	hospital	PROPN
ajlm-5	118	58	)	)	PUNCT
ajlm-5	118	59	,	,	PUNCT
ajlm-5	118	60	p.s	p.s	INTJ
ajlm-5	118	61	.	.	PUNCT
ajlm-5	119	1	(	(	PUNCT
ajlm-5	119	2	johns	johns	PROPN
ajlm-5	119	3	hopkins	hopkins	PROPN
ajlm-5	119	4	university	university	PROPN
ajlm-5	119	5	)	)	PUNCT
ajlm-5	119	6	,	,	PUNCT
ajlm-5	119	7	k.	k.	PROPN
ajlm-5	119	8	michael	michael	PROPN
ajlm-5	119	9	(	(	PUNCT
ajlm-5	119	10	johns	johns	PROPN
ajlm-5	119	11	hopkins	hopkins	PROPN
ajlm-5	119	12	university	university	PROPN
ajlm-5	119	13	)	)	PUNCT
ajlm-5	119	14	and	and	CCONJ
ajlm-5	119	15	m.h.-p	m.h.-p	ADJ
ajlm-5	119	16	.	.	PUNCT
ajlm-5	120	1	(	(	PUNCT
ajlm-5	120	2	harvard	harvard	PROPN
ajlm-5	120	3	school	school	NOUN
ajlm-5	120	4	of	of	ADP
ajlm-5	120	5	public	public	ADJ
ajlm-5	120	6	health	health	NOUN
ajlm-5	120	7	)	)	PUNCT
ajlm-5	120	8	wrote	write	VERB
ajlm-5	120	9	the	the	DET
ajlm-5	120	10	article	article	NOUN
ajlm-5	120	11	.	.	PUNCT
ajlm-5	121	1	s.	s.	PROPN
ajlm-5	121	2	moyo	moyo	PROPN
ajlm-5	121	3	and	and	CCONJ
ajlm-5	121	4	m.	m.	NOUN
ajlm-5	121	5	mine	mine	NOUN
ajlm-5	121	6	analysed	analyse	VERB
ajlm-5	121	7	the	the	DET
ajlm-5	121	8	data	datum	NOUN
ajlm-5	121	9	.	.	PUNCT
ajlm-5	122	1	clinical	clinical	ADJ
ajlm-5	122	2	support	support	NOUN
ajlm-5	122	3	was	be	AUX
ajlm-5	122	4	provided	provide	VERB
ajlm-5	122	5	by	by	ADP
ajlm-5	122	6	a.a	a.a	PROPN
ajlm-5	122	7	.	.	PROPN
ajlm-5	122	8	(	(	PUNCT
ajlm-5	122	9	bhp	bhp	PROPN
ajlm-5	122	10	princess	princess	PROPN
ajlm-5	122	11	marina	marina	PROPN
ajlm-5	122	12	hospital	hospital	PROPN
ajlm-5	122	13	)	)	PUNCT
ajlm-5	122	14	,	,	PUNCT
ajlm-5	122	15	n.n	n.n	PROPN
ajlm-5	122	16	.	.	PROPN
ajlm-5	122	17	(	(	PUNCT
ajlm-5	122	18	ministry	ministry	NOUN
ajlm-5	122	19	of	of	ADP
ajlm-5	122	20	health	health	PROPN
ajlm-5	122	21	)	)	PUNCT
ajlm-5	122	22	,	,	PUNCT
ajlm-5	122	23	j.m	j.m	PROPN
ajlm-5	122	24	.	.	PUNCT
ajlm-5	123	1	(	(	PUNCT
ajlm-5	123	2	bhp	bhp	PROPN
ajlm-5	123	3	princess	princess	PROPN
ajlm-5	123	4	marina	marina	PROPN
ajlm-5	123	5	hospital	hospital	PROPN
ajlm-5	123	6	)	)	PUNCT
ajlm-5	123	7	,	,	PUNCT
ajlm-5	123	8	k.s	k.s	PROPN
ajlm-5	123	9	.	.	PUNCT
ajlm-5	123	10	(	(	PUNCT
ajlm-5	123	11	ministry	ministry	NOUN
ajlm-5	123	12	of	of	ADP
ajlm-5	123	13	health	health	PROPN
ajlm-5	123	14	)	)	PUNCT
ajlm-5	123	15	,	,	PUNCT
ajlm-5	123	16	t.g	t.g	PROPN
ajlm-5	123	17	.	.	PROPN
ajlm-5	123	18	(	(	PUNCT
ajlm-5	123	19	bhp	bhp	PROPN
ajlm-5	123	20	princess	princess	PROPN
ajlm-5	123	21	marina	marina	PROPN
ajlm-5	123	22	hospital	hospital	PROPN
ajlm-5	123	23	)	)	PUNCT
ajlm-5	123	24	,	,	PUNCT
ajlm-5	123	25	e.w	e.w	PROPN
ajlm-5	123	26	.	.	PROPN
ajlm-5	123	27	(	(	PUNCT
ajlm-5	123	28	bhp	bhp	PROPN
ajlm-5	123	29	princess	princess	PROPN
ajlm-5	123	30	marina	marina	PROPN
ajlm-5	123	31	hospital	hospital	PROPN
ajlm-5	123	32	)	)	PUNCT
ajlm-5	123	33	and	and	CCONJ
ajlm-5	123	34	i.m	i.m	PROPN
ajlm-5	123	35	.	.	PUNCT
ajlm-5	124	1	(	(	PUNCT
ajlm-5	124	2	national	national	PROPN
ajlm-5	124	3	health	health	NOUN
ajlm-5	124	4	laboratory	laboratory	PROPN
ajlm-5	124	5	)	)	PUNCT
ajlm-5	124	6	(	(	PUNCT
ajlm-5	124	7	medical	medical	ADJ
ajlm-5	124	8	doctors	doctor	NOUN
ajlm-5	124	9	)	)	PUNCT
ajlm-5	124	10	,	,	PUNCT
ajlm-5	124	11	and	and	CCONJ
ajlm-5	124	12	by	by	ADP
ajlm-5	124	13	s.	s.	PROPN
ajlm-5	124	14	molefhabangwe	molefhabangwe	PROPN
ajlm-5	124	15	(	(	PUNCT
ajlm-5	124	16	deceased	deceased	ADJ
ajlm-5	124	17	)	)	PUNCT
ajlm-5	124	18	(	(	PUNCT
ajlm-5	124	19	bhp	bhp	PROPN
ajlm-5	124	20	princess	princess	PROPN
ajlm-5	124	21	marina	marina	PROPN
ajlm-5	124	22	hospital	hospital	PROPN
ajlm-5	124	23	)	)	PUNCT
ajlm-5	124	24	,	,	PUNCT
ajlm-5	124	25	as	as	ADV
ajlm-5	124	26	well	well	ADV
ajlm-5	124	27	as	as	ADP
ajlm-5	124	28	by	by	ADP
ajlm-5	124	29	g.m	g.m	PROPN
ajlm-5	124	30	.	.	PUNCT
ajlm-5	125	1	(	(	PUNCT
ajlm-5	125	2	bhp	bhp	PROPN
ajlm-5	125	3	princess	princess	PROPN
ajlm-5	125	4	marina	marina	PROPN
ajlm-5	125	5	hospital	hospital	PROPN
ajlm-5	125	6	)	)	PUNCT
ajlm-5	125	7	(	(	PUNCT
ajlm-5	125	8	study	study	NOUN
ajlm-5	125	9	nurses	nurse	NOUN
ajlm-5	125	10	and	and	CCONJ
ajlm-5	125	11	recruiters	recruiter	NOUN
ajlm-5	125	12	)	)	PUNCT
ajlm-5	125	13	.	.	PUNCT
ajlm-5	126	1	k.	k.	PROPN
ajlm-5	126	2	makhaola	makhaola	PROPN
ajlm-5	126	3	(	(	PUNCT
ajlm-5	126	4	national	national	PROPN
ajlm-5	126	5	health	health	NOUN
ajlm-5	126	6	laboratory	laboratory	PROPN
ajlm-5	126	7	)	)	PUNCT
ajlm-5	126	8	,	,	PUNCT
ajlm-5	126	9	t.m	t.m	PROPN
ajlm-5	126	10	.	.	PROPN
ajlm-5	126	11	(	(	PUNCT
ajlm-5	126	12	princess	princess	PROPN
ajlm-5	126	13	marina	marina	PROPN
ajlm-5	126	14	hospital	hospital	PROPN
ajlm-5	126	15	)	)	PUNCT
ajlm-5	126	16	,	,	PUNCT
ajlm-5	127	1	c.k	c.k	PROPN
ajlm-5	127	2	.	.	PUNCT
ajlm-5	128	1	(	(	PUNCT
ajlm-5	128	2	national	national	PROPN
ajlm-5	128	3	health	health	NOUN
ajlm-5	128	4	laboratory	laboratory	PROPN
ajlm-5	128	5	)	)	PUNCT
ajlm-5	128	6	,	,	PUNCT
ajlm-5	128	7	p.m.m	p.m.m	PROPN
ajlm-5	128	8	.	.	PUNCT
ajlm-5	129	1	(	(	PUNCT
ajlm-5	129	2	bhp	bhp	PROPN
ajlm-5	129	3	princess	princess	PROPN
ajlm-5	129	4	marina	marina	PROPN
ajlm-5	129	5	hospital	hospital	PROPN
ajlm-5	129	6	)	)	PUNCT
ajlm-5	129	7	,	,	PUNCT
ajlm-5	129	8	r.	r.	PROPN
ajlm-5	129	9	musonda	musonda	PROPN
ajlm-5	129	10	(	(	PUNCT
ajlm-5	129	11	bhp	bhp	PROPN
ajlm-5	129	12	princess	princess	PROPN
ajlm-5	129	13	marina	marina	PROPN
ajlm-5	129	14	hospital	hospital	PROPN
ajlm-5	129	15	)	)	PUNCT
ajlm-5	129	16	and	and	CCONJ
ajlm-5	129	17	m.	m.	NOUN
ajlm-5	129	18	motswaledi	motswaledi	PROPN
ajlm-5	129	19	(	(	PUNCT
ajlm-5	129	20	ministry	ministry	PROPN
ajlm-5	129	21	of	of	ADP
ajlm-5	129	22	health	health	NOUN
ajlm-5	129	23	)	)	PUNCT
ajlm-5	129	24	provided	provide	VERB
ajlm-5	129	25	laboratory	laboratory	NOUN
ajlm-5	129	26	support	support	NOUN
ajlm-5	129	27	.	.	PUNCT
ajlm-5	130	1	references	reference	NOUN
ajlm-5	130	2	top	top	VERB
ajlm-5	130	3	↑	↑	NOUN
ajlm-5	130	4	1	1	NUM
ajlm-5	130	5	.	.	PUNCT
ajlm-5	130	6	central	central	ADJ
ajlm-5	130	7	statistics	statistics	PROPN
ajlm-5	130	8	office	office	PROPN
ajlm-5	130	9	/	/	SYM
ajlm-5	130	10	national	national	ADJ
ajlm-5	130	11	aids	aid	NOUN
ajlm-5	130	12	coordinating	coordinate	VERB
ajlm-5	130	13	agency	agency	NOUN
ajlm-5	130	14	(	(	PUNCT
ajlm-5	130	15	cso	cso	PROPN
ajlm-5	130	16	/	/	SYM
ajlm-5	130	17	naca	naca	NOUN
ajlm-5	130	18	)	)	PUNCT
ajlm-5	130	19	.	.	PUNCT
ajlm-5	131	1	botswana	botswana	PROPN
ajlm-5	131	2	behavioural	behavioural	PROPN
ajlm-5	131	3	aids	aids	PROPN
ajlm-5	131	4	impact	impact	PROPN
ajlm-5	131	5	survey	survey	PROPN
ajlm-5	131	6	iii	iii	PROPN
ajlm-5	131	7	.	.	PUNCT
ajlm-5	131	8	gaborone	gaborone	PROPN
ajlm-5	131	9	,	,	PUNCT
ajlm-5	131	10	botswana	botswana	PROPN
ajlm-5	131	11	:	:	PUNCT
ajlm-5	131	12	central	central	ADJ
ajlm-5	131	13	statistics	statistics	PROPN
ajlm-5	131	14	office	office	PROPN
ajlm-5	131	15	/	/	SYM
ajlm-5	131	16	national	national	ADJ
ajlm-5	131	17	aids	aids	PROPN
ajlm-5	131	18	coordinating	coordinate	VERB
ajlm-5	131	19	agency	agency	NOUN
ajlm-5	131	20	;	;	PUNCT
ajlm-5	131	21	2010.2	2010.2	NUM
ajlm-5	131	22	.	.	PUNCT
ajlm-5	132	1	ministry	ministry	PROPN
ajlm-5	132	2	of	of	ADP
ajlm-5	132	3	health	health	PROPN
ajlm-5	132	4	botswana	botswana	PROPN
ajlm-5	132	5	.	.	PROPN
ajlm-5	132	6	2007	2007	NUM
ajlm-5	133	1	botswana	botswana	PROPN
ajlm-5	133	2	anc	anc	PROPN
ajlm-5	133	3	second	second	ADJ
ajlm-5	133	4	generation	generation	NOUN
ajlm-5	133	5	hiv	hiv	PROPN
ajlm-5	133	6	/	/	SYM
ajlm-5	133	7	aids	aids	PROPN
ajlm-5	133	8	sentinel	sentinel	ADJ
ajlm-5	133	9	surveillance	surveillance	NOUN
ajlm-5	133	10	.	.	PUNCT
ajlm-5	134	1	technical	technical	ADJ
ajlm-5	134	2	report	report	NOUN
ajlm-5	134	3	.	.	PUNCT
ajlm-5	135	1	de	de	PROPN
ajlm-5	135	2	la	la	PROPN
ajlm-5	135	3	hoz	hoz	PROPN
ajlm-5	135	4	gomez	gomez	PROPN
ajlm-5	135	5	f	f	PROPN
ajlm-5	135	6	,	,	PUNCT
ajlm-5	135	7	anderson	anderson	PROPN
ajlm-5	135	8	mg	mg	PROPN
ajlm-5	135	9	,	,	PUNCT
ajlm-5	135	10	bodika	bodika	PROPN
ajlm-5	135	11	s	s	PROPN
ajlm-5	135	12	,	,	PUNCT
ajlm-5	135	13	et	et	PROPN
ajlm-5	135	14	al	al	PROPN
ajlm-5	135	15	.	.	PROPN
ajlm-5	135	16	,	,	PUNCT
ajlm-5	135	17	editors	editor	NOUN
ajlm-5	135	18	.	.	PUNCT
ajlm-5	136	1	gaborone	gaborone	PROPN
ajlm-5	136	2	,	,	PUNCT
ajlm-5	136	3	botswana	botswana	PROPN
ajlm-5	136	4	:	:	PUNCT
ajlm-5	136	5	botswana	botswana	PROPN
ajlm-5	136	6	government	government	NOUN
ajlm-5	136	7	print	print	NOUN
ajlm-5	136	8	;	;	PUNCT
ajlm-5	136	9	2009	2009	NUM
ajlm-5	136	10	.	.	PUNCT
ajlm-5	137	1	3	3	X
ajlm-5	137	2	.	.	X
ajlm-5	137	3	plosmedicineeditors	plosmedicineeditor	NOUN
ajlm-5	137	4	.	.	PUNCT
ajlm-5	138	1	a	a	DET
ajlm-5	138	2	new	new	ADJ
ajlm-5	138	3	vision	vision	NOUN
ajlm-5	138	4	for	for	ADP
ajlm-5	138	5	clinical	clinical	ADJ
ajlm-5	138	6	trials	trial	NOUN
ajlm-5	138	7	in	in	ADP
ajlm-5	138	8	africa	africa	PROPN
ajlm-5	138	9	.	.	PUNCT
ajlm-5	139	1	plos	plos	PROPN
ajlm-5	139	2	med	med	PROPN
ajlm-5	139	3	.	.	PUNCT
ajlm-5	140	1	2004;1	2004;1	PROPN
ajlm-5	140	2	:	:	PUNCT
ajlm-5	140	3	e71	e71	NOUN
ajlm-5	140	4	.	.	PUNCT
ajlm-5	141	1	http://dx.doi.org/10.1371/journal.pmed.0010071	http://dx.doi.org/10.1371/journal.pmed.0010071	PROPN
ajlm-5	141	2	,	,	PUNCT
ajlm-5	141	3	pmid:15630472	pmid:15630472	NOUN
ajlm-5	141	4	,	,	PUNCT
ajlm-5	141	5	pmcid:539056	pmcid:539056	PROPN
ajlm-5	141	6	4	4	NUM
ajlm-5	141	7	.	.	PUNCT
ajlm-5	141	8	ojikutu	ojikutu	PROPN
ajlm-5	141	9	b	b	PROPN
ajlm-5	141	10	,	,	PUNCT
ajlm-5	141	11	makadzange	makadzange	NOUN
ajlm-5	141	12	at	at	ADP
ajlm-5	141	13	,	,	PUNCT
ajlm-5	141	14	gaolathe	gaolathe	ADJ
ajlm-5	141	15	t.	t.	NOUN
ajlm-5	141	16	scaling	scale	VERB
ajlm-5	141	17	up	up	ADP
ajlm-5	141	18	art	art	NOUN
ajlm-5	141	19	treatment	treatment	NOUN
ajlm-5	141	20	capacity	capacity	NOUN
ajlm-5	141	21	:	:	PUNCT
ajlm-5	141	22	lessons	lesson	NOUN
ajlm-5	141	23	learned	learn	VERB
ajlm-5	141	24	from	from	ADP
ajlm-5	141	25	south	south	PROPN
ajlm-5	141	26	africa	africa	PROPN
ajlm-5	141	27	,	,	PUNCT
ajlm-5	141	28	zimbabwe	zimbabwe	PROPN
ajlm-5	141	29	,	,	PUNCT
ajlm-5	141	30	and	and	CCONJ
ajlm-5	141	31	botswana	botswana	PROPN
ajlm-5	141	32	.	.	PUNCT
ajlm-5	142	1	curr	curr	PROPN
ajlm-5	142	2	infect	infect	PROPN
ajlm-5	142	3	dis	dis	PROPN
ajlm-5	142	4	rep	rep	PROPN
ajlm-5	142	5	.	.	PROPN
ajlm-5	142	6	2008;10:69–73	2008;10:69–73	NUM
ajlm-5	142	7	.	.	PUNCT
ajlm-5	143	1	http://dx.doi.org/10.1007/s11908-008-0012-0	http://dx.doi.org/10.1007/s11908-008-0012-0	PROPN
ajlm-5	143	2	,	,	PUNCT
ajlm-5	143	3	pmid:18377818	pmid:18377818	VERB
ajlm-5	143	4	5	5	NUM
ajlm-5	143	5	.	.	PUNCT
ajlm-5	144	1	bussmann	bussmann	PROPN
ajlm-5	144	2	h	h	PROPN
ajlm-5	144	3	,	,	PUNCT
ajlm-5	144	4	wester	wester	PROPN
ajlm-5	144	5	cw	cw	PROPN
ajlm-5	144	6	,	,	PUNCT
ajlm-5	144	7	ndwapi	ndwapi	ADJ
ajlm-5	144	8	n	n	CCONJ
ajlm-5	144	9	,	,	PUNCT
ajlm-5	144	10	et	et	PROPN
ajlm-5	144	11	al	al	PROPN
ajlm-5	144	12	.	.	PROPN
ajlm-5	145	1	five	five	NUM
ajlm-5	145	2	-	-	PUNCT
ajlm-5	145	3	year	year	NOUN
ajlm-5	145	4	outcomes	outcome	NOUN
ajlm-5	145	5	of	of	ADP
ajlm-5	145	6	initial	initial	ADJ
ajlm-5	145	7	patients	patient	NOUN
ajlm-5	145	8	treated	treat	VERB
ajlm-5	145	9	in	in	ADP
ajlm-5	145	10	botswana	botswana	PROPN
ajlm-5	145	11	’s	’s	PART
ajlm-5	145	12	national	national	ADJ
ajlm-5	145	13	antiretroviral	antiretroviral	ADJ
ajlm-5	145	14	treatment	treatment	NOUN
ajlm-5	145	15	program	program	NOUN
ajlm-5	145	16	.	.	PUNCT
ajlm-5	146	1	aids	aids	PROPN
ajlm-5	146	2	.	.	PUNCT
ajlm-5	147	1	2008;22:2303–2311	2008;22:2303–2311	NUM
ajlm-5	147	2	.	.	PUNCT
ajlm-5	148	1	http://dx.doi.org/10.1097/qad.0b013e3283129db0	http://dx.doi.org/10.1097/qad.0b013e3283129db0	PROPN
ajlm-5	148	2	,	,	PUNCT
ajlm-5	148	3	pmid:18981769	pmid:18981769	NOUN
ajlm-5	148	4	,	,	PUNCT
ajlm-5	148	5	pmcid:2853026	pmcid:2853026	NOUN
ajlm-5	148	6	6	6	NUM
ajlm-5	148	7	.	.	PUNCT
ajlm-5	148	8	excler	excler	PROPN
ajlm-5	148	9	jl	jl	PROPN
ajlm-5	148	10	.	.	PUNCT
ajlm-5	149	1	aids	aids	PROPN
ajlm-5	149	2	vaccine	vaccine	NOUN
ajlm-5	149	3	efficacy	efficacy	NOUN
ajlm-5	149	4	trials	trial	NOUN
ajlm-5	149	5	:	:	PUNCT
ajlm-5	149	6	expand	expand	VERB
ajlm-5	149	7	capacity	capacity	NOUN
ajlm-5	149	8	and	and	CCONJ
ajlm-5	149	9	prioritize	prioritize	VERB
ajlm-5	149	10	.	.	PUNCT
ajlm-5	150	1	expert	expert	NOUN
ajlm-5	150	2	rev	rev	VERB
ajlm-5	150	3	vaccines	vaccine	NOUN
ajlm-5	150	4	.	.	PUNCT
ajlm-5	151	1	2006;5:167–170	2006;5:167–170	X
ajlm-5	151	2	.	.	PUNCT
ajlm-5	152	1	http://dx.doi.org/10.1586/14760584.5.2.167	http://dx.doi.org/10.1586/14760584.5.2.167	NUM
ajlm-5	152	2	,	,	PUNCT
ajlm-5	152	3	pmid:16608417	pmid:16608417	PRON
ajlm-5	152	4	7	7	NUM
ajlm-5	152	5	.	.	PUNCT
ajlm-5	152	6	food	food	NOUN
ajlm-5	152	7	and	and	CCONJ
ajlm-5	152	8	drug	drug	PROPN
ajlm-5	152	9	administration	administration	PROPN
ajlm-5	152	10	(	(	PUNCT
ajlm-5	152	11	fda	fda	PROPN
ajlm-5	152	12	)	)	PUNCT
ajlm-5	152	13	.	.	PUNCT
ajlm-5	153	1	toxicity	toxicity	NOUN
ajlm-5	153	2	grading	grading	NOUN
ajlm-5	153	3	scale	scale	NOUN
ajlm-5	153	4	for	for	ADP
ajlm-5	153	5	healthy	healthy	ADJ
ajlm-5	153	6	adult	adult	NOUN
ajlm-5	153	7	and	and	CCONJ
ajlm-5	153	8	adolescent	adolescent	ADJ
ajlm-5	153	9	volunteers	volunteer	NOUN
ajlm-5	153	10	enrolled	enrol	VERB
ajlm-5	153	11	in	in	ADP
ajlm-5	153	12	preventive	preventive	ADJ
ajlm-5	153	13	vaccine	vaccine	NOUN
ajlm-5	153	14	clinical	clinical	ADJ
ajlm-5	153	15	trials	trial	NOUN
ajlm-5	153	16	.	.	PUNCT
ajlm-5	154	1	rockville	rockville	PROPN
ajlm-5	154	2	,	,	PUNCT
ajlm-5	154	3	md	md	PROPN
ajlm-5	154	4	:	:	PUNCT
ajlm-5	154	5	botswana	botswana	PROPN
ajlm-5	154	6	government	government	PROPN
ajlm-5	154	7	print	print	NOUN
ajlm-5	154	8	;	;	PUNCT
ajlm-5	154	9	2007	2007	NUM
ajlm-5	154	10	.	.	PUNCT
ajlm-5	155	1	8	8	X
ajlm-5	155	2	.	.	X
ajlm-5	156	1	kibaya	kibaya	NOUN
ajlm-5	156	2	rs	rs	PROPN
ajlm-5	156	3	,	,	PUNCT
ajlm-5	156	4	bautista	bautista	PROPN
ajlm-5	156	5	ct	ct	PROPN
ajlm-5	156	6	,	,	PUNCT
ajlm-5	156	7	sawe	sawe	PROPN
ajlm-5	156	8	fk	fk	INTJ
ajlm-5	156	9	,	,	PUNCT
ajlm-5	156	10	et	et	PROPN
ajlm-5	156	11	al	al	PROPN
ajlm-5	156	12	.	.	PROPN
ajlm-5	156	13	reference	reference	NOUN
ajlm-5	156	14	ranges	range	VERB
ajlm-5	156	15	for	for	ADP
ajlm-5	156	16	the	the	DET
ajlm-5	156	17	clinical	clinical	ADJ
ajlm-5	156	18	laboratory	laboratory	NOUN
ajlm-5	156	19	derived	derive	VERB
ajlm-5	156	20	from	from	ADP
ajlm-5	156	21	a	a	DET
ajlm-5	156	22	rural	rural	ADJ
ajlm-5	156	23	population	population	NOUN
ajlm-5	156	24	in	in	ADP
ajlm-5	156	25	kericho	kericho	PROPN
ajlm-5	156	26	,	,	PUNCT
ajlm-5	156	27	kenya	kenya	PROPN
ajlm-5	156	28	.	.	PUNCT
ajlm-5	157	1	plos	plos	PROPN
ajlm-5	157	2	one	one	NUM
ajlm-5	157	3	.	.	PUNCT
ajlm-5	158	1	2008;3	2008;3	NUM
ajlm-5	158	2	:	:	PUNCT
ajlm-5	158	3	e3327	e3327	NOUN
ajlm-5	158	4	.	.	PUNCT
ajlm-5	159	1	http://dx.doi.org/10.1371/journal.pone.0003327	http://dx.doi.org/10.1371/journal.pone.0003327	PROPN
ajlm-5	159	2	,	,	PUNCT
ajlm-5	159	3	pmid:18833329	pmid:18833329	PROPN
ajlm-5	159	4	,	,	PUNCT
ajlm-5	159	5	pmcid:2553265	pmcid:2553265	VERB
ajlm-5	159	6	9	9	NUM
ajlm-5	159	7	.	.	PUNCT
ajlm-5	159	8	bain	bain	NOUN
ajlm-5	159	9	bj	bj	PROPN
ajlm-5	159	10	.	.	PUNCT
ajlm-5	159	11	ethnic	ethnic	ADJ
ajlm-5	159	12	and	and	CCONJ
ajlm-5	159	13	sex	sex	NOUN
ajlm-5	159	14	differences	difference	NOUN
ajlm-5	159	15	in	in	ADP
ajlm-5	159	16	the	the	DET
ajlm-5	159	17	total	total	ADJ
ajlm-5	159	18	and	and	CCONJ
ajlm-5	159	19	differential	differential	ADJ
ajlm-5	159	20	white	white	ADJ
ajlm-5	159	21	cell	cell	NOUN
ajlm-5	159	22	count	count	NOUN
ajlm-5	159	23	and	and	CCONJ
ajlm-5	159	24	platelet	platelet	NOUN
ajlm-5	159	25	count	count	NOUN
ajlm-5	159	26	.	.	PUNCT
ajlm-5	160	1	j	j	PROPN
ajlm-5	160	2	clin	clin	PROPN
ajlm-5	160	3	pathol	pathol	PROPN
ajlm-5	160	4	.	.	PUNCT
ajlm-5	161	1	1996;49:664–666	1996;49:664–666	NUM
ajlm-5	161	2	.	.	PUNCT
ajlm-5	162	1	http://dx.doi.org/10.1136/jcp.49.8.664	http://dx.doi.org/10.1136/jcp.49.8.664	PROPN
ajlm-5	162	2	,	,	PUNCT
ajlm-5	162	3	pmid:8881919	pmid:8881919	NOUN
ajlm-5	162	4	,	,	PUNCT
ajlm-5	162	5	pmcid:500612	pmcid:500612	VERB
ajlm-5	162	6	10	10	NUM
ajlm-5	162	7	.	.	PUNCT
ajlm-5	163	1	mazzaccara	mazzaccara	NOUN
ajlm-5	163	2	c	c	NOUN
ajlm-5	163	3	,	,	PUNCT
ajlm-5	163	4	labruna	labruna	PROPN
ajlm-5	163	5	g	g	PROPN
ajlm-5	163	6	,	,	PUNCT
ajlm-5	163	7	cito	cito	PROPN
ajlm-5	163	8	g	g	PROPN
ajlm-5	163	9	,	,	PUNCT
ajlm-5	163	10	et	et	PROPN
ajlm-5	163	11	al	al	PROPN
ajlm-5	163	12	.	.	PUNCT
ajlm-5	163	13	age	age	NOUN
ajlm-5	163	14	-	-	PUNCT
ajlm-5	163	15	related	relate	VERB
ajlm-5	163	16	reference	reference	NOUN
ajlm-5	163	17	intervals	interval	NOUN
ajlm-5	163	18	of	of	ADP
ajlm-5	163	19	the	the	DET
ajlm-5	163	20	main	main	ADJ
ajlm-5	163	21	biochemical	biochemical	ADJ
ajlm-5	163	22	and	and	CCONJ
ajlm-5	163	23	hematological	hematological	ADJ
ajlm-5	163	24	parameters	parameter	NOUN
ajlm-5	163	25	in	in	ADP
ajlm-5	163	26	c57bl/6j	c57bl/6j	PROPN
ajlm-5	163	27	,	,	PUNCT
ajlm-5	163	28	129sv	129sv	PROPN
ajlm-5	163	29	/	/	SYM
ajlm-5	163	30	ev	ev	PROPN
ajlm-5	163	31	and	and	CCONJ
ajlm-5	163	32	c3h	c3h	PROPN
ajlm-5	163	33	/	/	SYM
ajlm-5	163	34	hej	hej	PROPN
ajlm-5	163	35	mouse	mouse	PROPN
ajlm-5	163	36	strains	strain	NOUN
ajlm-5	163	37	.	.	PUNCT
ajlm-5	164	1	plos	plos	PROPN
ajlm-5	164	2	one	one	NUM
ajlm-5	164	3	.	.	PUNCT
ajlm-5	165	1	2008;3	2008;3	NUM
ajlm-5	165	2	:	:	SYM
ajlm-5	165	3	e3772	e3772	PROPN
ajlm-5	165	4	.	.	PUNCT
ajlm-5	166	1	http://dx.doi.org/10.1371/journal.pone.0003772	http://dx.doi.org/10.1371/journal.pone.0003772	PROPN
ajlm-5	166	2	,	,	PUNCT
ajlm-5	166	3	pmid:19020657	pmid:19020657	X
ajlm-5	166	4	,	,	PUNCT
ajlm-5	166	5	pmcid:2582346	pmcid:2582346	VERB
ajlm-5	166	6	11	11	NUM
ajlm-5	166	7	.	.	PUNCT
ajlm-5	167	1	lugada	lugada	PROPN
ajlm-5	167	2	es	es	PROPN
ajlm-5	167	3	,	,	PUNCT
ajlm-5	167	4	mermin	mermin	PROPN
ajlm-5	167	5	j	j	PROPN
ajlm-5	167	6	,	,	PUNCT
ajlm-5	167	7	kaharuza	kaharuza	PROPN
ajlm-5	167	8	f	f	AUX
ajlm-5	167	9	,	,	PUNCT
ajlm-5	167	10	et	et	PROPN
ajlm-5	167	11	al	al	PROPN
ajlm-5	167	12	.	.	PUNCT
ajlm-5	168	1	population	population	NOUN
ajlm-5	168	2	-	-	PUNCT
ajlm-5	168	3	based	base	VERB
ajlm-5	168	4	hematologic	hematologic	NOUN
ajlm-5	168	5	and	and	CCONJ
ajlm-5	168	6	immunologic	immunologic	ADJ
ajlm-5	168	7	reference	reference	NOUN
ajlm-5	168	8	values	value	NOUN
ajlm-5	168	9	for	for	ADP
ajlm-5	168	10	a	a	DET
ajlm-5	168	11	healthy	healthy	ADJ
ajlm-5	168	12	ugandan	ugandan	ADJ
ajlm-5	168	13	population	population	NOUN
ajlm-5	168	14	.	.	PUNCT
ajlm-5	169	1	clin	clin	PROPN
ajlm-5	169	2	diagn	diagn	PROPN
ajlm-5	169	3	lab	lab	NOUN
ajlm-5	169	4	immunol	immunol	NOUN
ajlm-5	169	5	.	.	PUNCT
ajlm-5	170	1	2004;11:29–34	2004;11:29–34	NUM
ajlm-5	170	2	.	.	NUM
ajlm-5	170	3	pmid:1471554	pmid:1471554	NOUN
ajlm-5	170	4	,	,	PUNCT
ajlm-5	170	5	pmcid:321349	pmcid:321349	NOUN
ajlm-5	170	6	12	12	NUM
ajlm-5	170	7	.	.	PUNCT
ajlm-5	170	8	saathoff	saathoff	PROPN
ajlm-5	170	9	e	e	PROPN
ajlm-5	170	10	,	,	PUNCT
ajlm-5	170	11	schneider	schneider	PROPN
ajlm-5	170	12	p	p	PROPN
ajlm-5	170	13	,	,	PUNCT
ajlm-5	170	14	kleinfeldt	kleinfeldt	ADJ
ajlm-5	170	15	v	v	PROPN
ajlm-5	170	16	,	,	PUNCT
ajlm-5	170	17	et	et	PROPN
ajlm-5	170	18	al	al	PROPN
ajlm-5	170	19	.	.	PROPN
ajlm-5	171	1	laboratory	laboratory	NOUN
ajlm-5	171	2	reference	reference	NOUN
ajlm-5	171	3	values	value	NOUN
ajlm-5	171	4	for	for	ADP
ajlm-5	171	5	healthy	healthy	ADJ
ajlm-5	171	6	adults	adult	NOUN
ajlm-5	171	7	from	from	ADP
ajlm-5	171	8	southern	southern	ADJ
ajlm-5	171	9	tanzania	tanzania	PROPN
ajlm-5	171	10	.	.	PUNCT
ajlm-5	172	1	trop	trop	PROPN
ajlm-5	172	2	med	med	ADJ
ajlm-5	172	3	int	int	PROPN
ajlm-5	172	4	health	health	NOUN
ajlm-5	172	5	.	.	PUNCT
ajlm-5	173	1	2008;13:612–625	2008;13:612–625	NOUN
ajlm-5	173	2	.	.	PUNCT
ajlm-5	174	1	http://dx.doi.org/10.1111/j.1365-3156.2008.02047.x	http://dx.doi.org/10.1111/j.1365-3156.2008.02047.x	ADP
ajlm-5	174	2	13	13	NUM
ajlm-5	174	3	.	.	PUNCT
ajlm-5	175	1	tugume	tugume	PROPN
ajlm-5	175	2	sb	sb	PROPN
ajlm-5	175	3	,	,	PUNCT
ajlm-5	175	4	piwowar	piwowar	VERB
ajlm-5	175	5	em	em	PRON
ajlm-5	175	6	,	,	PUNCT
ajlm-5	175	7	lutalo	lutalo	PROPN
ajlm-5	175	8	t	t	PROPN
ajlm-5	175	9	,	,	PUNCT
ajlm-5	175	10	et	et	PROPN
ajlm-5	175	11	al	al	PROPN
ajlm-5	175	12	.	.	PUNCT
ajlm-5	176	1	hematological	hematological	ADJ
ajlm-5	176	2	reference	reference	NOUN
ajlm-5	176	3	ranges	range	VERB
ajlm-5	176	4	among	among	ADP
ajlm-5	176	5	healthy	healthy	ADJ
ajlm-5	176	6	ugandans	ugandans	PROPN
ajlm-5	176	7	.	.	PUNCT
ajlm-5	177	1	clin	clin	PROPN
ajlm-5	177	2	diagn	diagn	PROPN
ajlm-5	177	3	lab	lab	NOUN
ajlm-5	177	4	immunol	immunol	NOUN
ajlm-5	177	5	.	.	PUNCT
ajlm-5	178	1	1995;2:233–235	1995;2:233–235	X
ajlm-5	178	2	.	.	PUNCT
ajlm-5	178	3	pmid:7697535	pmid:7697535	PROPN
ajlm-5	178	4	,	,	PUNCT
ajlm-5	178	5	pmcid:170134	pmcid:170134	VERB
ajlm-5	178	6	14	14	NUM
ajlm-5	178	7	.	.	PUNCT
ajlm-5	179	1	lawrie	lawrie	PROPN
ajlm-5	179	2	d	d	PROPN
ajlm-5	179	3	,	,	PUNCT
ajlm-5	179	4	coetzee	coetzee	PROPN
ajlm-5	179	5	lm	lm	PROPN
ajlm-5	179	6	,	,	PUNCT
ajlm-5	179	7	becker	becker	PROPN
ajlm-5	180	1	p	p	X
ajlm-5	180	2	,	,	PUNCT
ajlm-5	180	3	mahlangu	mahlangu	PROPN
ajlm-5	180	4	j	j	PROPN
ajlm-5	180	5	,	,	PUNCT
ajlm-5	180	6	stevens	stevens	PROPN
ajlm-5	180	7	w	w	PROPN
ajlm-5	180	8	,	,	PUNCT
ajlm-5	180	9	glencross	glencross	ADJ
ajlm-5	180	10	dk	dk	PROPN
ajlm-5	180	11	.	.	PROPN
ajlm-5	181	1	local	local	ADJ
ajlm-5	181	2	reference	reference	NOUN
ajlm-5	181	3	ranges	range	VERB
ajlm-5	181	4	for	for	ADP
ajlm-5	181	5	full	full	ADJ
ajlm-5	181	6	blood	blood	NOUN
ajlm-5	181	7	count	count	NOUN
ajlm-5	181	8	and	and	CCONJ
ajlm-5	181	9	cd4	cd4	PROPN
ajlm-5	181	10	lymphocyte	lymphocyte	ADJ
ajlm-5	181	11	count	count	NOUN
ajlm-5	181	12	testing	testing	NOUN
ajlm-5	181	13	.	.	PUNCT
ajlm-5	182	1	s	s	PROPN
ajlm-5	182	2	afr	afr	PROPN
ajlm-5	182	3	med	med	PROPN
ajlm-5	182	4	j.	j.	PROPN
ajlm-5	182	5	2009;99:243–248	2009;99:243–248	PROPN
ajlm-5	182	6	.	.	PUNCT
ajlm-5	183	1	pmid:19588777	pmid:19588777	PROPN
ajlm-5	183	2	15	15	NUM
ajlm-5	183	3	.	.	PUNCT
ajlm-5	184	1	otahbachi	otahbachi	PROPN
ajlm-5	184	2	m	m	PROPN
ajlm-5	184	3	,	,	PUNCT
ajlm-5	184	4	simoni	simoni	PROPN
ajlm-5	184	5	j	j	PROPN
ajlm-5	184	6	,	,	PUNCT
ajlm-5	184	7	simoni	simoni	PROPN
ajlm-5	184	8	g	g	PROPN
ajlm-5	184	9	,	,	PUNCT
ajlm-5	184	10	et	et	PROPN
ajlm-5	184	11	al	al	PROPN
ajlm-5	184	12	.	.	PUNCT
ajlm-5	185	1	gender	gender	NOUN
ajlm-5	185	2	differences	difference	NOUN
ajlm-5	185	3	in	in	ADP
ajlm-5	185	4	platelet	platelet	NOUN
ajlm-5	185	5	aggregation	aggregation	NOUN
ajlm-5	185	6	in	in	ADP
ajlm-5	185	7	healthy	healthy	ADJ
ajlm-5	185	8	individuals	individual	NOUN
ajlm-5	185	9	.	.	PUNCT
ajlm-5	186	1	j	j	PROPN
ajlm-5	186	2	thromb	thromb	PROPN
ajlm-5	186	3	thrombolysis	thrombolysis	NOUN
ajlm-5	186	4	.	.	PUNCT
ajlm-5	187	1	2010;30:184–191	2010;30:184–191	X
ajlm-5	187	2	.	.	PUNCT
ajlm-5	188	1	http://dx.doi.org/10.1007/s11239-009-0436-x	http://dx.doi.org/10.1007/s11239-009-0436-x	PROPN
ajlm-5	188	2	,	,	PUNCT
ajlm-5	188	3	pmid:20039102	pmid:20039102	ADP
ajlm-5	188	4	16	16	NUM
ajlm-5	188	5	.	.	PUNCT
ajlm-5	188	6	tsegaye	tsegaye	VERB
ajlm-5	188	7	a	a	DET
ajlm-5	188	8	,	,	PUNCT
ajlm-5	188	9	wolday	wolday	NOUN
ajlm-5	188	10	d	d	PROPN
ajlm-5	188	11	,	,	PUNCT
ajlm-5	188	12	otto	otto	PROPN
ajlm-5	188	13	s	s	PROPN
ajlm-5	188	14	,	,	PUNCT
ajlm-5	188	15	et	et	PROPN
ajlm-5	188	16	al	al	PROPN
ajlm-5	188	17	.	.	PUNCT
ajlm-5	189	1	immunophenotyping	immunophenotype	VERB
ajlm-5	189	2	of	of	ADP
ajlm-5	189	3	blood	blood	NOUN
ajlm-5	189	4	lymphocytes	lymphocyte	VERB
ajlm-5	189	5	at	at	ADP
ajlm-5	189	6	birth	birth	NOUN
ajlm-5	189	7	,	,	PUNCT
ajlm-5	189	8	during	during	ADP
ajlm-5	189	9	childhood	childhood	NOUN
ajlm-5	189	10	,	,	PUNCT
ajlm-5	189	11	and	and	CCONJ
ajlm-5	189	12	during	during	ADP
ajlm-5	189	13	adulthood	adulthood	NOUN
ajlm-5	189	14	in	in	ADP
ajlm-5	189	15	hiv-1	hiv-1	ADV
ajlm-5	189	16	-	-	PUNCT
ajlm-5	189	17	uninfected	uninfected	ADJ
ajlm-5	189	18	ethiopians	ethiopians	PROPN
ajlm-5	189	19	.	.	PUNCT
ajlm-5	190	1	clin	clin	PROPN
ajlm-5	190	2	immunol	immunol	PROPN
ajlm-5	190	3	.	.	PUNCT
ajlm-5	191	1	2003;109:338–346	2003;109:338–346	NUM
ajlm-5	191	2	.	.	PUNCT
ajlm-5	192	1	http://dx.doi.org/10.1016/j.clim.2003.08.008	http://dx.doi.org/10.1016/j.clim.2003.08.008	NOUN
ajlm-5	192	2	,	,	PUNCT
ajlm-5	192	3	pmid:14697749	pmid:14697749	NOUN
ajlm-5	192	4	17	17	NUM
ajlm-5	192	5	.	.	PUNCT
ajlm-5	193	1	menard	menard	PROPN
ajlm-5	193	2	d	d	PROPN
ajlm-5	193	3	,	,	PUNCT
ajlm-5	193	4	mandeng	mandeng	PROPN
ajlm-5	193	5	mj	mj	PROPN
ajlm-5	193	6	,	,	PUNCT
ajlm-5	193	7	tothy	tothy	ADJ
ajlm-5	193	8	mb	mb	NOUN
ajlm-5	193	9	,	,	PUNCT
ajlm-5	193	10	kelembho	kelembho	PROPN
ajlm-5	193	11	ek	ek	PROPN
ajlm-5	193	12	,	,	PUNCT
ajlm-5	193	13	gresenguet	gresenguet	NOUN
ajlm-5	193	14	g	g	NOUN
ajlm-5	193	15	,	,	PUNCT
ajlm-5	193	16	talarmin	talarmin	ADJ
ajlm-5	193	17	a.	a.	NOUN
ajlm-5	193	18	immunohematological	immunohematological	ADJ
ajlm-5	193	19	reference	reference	NOUN
ajlm-5	193	20	ranges	range	VERB
ajlm-5	193	21	for	for	ADP
ajlm-5	193	22	adults	adult	NOUN
ajlm-5	193	23	from	from	ADP
ajlm-5	193	24	the	the	DET
ajlm-5	193	25	central	central	ADJ
ajlm-5	193	26	african	african	ADJ
ajlm-5	193	27	republic	republic	NOUN
ajlm-5	193	28	.	.	PUNCT
ajlm-5	194	1	clin	clin	PROPN
ajlm-5	194	2	diagn	diagn	PROPN
ajlm-5	194	3	lab	lab	NOUN
ajlm-5	194	4	immunol	immunol	NOUN
ajlm-5	194	5	.	.	PUNCT
ajlm-5	195	1	2003;10:443–445	2003;10:443–445	NOUN
ajlm-5	195	2	.	.	PUNCT
ajlm-5	196	1	pmid:12738646	pmid:12738646	PROPN
ajlm-5	196	2	,	,	PUNCT
ajlm-5	196	3	pmcid:154963	pmcid:154963	PROPN
ajlm-5	196	4	18	18	NUM
ajlm-5	196	5	.	.	PUNCT
ajlm-5	197	1	karita	karita	PROPN
ajlm-5	197	2	e	e	PROPN
ajlm-5	197	3	,	,	PUNCT
ajlm-5	197	4	ketter	ketter	NOUN
ajlm-5	197	5	n	n	CCONJ
ajlm-5	197	6	,	,	PUNCT
ajlm-5	197	7	price	price	NOUN
ajlm-5	197	8	ma	ma	PROPN
ajlm-5	197	9	,	,	PUNCT
ajlm-5	197	10	et	et	PROPN
ajlm-5	197	11	al	al	PROPN
ajlm-5	197	12	.	.	PUNCT
ajlm-5	197	13	clsi	clsi	NOUN
ajlm-5	197	14	-	-	PUNCT
ajlm-5	197	15	derived	derive	VERB
ajlm-5	197	16	hematology	hematology	NOUN
ajlm-5	197	17	and	and	CCONJ
ajlm-5	197	18	biochemistry	biochemistry	NOUN
ajlm-5	197	19	reference	reference	NOUN
ajlm-5	197	20	intervals	interval	NOUN
ajlm-5	197	21	for	for	ADP
ajlm-5	197	22	healthy	healthy	ADJ
ajlm-5	197	23	adults	adult	NOUN
ajlm-5	197	24	in	in	ADP
ajlm-5	197	25	eastern	eastern	ADJ
ajlm-5	197	26	and	and	CCONJ
ajlm-5	197	27	southern	southern	PROPN
ajlm-5	197	28	africa	africa	PROPN
ajlm-5	197	29	.	.	PUNCT
ajlm-5	198	1	plos	plos	PROPN
ajlm-5	198	2	one	one	NUM
ajlm-5	198	3	.	.	PUNCT
ajlm-5	199	1	2009;4	2009;4	NUM
ajlm-5	199	2	:	:	PUNCT
ajlm-5	200	1	e4401	e4401	NOUN
ajlm-5	200	2	.	.	PUNCT
ajlm-5	200	3	http://dx.doi.org/10.1371/journal.pone.0004401	http://dx.doi.org/10.1371/journal.pone.0004401	PROPN
ajlm-5	200	4	,	,	PUNCT
ajlm-5	200	5	pmid:19197365	pmid:19197365	NOUN
ajlm-5	200	6	,	,	PUNCT
ajlm-5	200	7	pmcid:2632744	pmcid:2632744	VERB
ajlm-5	200	8	19	19	NUM
ajlm-5	200	9	.	.	PUNCT
ajlm-5	200	10	eller	eller	PROPN
ajlm-5	200	11	la	la	PROPN
ajlm-5	200	12	,	,	PUNCT
ajlm-5	200	13	eller	eller	PROPN
ajlm-5	200	14	ma	ma	PROPN
ajlm-5	200	15	,	,	PUNCT
ajlm-5	200	16	ouma	ouma	PROPN
ajlm-5	200	17	b	b	PROPN
ajlm-5	200	18	,	,	PUNCT
ajlm-5	200	19	et	et	PROPN
ajlm-5	200	20	al	al	PROPN
ajlm-5	200	21	.	.	PROPN
ajlm-5	201	1	reference	reference	NOUN
ajlm-5	201	2	intervals	interval	NOUN
ajlm-5	201	3	in	in	ADP
ajlm-5	201	4	healthy	healthy	ADJ
ajlm-5	201	5	adult	adult	NOUN
ajlm-5	201	6	ugandan	ugandan	ADJ
ajlm-5	201	7	blood	blood	NOUN
ajlm-5	201	8	donors	donor	NOUN
ajlm-5	201	9	and	and	CCONJ
ajlm-5	201	10	their	their	PRON
ajlm-5	201	11	impact	impact	NOUN
ajlm-5	201	12	on	on	ADP
ajlm-5	201	13	conducting	conduct	VERB
ajlm-5	201	14	international	international	ADJ
ajlm-5	201	15	vaccine	vaccine	NOUN
ajlm-5	201	16	trials	trial	NOUN
ajlm-5	201	17	.	.	PUNCT
ajlm-5	202	1	plos	plos	PROPN
ajlm-5	202	2	one	one	NUM
ajlm-5	202	3	.	.	PUNCT
ajlm-5	203	1	2008;3	2008;3	NUM
ajlm-5	203	2	:	:	PUNCT
ajlm-5	203	3	e3919	e3919	PROPN
ajlm-5	203	4	.	.	PUNCT
ajlm-5	204	1	http://dx.doi.org/10.1371/journal.pone.0003919	http://dx.doi.org/10.1371/journal.pone.0003919	NOUN
ajlm-5	204	2	,	,	PUNCT
ajlm-5	204	3	pmid:19079547	pmid:19079547	NOUN
ajlm-5	204	4	,	,	PUNCT
ajlm-5	204	5	pmcid:2593783	pmcid:2593783	NOUN
ajlm-5	204	6	20	20	NUM
ajlm-5	204	7	.	.	PUNCT
ajlm-5	205	1	wells	wells	PROPN
ajlm-5	205	2	j	j	PROPN
ajlm-5	205	3	,	,	PUNCT
ajlm-5	205	4	shetty	shetty	PROPN
ajlm-5	205	5	ak	ak	PROPN
ajlm-5	205	6	,	,	PUNCT
ajlm-5	205	7	stranix	stranix	NOUN
ajlm-5	205	8	l	l	NOUN
ajlm-5	205	9	,	,	PUNCT
ajlm-5	205	10	et	et	PROPN
ajlm-5	205	11	al	al	PROPN
ajlm-5	205	12	.	.	PROPN
ajlm-5	205	13	range	range	NOUN
ajlm-5	205	14	of	of	ADP
ajlm-5	205	15	normal	normal	ADJ
ajlm-5	205	16	neutrophil	neutrophil	ADJ
ajlm-5	205	17	counts	count	NOUN
ajlm-5	205	18	in	in	ADP
ajlm-5	205	19	healthy	healthy	ADJ
ajlm-5	205	20	zimbabwean	zimbabwean	ADJ
ajlm-5	205	21	infants	infant	NOUN
ajlm-5	205	22	:	:	PUNCT
ajlm-5	205	23	implications	implication	NOUN
ajlm-5	205	24	for	for	ADP
ajlm-5	205	25	monitoring	monitor	VERB
ajlm-5	205	26	antiretroviral	antiretroviral	ADJ
ajlm-5	205	27	drug	drug	NOUN
ajlm-5	205	28	toxicity	toxicity	NOUN
ajlm-5	205	29	.	.	PUNCT
ajlm-5	206	1	j	j	PROPN
ajlm-5	206	2	acquir	acquir	PROPN
ajlm-5	206	3	immune	immune	VERB
ajlm-5	206	4	defic	defic	ADJ
ajlm-5	206	5	syndr	syndr	NOUN
ajlm-5	206	6	.	.	PUNCT
ajlm-5	207	1	2006;42:460–463	2006;42:460–463	NUM
ajlm-5	207	2	.	.	PUNCT
ajlm-5	208	1	http://dx.doi.org/10.1097/01.qai.0000224975.45091.a5	http://dx.doi.org/10.1097/01.qai.0000224975.45091.a5	PROPN
ajlm-5	208	2	,	,	PUNCT
ajlm-5	208	3	pmid:16810112	pmid:16810112	NOUN
ajlm-5	208	4	21	21	NUM
ajlm-5	208	5	.	.	PUNCT
ajlm-5	209	1	lubega	lubega	PROPN
ajlm-5	209	2	ir	ir	PROPN
ajlm-5	209	3	,	,	PUNCT
ajlm-5	209	4	fowler	fowler	PROPN
ajlm-5	209	5	mg	mg	PROPN
ajlm-5	209	6	,	,	PUNCT
ajlm-5	209	7	musoke	musoke	PROPN
ajlm-5	209	8	pm	pm	PROPN
ajlm-5	209	9	,	,	PUNCT
ajlm-5	209	10	et	et	PROPN
ajlm-5	209	11	al	al	PROPN
ajlm-5	209	12	.	.	PUNCT
ajlm-5	209	13	considerations	consideration	NOUN
ajlm-5	209	14	in	in	ADP
ajlm-5	209	15	using	use	VERB
ajlm-5	209	16	us	we	PRON
ajlm-5	209	17	-	-	PUNCT
ajlm-5	209	18	based	base	VERB
ajlm-5	209	19	laboratory	laboratory	NOUN
ajlm-5	209	20	toxicity	toxicity	NOUN
ajlm-5	209	21	tables	table	NOUN
ajlm-5	209	22	to	to	PART
ajlm-5	209	23	evaluate	evaluate	VERB
ajlm-5	209	24	laboratory	laboratory	NOUN
ajlm-5	209	25	toxicities	toxicity	NOUN
ajlm-5	209	26	among	among	ADP
ajlm-5	209	27	healthy	healthy	ADJ
ajlm-5	209	28	malawian	malawian	ADJ
ajlm-5	209	29	and	and	CCONJ
ajlm-5	209	30	ugandan	ugandan	ADJ
ajlm-5	209	31	infants	infant	NOUN
ajlm-5	209	32	.	.	PUNCT
ajlm-5	210	1	j	j	PROPN
ajlm-5	210	2	acquir	acquir	PROPN
ajlm-5	210	3	immune	immune	VERB
ajlm-5	210	4	defic	defic	ADJ
ajlm-5	210	5	syndr	syndr	NOUN
ajlm-5	210	6	.	.	PUNCT
ajlm-5	211	1	2010;55:58–64	2010;55:58–64	NUM
ajlm-5	211	2	.	.	PUNCT
ajlm-5	212	1	http://dx.doi.org/10.1097/qai.0b013e3181db059d	http://dx.doi.org/10.1097/qai.0b013e3181db059d	NOUN
ajlm-5	212	2	,	,	PUNCT
ajlm-5	212	3	pmid:20588184	pmid:20588184	NOUN
ajlm-5	212	4	,	,	PUNCT
ajlm-5	212	5	pmcid:3033212	pmcid:3033212	ADJ
ajlm-5	212	6	22	22	NUM
ajlm-5	212	7	.	.	PUNCT
ajlm-5	213	1	division	division	NOUN
ajlm-5	213	2	of	of	ADP
ajlm-5	213	3	aids	aids	PROPN
ajlm-5	213	4	(	(	PUNCT
ajlm-5	213	5	daids	daid	NOUN
ajlm-5	213	6	)	)	PUNCT
ajlm-5	213	7	.	.	PUNCT
ajlm-5	214	1	the	the	DET
ajlm-5	214	2	division	division	NOUN
ajlm-5	214	3	of	of	ADP
ajlm-5	214	4	aids	aids	PROPN
ajlm-5	214	5	table	table	NOUN
ajlm-5	214	6	for	for	ADP
ajlm-5	214	7	grading	grade	VERB
ajlm-5	214	8	the	the	DET
ajlm-5	214	9	severity	severity	NOUN
ajlm-5	214	10	of	of	ADP
ajlm-5	214	11	adult	adult	NOUN
ajlm-5	214	12	and	and	CCONJ
ajlm-5	214	13	pediatric	pediatric	ADJ
ajlm-5	214	14	adverse	adverse	ADJ
ajlm-5	214	15	events	event	NOUN
ajlm-5	214	16	(	(	PUNCT
ajlm-5	214	17	daids	daid	NOUN
ajlm-5	214	18	ae	ae	PROPN
ajlm-5	214	19	grading	grade	VERB
ajlm-5	214	20	table	table	NOUN
ajlm-5	214	21	)	)	PUNCT
ajlm-5	214	22	.	.	PUNCT
ajlm-5	215	1	usa	usa	PROPN
ajlm-5	215	2	:	:	PUNCT
ajlm-5	215	3	national	national	PROPN
ajlm-5	215	4	institutes	institutes	PROPN
ajlm-5	215	5	of	of	ADP
ajlm-5	215	6	health	health	NOUN
ajlm-5	215	7	;	;	PUNCT
ajlm-5	215	8	2004	2004	NUM
ajlm-5	215	9	.	.	PUNCT
ajlm-5	216	1	23	23	NUM
ajlm-5	216	2	.	.	PUNCT
ajlm-5	217	1	bussmann	bussmann	PROPN
ajlm-5	217	2	h	h	PROPN
ajlm-5	217	3	,	,	PUNCT
ajlm-5	217	4	wester	wester	PROPN
ajlm-5	217	5	cw	cw	NOUN
ajlm-5	217	6	,	,	PUNCT
ajlm-5	217	7	masupu	masupu	VERB
ajlm-5	217	8	kv	kv	PROPN
ajlm-5	217	9	,	,	PUNCT
ajlm-5	217	10	et	et	PROPN
ajlm-5	217	11	al	al	PROPN
ajlm-5	217	12	.	.	PROPN
ajlm-5	217	13	low	low	PROPN
ajlm-5	217	14	cd4	cd4	PROPN
ajlm-5	217	15	+	+	PROPN
ajlm-5	217	16	t	t	PROPN
ajlm-5	217	17	-	-	PUNCT
ajlm-5	217	18	lymphocyte	lymphocyte	ADJ
ajlm-5	217	19	values	value	NOUN
ajlm-5	217	20	in	in	ADP
ajlm-5	217	21	human	human	ADJ
ajlm-5	217	22	immunodeficiency	immunodeficiency	NOUN
ajlm-5	217	23	virus	virus	NOUN
ajlm-5	217	24	-	-	PUNCT
ajlm-5	217	25	negative	negative	ADJ
ajlm-5	217	26	adults	adult	NOUN
ajlm-5	217	27	in	in	ADP
ajlm-5	217	28	botswana	botswana	PROPN
ajlm-5	217	29	.	.	PUNCT
ajlm-5	218	1	clin	clin	PROPN
ajlm-5	218	2	diagn	diagn	PROPN
ajlm-5	218	3	lab	lab	NOUN
ajlm-5	218	4	immunol	immunol	NOUN
ajlm-5	218	5	.	.	PUNCT
ajlm-5	219	1	2004;11:930–935	2004;11:930–935	X
ajlm-5	219	2	.	.	PUNCT
ajlm-5	220	1	pmid:15358655	pmid:15358655	ADJ
ajlm-5	220	2	,	,	PUNCT
ajlm-5	220	3	pmcid:515279	pmcid:515279	NOUN
ajlm-5	220	4	24	24	NUM
ajlm-5	220	5	.	.	PUNCT
ajlm-5	221	1	lawrie	lawrie	PROPN
ajlm-5	221	2	d	d	PROPN
ajlm-5	221	3	,	,	PUNCT
ajlm-5	221	4	coetzee	coetzee	PROPN
ajlm-5	221	5	lm	lm	PROPN
ajlm-5	221	6	,	,	PUNCT
ajlm-5	221	7	becker	becker	PROPN
ajlm-5	222	1	p	p	X
ajlm-5	222	2	,	,	PUNCT
ajlm-5	222	3	mahlangu	mahlangu	PROPN
ajlm-5	222	4	j	j	PROPN
ajlm-5	222	5	,	,	PUNCT
ajlm-5	222	6	stevens	stevens	PROPN
ajlm-5	222	7	w	w	PROPN
ajlm-5	222	8	,	,	PUNCT
ajlm-5	222	9	glencross	glencross	ADJ
ajlm-5	222	10	dk	dk	PROPN
ajlm-5	222	11	.	.	PROPN
ajlm-5	223	1	local	local	ADJ
ajlm-5	223	2	reference	reference	NOUN
ajlm-5	223	3	ranges	range	VERB
ajlm-5	223	4	for	for	ADP
ajlm-5	223	5	full	full	ADJ
ajlm-5	223	6	blood	blood	NOUN
ajlm-5	223	7	count	count	NOUN
ajlm-5	223	8	and	and	CCONJ
ajlm-5	223	9	cd4	cd4	PROPN
ajlm-5	223	10	lymphocyte	lymphocyte	ADJ
ajlm-5	223	11	count	count	NOUN
ajlm-5	223	12	testing	testing	NOUN
ajlm-5	223	13	.	.	PUNCT
ajlm-5	224	1	s	s	PROPN
ajlm-5	224	2	afr	afr	PROPN
ajlm-5	224	3	med	med	PROPN
ajlm-5	224	4	j.	j.	PROPN
ajlm-5	224	5	2010;99	2010;99	PROPN
ajlm-5	224	6	.	.	PUNCT
ajlm-5	225	1	pmid:20459912	pmid:20459912	PROPN
ajlm-5	225	2	25	25	NUM
ajlm-5	225	3	.	.	PUNCT
ajlm-5	226	1	mills	mill	NOUN
ajlm-5	226	2	e	e	PROPN
ajlm-5	226	3	,	,	PUNCT
ajlm-5	226	4	cooper	cooper	PROPN
ajlm-5	226	5	c	c	PROPN
ajlm-5	226	6	,	,	PUNCT
ajlm-5	226	7	guyatt	guyatt	PROPN
ajlm-5	226	8	g	g	PROPN
ajlm-5	226	9	,	,	PUNCT
ajlm-5	226	10	et	et	PROPN
ajlm-5	226	11	al	al	PROPN
ajlm-5	226	12	.	.	PUNCT
ajlm-5	226	13	barriers	barrier	NOUN
ajlm-5	226	14	to	to	ADP
ajlm-5	226	15	participating	participate	VERB
ajlm-5	226	16	in	in	ADP
ajlm-5	226	17	an	an	DET
ajlm-5	226	18	hiv	hiv	PROPN
ajlm-5	226	19	vaccine	vaccine	NOUN
ajlm-5	226	20	trial	trial	NOUN
ajlm-5	226	21	:	:	PUNCT
ajlm-5	226	22	a	a	DET
ajlm-5	226	23	systematic	systematic	ADJ
ajlm-5	226	24	review	review	NOUN
ajlm-5	226	25	.	.	PUNCT
ajlm-5	227	1	aids	aids	PROPN
ajlm-5	227	2	.	.	PUNCT
ajlm-5	228	1	2004;18:2235	2004;18:2235	NUM
ajlm-5	228	2	.	.	PUNCT
ajlm-5	229	1	http://dx.doi.org/10.1097/00002030-200411190-00003	http://dx.doi.org/10.1097/00002030-200411190-00003	PROPN
ajlm-5	229	2	,	,	PUNCT
ajlm-5	229	3	pmid:15577535	pmid:15577535	NOUN
ajlm-5	229	4	26	26	NUM
ajlm-5	229	5	.	.	PUNCT
ajlm-5	230	1	gilmour	gilmour	PROPN
ajlm-5	230	2	jw	jw	PROPN
ajlm-5	230	3	,	,	PUNCT
ajlm-5	230	4	stevens	stevens	PROPN
ajlm-5	230	5	ws	ws	PROPN
ajlm-5	230	6	,	,	PUNCT
ajlm-5	230	7	gray	gray	ADJ
ajlm-5	230	8	c	c	NOUN
ajlm-5	230	9	,	,	PUNCT
ajlm-5	230	10	de	de	PROPN
ajlm-5	230	11	souza	souza	PROPN
ajlm-5	230	12	m.	m.	PROPN
ajlm-5	230	13	laboratory	laboratory	PROPN
ajlm-5	230	14	expansion	expansion	NOUN
ajlm-5	230	15	to	to	ADP
ajlm-5	230	16	large	large	ADJ
ajlm-5	230	17	-	-	PUNCT
ajlm-5	230	18	scale	scale	NOUN
ajlm-5	230	19	international	international	ADJ
ajlm-5	230	20	hiv	hiv	PROPN
ajlm-5	230	21	preventive	preventive	ADJ
ajlm-5	230	22	vaccine	vaccine	NOUN
ajlm-5	230	23	trials	trial	NOUN
ajlm-5	230	24	.	.	PUNCT
ajlm-5	231	1	curr	curr	PROPN
ajlm-5	231	2	opin	opin	PROPN
ajlm-5	231	3	hiv	hiv	PROPN
ajlm-5	231	4	aids	aids	PROPN
ajlm-5	231	5	.	.	PUNCT
ajlm-5	232	1	2007;2:201	2007;2:201	X
ajlm-5	232	2	.	.	PUNCT
ajlm-5	233	1	http://dx.doi.org/10.1097/coh.0b013e3280eec77a	http://dx.doi.org/10.1097/coh.0b013e3280eec77a	ADJ
ajlm-5	233	2	,	,	PUNCT
ajlm-5	233	3	pmid:19372887	pmid:19372887	ADJ
ajlm-5	233	4	27	27	NUM
ajlm-5	233	5	.	.	PUNCT
ajlm-5	234	1	stevens	stevens	PROPN
ajlm-5	234	2	w	w	PROPN
ajlm-5	234	3	,	,	PUNCT
ajlm-5	234	4	kamali	kamali	PROPN
ajlm-5	234	5	a	a	X
ajlm-5	234	6	,	,	PUNCT
ajlm-5	234	7	karita	karita	NOUN
ajlm-5	234	8	e	e	NOUN
ajlm-5	234	9	,	,	PUNCT
ajlm-5	234	10	et	et	PROPN
ajlm-5	234	11	al	al	PROPN
ajlm-5	234	12	.	.	PROPN
ajlm-5	234	13	baseline	baseline	PROPN
ajlm-5	234	14	morbidity	morbidity	NOUN
ajlm-5	234	15	in	in	ADP
ajlm-5	234	16	2,990	2,990	NUM
ajlm-5	234	17	adult	adult	NOUN
ajlm-5	234	18	african	african	ADJ
ajlm-5	234	19	volunteers	volunteer	NOUN
ajlm-5	234	20	recruited	recruit	VERB
ajlm-5	234	21	to	to	PART
ajlm-5	234	22	characterize	characterize	VERB
ajlm-5	234	23	laboratory	laboratory	NOUN
ajlm-5	234	24	reference	reference	NOUN
ajlm-5	234	25	intervals	interval	NOUN
ajlm-5	234	26	for	for	ADP
ajlm-5	234	27	future	future	ADJ
ajlm-5	234	28	hiv	hiv	PROPN
ajlm-5	234	29	vaccine	vaccine	NOUN
ajlm-5	234	30	clinical	clinical	ADJ
ajlm-5	234	31	trials	trial	NOUN
ajlm-5	234	32	.	.	PUNCT
ajlm-5	235	1	plos	plos	PROPN
ajlm-5	235	2	one	one	NUM
ajlm-5	235	3	.	.	PUNCT
ajlm-5	236	1	2008;3	2008;3	NUM
ajlm-5	236	2	:	:	PUNCT
ajlm-5	236	3	e2043	e2043	NOUN
ajlm-5	236	4	.	.	PUNCT
ajlm-5	237	1	http://dx.doi.org/10.1371/journal.pone.0002043	http://dx.doi.org/10.1371/journal.pone.0002043	PROPN
ajlm-5	237	2	,	,	PUNCT
ajlm-5	237	3	pmid:18446196	pmid:18446196	NOUN
ajlm-5	237	4	,	,	PUNCT
ajlm-5	237	5	pmcid:2312327	pmcid:2312327	NOUN
ajlm-5	237	6	28	28	NUM
ajlm-5	237	7	.	.	PUNCT
ajlm-5	238	1	national	national	PROPN
ajlm-5	238	2	committee	committee	PROPN
ajlm-5	238	3	for	for	ADP
ajlm-5	238	4	clinical	clinical	ADJ
ajlm-5	238	5	laboratory	laboratory	NOUN
ajlm-5	238	6	standards	standard	NOUN
ajlm-5	238	7	(	(	PUNCT
ajlm-5	238	8	nccls	nccls	NOUN
ajlm-5	238	9	)	)	PUNCT
ajlm-5	238	10	.	.	PUNCT
ajlm-5	239	1	how	how	SCONJ
ajlm-5	239	2	to	to	PART
ajlm-5	239	3	define	define	VERB
ajlm-5	239	4	and	and	CCONJ
ajlm-5	239	5	determine	determine	VERB
ajlm-5	239	6	reference	reference	NOUN
ajlm-5	239	7	intervals	interval	NOUN
ajlm-5	239	8	in	in	ADP
ajlm-5	239	9	the	the	DET
ajlm-5	239	10	clinical	clinical	ADJ
ajlm-5	239	11	laboratory	laboratory	NOUN
ajlm-5	239	12	:	:	PUNCT
ajlm-5	239	13	approved	approve	VERB
ajlm-5	239	14	guideline	guideline	NOUN
ajlm-5	239	15	.	.	PUNCT
ajlm-5	240	1	2nd	2nd	ADJ
ajlm-5	240	2	ed	ed	NOUN
ajlm-5	240	3	.	.	PUNCT
ajlm-5	241	1	wayne	wayne	PROPN
ajlm-5	241	2	,	,	PUNCT
ajlm-5	241	3	pa	pa	PROPN
ajlm-5	241	4	:	:	PUNCT
ajlm-5	241	5	national	national	PROPN
ajlm-5	241	6	committee	committee	PROPN
ajlm-5	241	7	for	for	ADP
ajlm-5	241	8	clinical	clinical	ADJ
ajlm-5	241	9	laboratory	laboratory	NOUN
ajlm-5	241	10	standards	standard	NOUN
ajlm-5	241	11	;	;	PUNCT
ajlm-5	241	12	2000	2000	NUM
ajlm-5	241	13	.	.	PUNCT
ajlm-5	242	1	29	29	NUM
ajlm-5	242	2	.	.	PUNCT
ajlm-5	242	3	rhoads	rhoad	VERB
ajlm-5	242	4	dg	dg	PROPN
ajlm-5	242	5	.	.	PUNCT
ajlm-5	243	1	understading	understading	ADJ
ajlm-5	243	2	reference	reference	NOUN
ajlm-5	243	3	intervals	interval	NOUN
ajlm-5	243	4	.	.	PUNCT
ajlm-5	244	1	in	in	ADP
ajlm-5	244	2	:	:	PUNCT
ajlm-5	244	3	rhoads	rhoad	NOUN
ajlm-5	244	4	dg	dg	PROPN
ajlm-5	244	5	,	,	PUNCT
ajlm-5	244	6	editor	editor	NOUN
ajlm-5	244	7	.	.	PUNCT
ajlm-5	245	1	ep	ep	PROPN
ajlm-5	245	2	evaluator	evaluator	NOUN
ajlm-5	245	3	release	release	NOUN
ajlm-5	245	4	8	8	NUM
ajlm-5	245	5	for	for	ADP
ajlm-5	245	6	evaluating	evaluate	VERB
ajlm-5	245	7	clinical	clinical	ADJ
ajlm-5	245	8	laboratory	laboratory	NOUN
ajlm-5	245	9	methods	method	NOUN
ajlm-5	245	10	.	.	PUNCT
ajlm-5	246	1	kennett	kennett	PROPN
ajlm-5	246	2	square	square	PROPN
ajlm-5	246	3	,	,	PUNCT
ajlm-5	246	4	pennsylavania	pennsylavania	NOUN
ajlm-5	246	5	:	:	PUNCT
ajlm-5	246	6	david	david	PROPN
ajlm-5	246	7	g.	g.	PROPN
ajlm-5	246	8	rhoads	rhoads	PROPN
ajlm-5	246	9	and	and	CCONJ
ajlm-5	246	10	associates	associates	PROPN
ajlm-5	246	11	,	,	PUNCT
ajlm-5	246	12	inc	inc	PROPN
ajlm-5	246	13	.	.	PROPN
ajlm-5	246	14	;	;	PUNCT
ajlm-5	246	15	2007	2007	NUM
ajlm-5	246	16	.	.	PUNCT
ajlm-5	247	1	30	30	NUM
ajlm-5	247	2	.	.	PUNCT
ajlm-5	247	3	cabot	cabot	PROPN
ajlm-5	247	4	rc	rc	PROPN
ajlm-5	247	5	,	,	PUNCT
ajlm-5	247	6	harris	harris	PROPN
ajlm-5	247	7	nl	nl	PROPN
ajlm-5	247	8	,	,	PUNCT
ajlm-5	247	9	shepard	shepard	NOUN
ajlm-5	247	10	j	j	PROPN
ajlm-5	247	11	-	-	PUNCT
ajlm-5	247	12	ao	ao	PROPN
ajlm-5	247	13	,	,	PUNCT
ajlm-5	247	14	et	et	PROPN
ajlm-5	247	15	al	al	PROPN
ajlm-5	247	16	.	.	PROPN
ajlm-5	248	1	normal	normal	ADJ
ajlm-5	248	2	reference	reference	NOUN
ajlm-5	248	3	laboratory	laboratory	NOUN
ajlm-5	248	4	values	value	NOUN
ajlm-5	248	5	.	.	PUNCT
ajlm-5	249	1	n	n	PROPN
ajlm-5	249	2	engl	engl	PROPN
ajlm-5	249	3	j	j	PROPN
ajlm-5	249	4	med	med	PROPN
ajlm-5	249	5	.	.	PUNCT
ajlm-5	250	1	2004;351:1548–1563	2004;351:1548–1563	NUM
ajlm-5	250	2	.	.	PUNCT
ajlm-5	251	1	http://dx.doi.org/10.1056/nejmcpc049016	http://dx.doi.org/10.1056/nejmcpc049016	NUM
ajlm-5	251	2	,	,	PUNCT
ajlm-5	251	3	pmid:15470219	pmid:15470219	ADJ
ajlm-5	251	4	31	31	NUM
ajlm-5	251	5	.	.	PUNCT
ajlm-5	252	1	malone	malone	PROPN
ajlm-5	252	2	jl	jl	PROPN
ajlm-5	252	3	,	,	PUNCT
ajlm-5	252	4	simms	simms	PROPN
ajlm-5	252	5	te	te	PROPN
ajlm-5	252	6	,	,	PUNCT
ajlm-5	252	7	gray	gray	PROPN
ajlm-5	252	8	gc	gc	PROPN
ajlm-5	252	9	,	,	PUNCT
ajlm-5	252	10	wagner	wagner	PROPN
ajlm-5	252	11	kf	kf	PROPN
ajlm-5	252	12	,	,	PUNCT
ajlm-5	252	13	burge	burge	PROPN
ajlm-5	252	14	jr	jr	PROPN
ajlm-5	252	15	,	,	PUNCT
ajlm-5	252	16	burke	burke	PROPN
ajlm-5	252	17	ds	ds	PROPN
ajlm-5	252	18	.	.	PROPN
ajlm-5	252	19	sources	source	NOUN
ajlm-5	252	20	of	of	ADP
ajlm-5	252	21	variability	variability	NOUN
ajlm-5	252	22	in	in	ADP
ajlm-5	252	23	repeated	repeat	VERB
ajlm-5	252	24	t	t	PROPN
ajlm-5	252	25	-	-	PUNCT
ajlm-5	252	26	helper	helper	NOUN
ajlm-5	252	27	lymphocyte	lymphocyte	NOUN
ajlm-5	252	28	counts	count	NOUN
ajlm-5	252	29	from	from	ADP
ajlm-5	252	30	human	human	ADJ
ajlm-5	252	31	immunodeficiency	immunodeficiency	NOUN
ajlm-5	252	32	virus	virus	NOUN
ajlm-5	252	33	type	type	VERB
ajlm-5	252	34	1	1	NUM
ajlm-5	252	35	-	-	PUNCT
ajlm-5	252	36	infected	infect	VERB
ajlm-5	252	37	patients	patient	NOUN
ajlm-5	252	38	:	:	PUNCT
ajlm-5	252	39	total	total	ADJ
ajlm-5	252	40	lymphocyte	lymphocyte	ADJ
ajlm-5	252	41	count	count	NOUN
ajlm-5	252	42	fluctuations	fluctuation	NOUN
ajlm-5	252	43	and	and	CCONJ
ajlm-5	252	44	diurnal	diurnal	ADJ
ajlm-5	252	45	cycle	cycle	NOUN
ajlm-5	252	46	are	be	AUX
ajlm-5	252	47	important	important	ADJ
ajlm-5	252	48	.	.	PUNCT
ajlm-5	253	1	j	j	PROPN
ajlm-5	253	2	acquir	acquir	PROPN
ajlm-5	253	3	immune	immune	VERB
ajlm-5	253	4	defic	defic	ADJ
ajlm-5	253	5	syndr	syndr	NOUN
ajlm-5	253	6	.	.	PUNCT
ajlm-5	254	1	1990;3:144–151	1990;3:144–151	NUM
ajlm-5	254	2	.	.	PUNCT
ajlm-5	254	3	pmcid:1967309	pmcid:1967309	PROPN
ajlm-5	254	4	32	32	NUM
ajlm-5	254	5	.	.	PUNCT
ajlm-5	255	1	bussmann	bussmann	PROPN
ajlm-5	255	2	h	h	PROPN
ajlm-5	255	3	,	,	PUNCT
ajlm-5	255	4	wester	wester	PROPN
ajlm-5	255	5	cw	cw	NOUN
ajlm-5	255	6	,	,	PUNCT
ajlm-5	255	7	masupu	masupu	VERB
ajlm-5	255	8	kv	kv	PROPN
ajlm-5	255	9	,	,	PUNCT
ajlm-5	255	10	et	et	PROPN
ajlm-5	255	11	al	al	PROPN
ajlm-5	255	12	.	.	PROPN
ajlm-5	255	13	low	low	PROPN
ajlm-5	255	14	cd4	cd4	PROPN
ajlm-5	255	15	+	+	PROPN
ajlm-5	255	16	t	t	PROPN
ajlm-5	255	17	-	-	PUNCT
ajlm-5	255	18	lymphocyte	lymphocyte	ADJ
ajlm-5	255	19	values	value	NOUN
ajlm-5	255	20	in	in	ADP
ajlm-5	255	21	human	human	ADJ
ajlm-5	255	22	immunodeficiency	immunodeficiency	NOUN
ajlm-5	255	23	virus	virus	NOUN
ajlm-5	255	24	-	-	PUNCT
ajlm-5	255	25	negative	negative	ADJ
ajlm-5	255	26	adults	adult	NOUN
ajlm-5	255	27	in	in	ADP
ajlm-5	255	28	botswana	botswana	PROPN
ajlm-5	255	29	.	.	PUNCT
ajlm-5	256	1	clin	clin	PROPN
ajlm-5	256	2	diagn	diagn	PROPN
ajlm-5	256	3	lab	lab	NOUN
ajlm-5	256	4	immunol	immunol	NOUN
ajlm-5	256	5	.	.	PUNCT
ajlm-5	257	1	2004;11:930–935	2004;11:930–935	X
ajlm-5	257	2	.	.	PUNCT
ajlm-5	258	1	pmid:15358655	pmid:15358655	ADJ
ajlm-5	258	2	,	,	PUNCT
ajlm-5	258	3	pmcid:515279	pmcid:515279	VERB